{
    "studies": [
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT02458027",
                    "orgStudyIdInfo": {
                        "id": "B2014:115-3"
                    },
                    "organization": {
                        "fullName": "University of Manitoba",
                        "class": "OTHER"
                    },
                    "briefTitle": "Acute Food INtake Effect of Hemp Protein (A FINEH Protein) Trial - Part 2",
                    "officialTitle": "Acute Food INtake Effect of Hemp Protein (A FINEH Protein) Trial - Part 2 - Are Acute Effects of Hemp Protein on Blood Glucose and Appetite Insulin-dependent?"
                },
                "statusModule": {
                    "statusVerifiedDate": "2021-04",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2015-07"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2016-07-13",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2016-07-13",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2015-05-27",
                    "studyFirstSubmitQcDate": "2015-05-27",
                    "studyFirstPostDateStruct": {
                        "date": "2015-05-29",
                        "type": "ESTIMATED"
                    },
                    "lastUpdateSubmitDate": "2023-03-20",
                    "lastUpdatePostDateStruct": {
                        "date": "2023-03-23",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "University of Manitoba",
                        "class": "OTHER"
                    },
                    "collaborators": [
                        {
                            "name": "Manitoba Harvest",
                            "class": "OTHER"
                        }
                    ]
                },
                "oversightModule": {
                    "oversightHasDmc": false
                },
                "descriptionModule": {
                    "briefSummary": "The objectives of this trial are to investigate whether the effects of hemp protein on glycemic and appetite control are insulin-dependent by measuring 1) blood glucose, insulin and appetite for one hour following consumption, 2) blood glucose, insulin and appetite following a fixed energy meal to determine the \"second meal effect\" of hemp protein versus soybean protein and a non-protein control.",
                    "detailedDescription": "The objectives of this trial are to investigate whether the effects of hemp protein on glycemic and appetite control are insulin-dependent by measuring 1) blood glucose, insulin and appetite for one hour following consumption, 2) blood glucose, insulin and appetite following a fixed energy meal to determine the \"second meal effect\" of hemp protein versus soybean protein and a non-protein control. The objectives of this trial are to investigate whether the effects of hemp protein on glycemic and appetite control are insulin-dependent by measuring 1) blood glucose, insulin and appetite for one hour following consumption, 2) blood glucose, insulin and appetite following a fixed energy meal to determine the \"second meal effect\" of hemp protein versus soybean protein and a non-protein control."
                },
                "conditionsModule": {
                    "conditions": [
                        "Diabetes Prevention",
                        "Obesity Prevention"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "NA"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "CROSSOVER",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "SINGLE",
                            "whoMasked": [
                                "PARTICIPANT"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 15,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "20g Hemp Protein Shake",
                            "type": "EXPERIMENTAL",
                            "description": "Hemp protein shake, 20 grams, given once at beginning of acute trial.",
                            "interventionNames": [
                                "Dietary Supplement: Hemp Shake"
                            ]
                        },
                        {
                            "label": "40 g Hemp Protein",
                            "type": "EXPERIMENTAL",
                            "description": "Hemp protein shake, 40 grams, given once, at beginning of acute trial.",
                            "interventionNames": [
                                "Dietary Supplement: Hemp"
                            ]
                        },
                        {
                            "label": "20 g Soybean Protein Shake",
                            "type": "ACTIVE_COMPARATOR",
                            "description": "Soybean protein shake, 20 grams, given once, at beginning of acute trial.",
                            "interventionNames": [
                                "Dietary Supplement: Soybean Shake"
                            ]
                        },
                        {
                            "label": "40 g Soybean Protein",
                            "type": "EXPERIMENTAL",
                            "description": "Soybean protein shake, 40 grams, given once, at beginning of acute trial.",
                            "interventionNames": [
                                "Dietary Supplement: Soybean"
                            ]
                        },
                        {
                            "label": "Control Shake",
                            "type": "PLACEBO_COMPARATOR",
                            "description": "Non-protein control shake, given once, at beginning of acute trial.",
                            "interventionNames": [
                                "Dietary Supplement: Control"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DIETARY_SUPPLEMENT",
                            "name": "Hemp Shake",
                            "description": "Hemp Protein",
                            "armGroupLabels": [
                                "20g Hemp Protein Shake"
                            ]
                        },
                        {
                            "type": "DIETARY_SUPPLEMENT",
                            "name": "Hemp",
                            "description": "Hemp Protein Shake",
                            "armGroupLabels": [
                                "40 g Hemp Protein"
                            ]
                        },
                        {
                            "type": "DIETARY_SUPPLEMENT",
                            "name": "Soybean Shake",
                            "description": "Soybean Protein",
                            "armGroupLabels": [
                                "20 g Soybean Protein Shake"
                            ]
                        },
                        {
                            "type": "DIETARY_SUPPLEMENT",
                            "name": "Soybean",
                            "description": "Soybean Protein Shake",
                            "armGroupLabels": [
                                "40 g Soybean Protein"
                            ]
                        },
                        {
                            "type": "DIETARY_SUPPLEMENT",
                            "name": "Control",
                            "description": "Non-Protein Shake",
                            "armGroupLabels": [
                                "Control Shake"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Plasma Glucose and Insulin Concentrations",
                            "description": "Measured in blood using intravenous catheter at 12 time points, used to calculate area under curve (AUC). Glucose will be determined by automated methods using Abbot Spectrum CCX Analyzer, and Insulin will be measured by commercially available RIA kits. (Composite measure)",
                            "timeFrame": "0-200 minutes"
                        },
                        {
                            "measure": "Appetite",
                            "description": "Measured by VAS Questionnaire.",
                            "timeFrame": "0-200 minutes"
                        },
                        {
                            "measure": "Food Intake",
                            "description": "Measured by fixed energy meal.",
                            "timeFrame": "0-200 minutes"
                        },
                        {
                            "measure": "Blood Pressure",
                            "description": "Measured by automated bood pressure cuff.",
                            "timeFrame": "0-200 minutes"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Palatability of Treatments and Meal",
                            "description": "Measured by VAS Questionnaire.",
                            "timeFrame": "5-80 minutes"
                        },
                        {
                            "measure": "Physical Comfort",
                            "description": "Measured by VAS Questionnaire.",
                            "timeFrame": "0-200 minutes"
                        },
                        {
                            "measure": "Energy/Fatigue",
                            "description": "Measured by VAS Questionnaire.",
                            "timeFrame": "0-200 minutes"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Normoglycemic (\\<5.6 mmol/L)\n* Body mass index (BMI) of 18.5-29.9 kg/m2.\n\nExclusion Criteria:\n\n* Restrained eaters\n* Regularly skip breakfast\n* Smokers\n* Those on medications that may influence study outcomes or have experienced any gastrointestinal related health conditions/surgeries over the past year.",
                    "healthyVolunteers": true,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "maximumAge": "45 Years",
                    "stdAges": [
                        "ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Peter Jones, Ph.D.",
                            "affiliation": "University of Manitoba, Richardson Centre for Functional Foods and Nutraceuticals",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Richardson Centre for Functional Foods and Nutraceuticals",
                            "city": "Winnipeg",
                            "state": "Manitoba",
                            "zip": "R3T 2N2",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 49.8844,
                                "lon": -97.14704
                            }
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2025-05-07"
                },
                "conditionBrowseModule": {
                    "browseLeaves": [
                        {
                            "id": "M12701",
                            "name": "Obesity",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7115",
                            "name": "Diabetes Mellitus",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T170",
                            "name": "Acute Graft Versus Host Disease",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC18",
                            "name": "Nutritional and Metabolic Diseases"
                        },
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC19",
                            "name": "Gland and Hormone Related Diseases"
                        },
                        {
                            "abbrev": "Rare",
                            "name": "Rare Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "browseLeaves": [
                        {
                            "id": "M10365",
                            "name": "Insulin",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M173166",
                            "name": "Insulin, Globin Zinc",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T294",
                            "name": "Soy Bean",
                            "asFound": "Hormone Receptor",
                            "relevance": "HIGH"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "Hypo",
                            "name": "Hypoglycemic Agents"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "HB",
                            "name": "Herbal and Botanical"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT01880827",
                    "orgStudyIdInfo": {
                        "id": "2012-002689-10"
                    },
                    "organization": {
                        "fullName": "Turku University Hospital",
                        "class": "OTHER_GOV"
                    },
                    "briefTitle": "Splanchnic Blood Redistribution After Incretin Hormone Infusion and Obesity Surgery",
                    "officialTitle": "The Effects of Glucose-dependent Insulinotrophic Peptide (GIP) and Glucagon-like Peptide 1 (GLP-1) on Splanchnic Redistribution of Blood Flow at Postprandial State and After Roux-en-Y Gastric Bypass and Sleeve",
                    "acronym": "GIP-PET"
                },
                "statusModule": {
                    "statusVerifiedDate": "2021-10",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2013-01"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2015-11",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2016-01",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2013-02-25",
                    "studyFirstSubmitQcDate": "2013-06-18",
                    "studyFirstPostDateStruct": {
                        "date": "2013-06-19",
                        "type": "ESTIMATED"
                    },
                    "lastUpdateSubmitDate": "2021-10-12",
                    "lastUpdatePostDateStruct": {
                        "date": "2021-10-20",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "PRINCIPAL_INVESTIGATOR",
                        "investigatorFullName": "Pirjo Nuutila",
                        "investigatorTitle": "Professor",
                        "investigatorAffiliation": "Turku University Hospital"
                    },
                    "leadSponsor": {
                        "name": "Turku University Hospital",
                        "class": "OTHER_GOV"
                    },
                    "collaborators": [
                        {
                            "name": "Lund University",
                            "class": "OTHER"
                        }
                    ]
                },
                "oversightModule": {
                    "oversightHasDmc": false
                },
                "descriptionModule": {
                    "briefSummary": "Obesity is a worldwide problem and leads to multiple metabolic and endocrinological problems.\n\nBariatric surgeries are a growing field as a treatment choice for morbid obesity (BMI \\> 35 kg/m2). Clinical and research evidence shows that shortly after RYGB, T2DM resolves with improving glucose tolerance. Foregut hypothesis behind bariatric surgeries postulate, that bypassed portions of intestine contain a substance, that acts as an anti-incretin, ie. to counteract metabolically favourable incretins. In view of the recent studies, it may be that GIP is really the anti-incretin behind this hypothesis.\n\nThe current study is conducted to investigate the vasoactive roles of the GIP. The investigators aim to show that GIP is the major contributor to the blood flow and tissue blood volume observed in postprandial state.",
                    "detailedDescription": "Obesity is a worldwide problem and leads to multiple metabolic and endocrinological problems, including type 2 diabetes mellitus (T2DM). In T2DM, body is unable to response to circulating insulin levels, which ultimately destroys pancreatic β-cells, leading to chronic hyperglycaemia with ensuing consequences\n\nIntestine is able to produce endocrinologically active substances, which affect to body's intermediary metabolism. One of these substances in glucose-dependent insulinotrophic polypeptide (GIP, part of the incretin family), which potentiates the release of insulin postprandially. However, recent evidence suggests, that GIP may have more harmful than beneficial role in the pathogenesis: it has been shown that GIP participates in the development of insulin resistance, the key defect in the process of metabolic dysfunction. GIP may also regulate postprandial redistribution of splanchnic blood flow which might act in the body's nutrition handling \\[8\\].\n\nBariatric surgeries are a growing field as a treatment choice for morbid obesity (BMI \\> 35 kg/m2). Most established of these procedures is a Roux-en-Y gastric bypass (RYGB), where duodenum and proximal jejunum is bypassed. Clinical and research evidence shows that shortly (before any significant weight loss) after RYGB, T2DM resolves with improving glucose tolerance. Foregut hypothesis behind bariatric surgeries postulate, that bypassed portions of intestine contain a substance, that acts as an anti-incretin¬, ie. to counteract metabolically favourable incretins. In view of the recent studies, it may be that GIP is really the anti-incretin behind this hypothesis.\n\nPositron emission tomography (PET) is a modern imaging technique, which can be used to study perfusion and metabolism of different organs non-invasively. When radiowater measurement is combined with \\[15O\\]CO, both tissues specific perfusion and blood volume can be measured, respectively. When coupled with magnetic imaging (ie. PET-MRI), the volumes-of-interests can be accurately drawn to the desired organs.\n\nThe current study is conducted to investigate the vasoactive roles of the GIP. We aim to show that GIP is the major contributor to the blood flow and tissue blood volume observed in postprandial state. Moreover, we hypothesize that the elimination of GIP-effect has a central role in the improved intermediary metabolism observed after bariatric surgery procedures, and that part this change is mediated by changes in splanchnic circulation. Furthermore, we investigate the effect of GLP-1 (glucagon-like peptide 1, another member of incretin family) on splanchnic circulation.\n\nIn the present study intestinal, hepatic and pancreatic blood flow and volume are measured using \\[15O\\]H2O- and \\[15O\\]CO radiotracers and PET-MRI imaging in healthy normal weight volunteers (n = 20, BMI ≤ 27 kg/m2) and in morbidly obese T2DM patients (n = 30, BMI ≤ 35 kg/m2) before and after the bariatric surgery operation. The PET imaging will be performed at fasting state but also separately either during 1) mixed meal solution (MMS), 2) GIP-, or 3) GLP-1-infusion. Also abdominal subcutaneous and visceral adipose tissue, intestinal and hepatic tissue samples will be collected."
                },
                "conditionsModule": {
                    "conditions": [
                        "Type 2 Diabetes",
                        "Obesity"
                    ],
                    "keywords": [
                        "GIP",
                        "GLP-1",
                        "type 2 diabetes",
                        "obesity",
                        "splanchnic blood flow",
                        "incretin hormones"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE1"
                    ],
                    "designInfo": {
                        "allocation": "NON_RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "BASIC_SCIENCE",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 36,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Royx-en-Y surgery",
                            "type": "ACTIVE_COMPARATOR",
                            "description": "Mixed meal test (MMS) with flow studies before and 2 months after the operation",
                            "interventionNames": [
                                "Procedure: Roux-en-Y",
                                "Drug: GIP-infusion",
                                "Drug: MMS"
                            ]
                        },
                        {
                            "label": "Control",
                            "type": "ACTIVE_COMPARATOR",
                            "description": "Healthy volunteer group, GIP, GLP-1 and MMS studies",
                            "interventionNames": [
                                "Drug: GIP-infusion",
                                "Drug: GLP-1",
                                "Drug: MMS"
                            ]
                        },
                        {
                            "label": "Sleeve gastrectomy",
                            "type": "EXPERIMENTAL",
                            "description": "Mixed meal test (MMS) with flow studies before and 2 months after the operation",
                            "interventionNames": [
                                "Drug: GIP-infusion",
                                "Drug: MMS",
                                "Procedure: Sleeve gastrectomy"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "PROCEDURE",
                            "name": "Roux-en-Y",
                            "description": "Subjects in the intervention group will be divided into two consecutive surgical groups, RYGB or SG. After the surgery, subjects are controlled in hospital ward for approximately three days.",
                            "armGroupLabels": [
                                "Royx-en-Y surgery"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "GIP-infusion",
                            "description": "Blood flow and volume during infusion",
                            "armGroupLabels": [
                                "Control",
                                "Royx-en-Y surgery",
                                "Sleeve gastrectomy"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "GLP-1",
                            "description": "Blood flow and volume during infusion",
                            "armGroupLabels": [
                                "Control"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "MMS",
                            "description": "Blood flow and volume after meal solution",
                            "armGroupLabels": [
                                "Control",
                                "Royx-en-Y surgery",
                                "Sleeve gastrectomy"
                            ]
                        },
                        {
                            "type": "PROCEDURE",
                            "name": "Sleeve gastrectomy",
                            "description": "as in RYGS group",
                            "armGroupLabels": [
                                "Sleeve gastrectomy"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Splanchnic blood flow",
                            "description": "Flow is measured using radiowater H2O and PET",
                            "timeFrame": "24 months"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "GIP and GLP-1 blood concetrations",
                            "description": "Blood concentrations are measured from samples",
                            "timeFrame": "24 months"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n1. BMI \\> 35 kg/m2\n2. Type 2 diabetes mellitus (fasting glucose more than 7 mmol/l)\n3. Age: 18-60 years\n4. Previous, carefully planned, conservative treatments for obesity have failed\n\nExclusion Criteria:\n\n1. BMI over 60 kg/m2\n2. Weight more than 170 kg\n3. Waist circumference \\> 150 cm\n4. Insulin treatment requiring type 2 diabetes mellitus\n5. Mental disorder or poor compliance\n6. Eating disorder or excessive use of alcohol\n7. Active ulcus-disease\n8. Pregnancy\n9. Past dose of radiation\n10. Presence of any ferromagnetic objects that would make MR imaging contraindicated\n11. Any other condition that in the opinion of the investigator could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results\n\nInclusion criteria for the control group\n\n1. BMI 18-27 kg/m2\n2. Age 18-60 years\n3. Fasting plasma glucose less than 6.1 mmol/l\n4. Normal glucose tolerance test (OGTT)\n\nExclusion criteria for the control group\n\n1. Blood pressure \\> 140/90 mmHg\n2. Any chronic disease\n3. Mental disorder or poor compliance\n4. Any chronic medical defect or injury which hinder/interfere everyday life\n5. Eating disorder or excessive use of alcohol\n6. Pregnancy\n7. Past dose of radiation\n8. Any other condition that in the opinion of the investigator could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results\n9. Presence of any ferromagnetic objects that would make MR imaging contraindicated\n10. Smoking",
                    "healthyVolunteers": true,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "maximumAge": "60 Years",
                    "stdAges": [
                        "ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Pirjo Nuutila, Prof",
                            "affiliation": "PET centre, Turku",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Turku univercity hospital, PET center",
                            "city": "Turku",
                            "zip": "20540",
                            "country": "Finland",
                            "geoPoint": {
                                "lat": 60.45148,
                                "lon": 22.26869
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "35363252",
                            "type": "DERIVED",
                            "citation": "Saari T, Koffert J, Honka H, Kauhanen S, U-Din M, Wierup N, Lindqvist A, Groop L, Virtanen KA, Nuutila P. Obesity-associated Blunted Subcutaneous Adipose Tissue Blood Flow After Meal Improves After Bariatric Surgery. J Clin Endocrinol Metab. 2022 Jun 16;107(7):1930-1938. doi: 10.1210/clinem/dgac191."
                        },
                        {
                            "pmid": "28096259",
                            "type": "DERIVED",
                            "citation": "Honka H, Koffert J, Kauhanen S, Teuho J, Hurme S, Mari A, Lindqvist A, Wierup N, Groop L, Nuutila P. Bariatric Surgery Enhances Splanchnic Vascular Responses in Patients With Type 2 Diabetes. Diabetes. 2017 Apr;66(4):880-885. doi: 10.2337/db16-0762. Epub 2017 Jan 17."
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO"
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2025-05-07"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D009765",
                            "term": "Obesity"
                        },
                        {
                            "id": "D003924",
                            "term": "Diabetes Mellitus, Type 2"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D050177",
                            "term": "Overweight"
                        },
                        {
                            "id": "D044343",
                            "term": "Overnutrition"
                        },
                        {
                            "id": "D009748",
                            "term": "Nutrition Disorders"
                        },
                        {
                            "id": "D001835",
                            "term": "Body Weight"
                        },
                        {
                            "id": "D003920",
                            "term": "Diabetes Mellitus"
                        },
                        {
                            "id": "D044882",
                            "term": "Glucose Metabolism Disorders"
                        },
                        {
                            "id": "D008659",
                            "term": "Metabolic Diseases"
                        },
                        {
                            "id": "D004700",
                            "term": "Endocrine System Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M12701",
                            "name": "Obesity",
                            "asFound": "Obesity",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M7115",
                            "name": "Diabetes Mellitus",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7119",
                            "name": "Diabetes Mellitus, Type 2",
                            "asFound": "Type 2 Diabetes",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M26186",
                            "name": "Overweight",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M25307",
                            "name": "Overnutrition",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M12684",
                            "name": "Nutrition Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5114",
                            "name": "Body Weight",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M11639",
                            "name": "Metabolic Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M25403",
                            "name": "Glucose Metabolism Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7862",
                            "name": "Endocrine System Diseases",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC18",
                            "name": "Nutritional and Metabolic Diseases"
                        },
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC19",
                            "name": "Gland and Hormone Related Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "browseLeaves": [
                        {
                            "id": "M21860",
                            "name": "Pharmaceutical Solutions",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9789",
                            "name": "Hormones",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9043",
                            "name": "Glucagon",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8866",
                            "name": "Gastric Inhibitory Polypeptide",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M26997",
                            "name": "Glucagon-Like Peptide 1",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M27905",
                            "name": "Incretins",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "PhSol",
                            "name": "Pharmaceutical Solutions"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "Gast",
                            "name": "Gastrointestinal Agents"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT03813927",
                    "orgStudyIdInfo": {
                        "id": "REG-48-2015"
                    },
                    "organization": {
                        "fullName": "Zealand University Hospital",
                        "class": "OTHER"
                    },
                    "briefTitle": "Vitamin D Treatment of Diabetic Patients With Foot Ulcers",
                    "officialTitle": "Systemic Vitamin D Treatment of Diabetic Patients With Foot Ulcers: a Clinical Controlled Investigation of the Effect on Healing"
                },
                "statusModule": {
                    "statusVerifiedDate": "2019-01",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2016-04-01",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2017-12-31",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2018-07-03",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2019-01-09",
                    "studyFirstSubmitQcDate": "2019-01-21",
                    "studyFirstPostDateStruct": {
                        "date": "2019-01-23",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2019-01-21",
                    "lastUpdatePostDateStruct": {
                        "date": "2019-01-23",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Zealand University Hospital",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": true,
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "The purpose of this study, is to determine whether daily supplements of vitamin D improves wound healing in diabetic patients with chronic foot ulcers.",
                    "detailedDescription": "Project title\n\n\"Treatment with oral vitamin D in diabetic patients with chronic foot ulcers on the lower limb; a clinical controlled study of the effect on wound healing\".\n\nAbstract\n\nAims and objectives\n\nThe purpose of this study is to determine whether daily supplements of vitamin D improves wound healing in diabetic patients with chronic foot ulcers.\n\nBackground\n\nLifetime risk of developing chronic lower extremity ulcers summarized in type I and type II diabetics is about 25% and the prevalence is approximately 7%. There is often a long term resource consuming disorder where 47% of the diabetic leg and foot ulcers effectively can be treated within 12 months.\n\nIn Denmark in 2011 there were more than 300,000 diagnosed type I and type II diabetics, and estimated about 200,000 undiagnosed type II diabetics. Therefore, approximately 35,000 diabetics each year are treated for chronic leg or foot ulcers in the Danish health sector. The treatment of these chronic wounds are associated with significant costs, as well as emotional, physical and financial.\n\nVitamin D deficiency is a widespread problem, and it is estimated that worldwide there is 1 billion people suffering from vitamin D deficiency. A Danish study from 2012 showed vitamin D deficiency in 52% of adults aged 30 60 years. Vitamin D deficiency is more common in diabetics with chronic foot or leg ulcers, when compared with non diabetics and diabetics without ulcers.\n\nMethods and materials\n\n48 diabetic patients with chronic foot ulcers will be included in the study. The patients will be recruited from the outpatient clinic, department of orthopaedic surgery at Zealand University Hospital, Denmark. The patients will randomly be divided into two groups, respectively treated with vitamin D or placebo.\n\nExpected outcome and perspectives\n\nThe investigators expect that this study will show that supplementation with oral vitamin D, will result in a significant effect on wound treatment and healing for a large group of diabetic patients with chronic foot ulcers. This will contribute to a changed procedure in this specific group of patients, leading to measurement of vitamin D status and supplementation with vitamin D if needed."
                },
                "conditionsModule": {
                    "conditions": [
                        "Diabetic Foot Ulcers",
                        "Vitamin D Deficiency"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "NA"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "BASIC_SCIENCE",
                        "maskingInfo": {
                            "masking": "TRIPLE",
                            "whoMasked": [
                                "PARTICIPANT",
                                "CARE_PROVIDER",
                                "INVESTIGATOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 48,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Vitamin D",
                            "type": "EXPERIMENTAL",
                            "description": "supplementation with tablet 170 μg Vitamin D each day.",
                            "interventionNames": [
                                "Dietary Supplement: Vitamin D"
                            ]
                        },
                        {
                            "label": "Placebo",
                            "type": "PLACEBO_COMPARATOR",
                            "description": "Placebo, tablet with 20 μg Vitamin D each day.",
                            "interventionNames": [
                                "Dietary Supplement: Placebo"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DIETARY_SUPPLEMENT",
                            "name": "Vitamin D",
                            "description": "Supplementation with tablet 170 μg Vitamin each day.",
                            "armGroupLabels": [
                                "Vitamin D"
                            ]
                        },
                        {
                            "type": "DIETARY_SUPPLEMENT",
                            "name": "Placebo",
                            "description": "Placebo with tablet 20 μg Vitamin each day.",
                            "armGroupLabels": [
                                "Placebo"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Wound healing",
                            "description": "Wound healing, measured in square cm",
                            "timeFrame": "48 weeks or wound healing."
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Vitamin D blod level status",
                            "description": "Vitamin D blod level status in intervention Group after supplementation.",
                            "timeFrame": "48 weeks or wound healing."
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age \\> 18 years\n2. Diagnosed diabetes.\n3. Foot ulcers more than 6 weeks.\n4. Informed consent\n\nExclusion Criteria:\n\n1. Pregnancy\n2. Granulomatous diseases such as tuberculosis, sarcoidosis and silicosis\n3. Hypercalcemia\n4. Supplementation of vitamin D \\> 20 μg a day\n5. Renal disease\n6. Liver disease\n7. Osteomyelitis\n8. Skin cancer.\n9. Epilepsy.\n10. High blod pressure (\\> 150/100 mmHg).\n11. Indication for surgical revision.",
                    "healthyVolunteers": true,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Peter Max Halschou-Jensen, MD",
                            "affiliation": "Zeeland University Hospital, Denmark",
                            "role": "STUDY_DIRECTOR"
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "UNDECIDED"
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2025-05-07"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D017719",
                            "term": "Diabetic Foot"
                        },
                        {
                            "id": "D016523",
                            "term": "Foot Ulcer"
                        },
                        {
                            "id": "D014808",
                            "term": "Vitamin D Deficiency"
                        },
                        {
                            "id": "D014456",
                            "term": "Ulcer"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D010335",
                            "term": "Pathologic Processes"
                        },
                        {
                            "id": "D003925",
                            "term": "Diabetic Angiopathies"
                        },
                        {
                            "id": "D014652",
                            "term": "Vascular Diseases"
                        },
                        {
                            "id": "D002318",
                            "term": "Cardiovascular Diseases"
                        },
                        {
                            "id": "D007871",
                            "term": "Leg Ulcer"
                        },
                        {
                            "id": "D012883",
                            "term": "Skin Ulcer"
                        },
                        {
                            "id": "D012871",
                            "term": "Skin Diseases"
                        },
                        {
                            "id": "D048909",
                            "term": "Diabetes Complications"
                        },
                        {
                            "id": "D003920",
                            "term": "Diabetes Mellitus"
                        },
                        {
                            "id": "D004700",
                            "term": "Endocrine System Diseases"
                        },
                        {
                            "id": "D003929",
                            "term": "Diabetic Neuropathies"
                        },
                        {
                            "id": "D005534",
                            "term": "Foot Diseases"
                        },
                        {
                            "id": "D001361",
                            "term": "Avitaminosis"
                        },
                        {
                            "id": "D003677",
                            "term": "Deficiency Diseases"
                        },
                        {
                            "id": "D044342",
                            "term": "Malnutrition"
                        },
                        {
                            "id": "D009748",
                            "term": "Nutrition Disorders"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M17206",
                            "name": "Ulcer",
                            "asFound": "Ulcer",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M19933",
                            "name": "Diabetic Foot",
                            "asFound": "Diabetic Foot",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M18919",
                            "name": "Foot Ulcer",
                            "asFound": "Foot Ulcer",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M17551",
                            "name": "Vitamin D Deficiency",
                            "asFound": "Vitamin D Deficiency",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M7120",
                            "name": "Diabetic Angiopathies",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17400",
                            "name": "Vascular Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10883",
                            "name": "Leg Ulcer",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M15686",
                            "name": "Skin Ulcer",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M15674",
                            "name": "Skin Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7115",
                            "name": "Diabetes Mellitus",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M26004",
                            "name": "Diabetes Complications",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7862",
                            "name": "Endocrine System Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7124",
                            "name": "Diabetic Neuropathies",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8658",
                            "name": "Foot Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4660",
                            "name": "Avitaminosis",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M6879",
                            "name": "Deficiency Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M25306",
                            "name": "Malnutrition",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M12684",
                            "name": "Nutrition Disorders",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC14",
                            "name": "Heart and Blood Diseases"
                        },
                        {
                            "abbrev": "BC17",
                            "name": "Skin and Connective Tissue Diseases"
                        },
                        {
                            "abbrev": "BC19",
                            "name": "Gland and Hormone Related Diseases"
                        },
                        {
                            "abbrev": "BC18",
                            "name": "Nutritional and Metabolic Diseases"
                        },
                        {
                            "abbrev": "BC10",
                            "name": "Nervous System Diseases"
                        },
                        {
                            "abbrev": "BC05",
                            "name": "Musculoskeletal Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D014807",
                            "term": "Vitamin D"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D014815",
                            "term": "Vitamins"
                        },
                        {
                            "id": "D018977",
                            "term": "Micronutrients"
                        },
                        {
                            "id": "D045505",
                            "term": "Physiological Effects of Drugs"
                        },
                        {
                            "id": "D050071",
                            "term": "Bone Density Conservation Agents"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M17550",
                            "name": "Vitamin D",
                            "asFound": "Saline",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M6003",
                            "name": "Cholecalciferol",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17558",
                            "name": "Vitamins",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M21009",
                            "name": "Micronutrients",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M16885",
                            "name": "Trace Elements",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M26165",
                            "name": "Bone Density Conservation Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T479",
                            "name": "Vitamin D3",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T442",
                            "name": "Cholecalciferol",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T440",
                            "name": "Calciferol",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BDCA",
                            "name": "Bone Density Conservation Agents"
                        },
                        {
                            "abbrev": "Micro",
                            "name": "Micronutrients"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "Vi",
                            "name": "Vitamins"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT00663260",
                    "orgStudyIdInfo": {
                        "id": "MB102-029"
                    },
                    "organization": {
                        "fullName": "AstraZeneca",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment",
                    "officialTitle": "A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group, Randomized, Phase 2/3 Trial to Evaluate the Glycemic Efficacy, Renal Safety, Pharmacokinetics, and Pharmacodynamics of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment Who Have Inadequate Glycemic Control"
                },
                "statusModule": {
                    "statusVerifiedDate": "2016-12",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2008-06"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2009-12",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2011-06",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2008-04-18",
                    "studyFirstSubmitQcDate": "2008-04-21",
                    "studyFirstPostDateStruct": {
                        "date": "2008-04-22",
                        "type": "ESTIMATED"
                    },
                    "resultsFirstSubmitDate": "2016-09-28",
                    "resultsFirstSubmitQcDate": "2016-12-20",
                    "resultsFirstPostDateStruct": {
                        "date": "2017-02-10",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2016-12-20",
                    "lastUpdatePostDateStruct": {
                        "date": "2017-02-10",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "AstraZeneca",
                        "class": "INDUSTRY"
                    },
                    "collaborators": [
                        {
                            "name": "Bristol-Myers Squibb",
                            "class": "INDUSTRY"
                        }
                    ]
                },
                "oversightModule": {
                    "oversightHasDmc": true
                },
                "descriptionModule": {
                    "briefSummary": "The purpose of this study is to determine whether dapagliflozin is effective in the treatment of type 2 diabetes in subjects with poor blood sugar control and moderate renal impairment",
                    "detailedDescription": "All eligible subjects will receive a single-blind placebo medication during a 1-week lead-in period prior to randomization. All arms may include the addition of open label medication described (as needed for rescue based on protocol specific criteria). Rescue medication is defined as the addition of an approved, appropriate antihyperglycemic agent, except metformin, used according to conventional standards of care, to treat hyperglycemia, which may therefore allow the subject to remain in the trial"
                },
                "conditionsModule": {
                    "conditions": [
                        "Diabetes Mellitus, Type 2"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE2",
                        "PHASE3"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "DOUBLE",
                            "whoMasked": [
                                "PARTICIPANT",
                                "INVESTIGATOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 631,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Dapagliflozin (10 mg)",
                            "type": "ACTIVE_COMPARATOR",
                            "interventionNames": [
                                "Drug: Dapagliflozin"
                            ]
                        },
                        {
                            "label": "Dapagliflozin (5 mg)",
                            "type": "ACTIVE_COMPARATOR",
                            "interventionNames": [
                                "Drug: Dapagliflozin"
                            ]
                        },
                        {
                            "label": "Placebo",
                            "type": "PLACEBO_COMPARATOR",
                            "interventionNames": [
                                "Drug: Placebo"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "Dapagliflozin",
                            "description": "Tablets, Oral, 10 mg, Once Daily, 104 weeks",
                            "armGroupLabels": [
                                "Dapagliflozin (10 mg)"
                            ],
                            "otherNames": [
                                "BMS-512148"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Dapagliflozin",
                            "description": "Tablets, Oral, 5 mg, Once Daily, 104 weeks",
                            "armGroupLabels": [
                                "Dapagliflozin (5 mg)"
                            ],
                            "otherNames": [
                                "BMS-512148"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Placebo",
                            "description": "Tablets, Oral, 0 mg, Once Daily, 104 weeks",
                            "armGroupLabels": [
                                "Placebo"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Adjusted Mean Change From Baseline in Hemoglobin A1C (HbA1c) at Week 24 (Last Observation Carried Forward [LOCF]",
                            "description": "HbA1c was measured as percent of hemoglobin by a central laboratory. Data after rescue medication was excluded from this analysis. Baseline was defined as the last assessment prior to the start date and time of the first dose of the double-blind study medication. In cases where time of the first dose or time of the assessment was not available, baseline was defined as the last assessment on or prior to the date of the first dose of the double-blind study medication. HbA1c measurements were obtained during the qualification and lead-in periods and on Day 1 and Weeks 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, and 24 in the double-blind period.",
                            "timeFrame": "From Baseline to Week 24"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Adjusted Mean Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24 (Last Observation Carried Forward [LOCF])",
                            "description": "Secondary endpoints were tested using sequential testing procedure and are presented in hierarchical order. Fasting plasma glucose was measured as milligrams per deciliter(mg/dL) by a central laboratory. Baseline was defined as the last assessment prior to the start date and time of the first dose of the double-blind study medication. In cases where time of the first dose or time of the assessment was not available, baseline was defined as the last assessment on or prior to the date of the first dose of the double-blind study medication. FPG measurements were obtained during the qualification and lead-in periods and on Day 1 and Weeks 1, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, and 24 in the double-blind period",
                            "timeFrame": "From Baseline to Week 24"
                        },
                        {
                            "measure": "Adjusted Mean Change From Baseline in Total Body Weight (kg) at Week 24 (Last Observation Carried Forward [LOCF])",
                            "description": "Secondary endpoints were tested using sequential testing procedure and are presented in hierarchical order. Adjusted mean change from baseline in total body weight at Week 24 (or the last postbaseline measurement prior to Week 24 if no Week 24 assessment was available was determined. Data after rescue medication was excluded from this analysis. Baseline was defined as the last assessment prior to the start date and time of the first dose of the double-blind study medication. In cases where time of the first dose or time of the assessment was not available, baseline was defined as the last assessment on or prior to the date of the first dose of the double-blind study medication. Body weight measurements were obtained during the qualification and lead-in periods and on Day 1 and Weeks 1, 2, 4, 8, 12, 16, 20, and 24 of the double-blind period.",
                            "timeFrame": "From Baseline to Week 24"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Males and females, ≥18 years old, with type 2 diabetes and with inadequate glycemic control\n* Clinical diagnosis of moderate renal impairment\n\nExclusion Criteria:\n\n* AST and /or ALT \\> 3.0 times the upper limit of normal\n* Serum total bilirubin \\> 1.5 times ULN\n* Symptoms of severely uncontrolled diabetes\n* Currently unstable or serious cardiovascular, hepatic, hematological, oncological, endocrine, psychiatric, or rheumatic diseases",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Bristol-Myers Squibb",
                            "affiliation": "Bristol-Myers Squibb",
                            "role": "STUDY_DIRECTOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Vista Medical Research, Inc.",
                            "city": "Mesa",
                            "state": "Arizona",
                            "zip": "85206",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.42227,
                                "lon": -111.82264
                            }
                        },
                        {
                            "facility": "Valley Research",
                            "city": "Fresno",
                            "state": "California",
                            "zip": "93720",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.74773,
                                "lon": -119.77237
                            }
                        },
                        {
                            "facility": "Marin Endocrine Care & Research, Inc.",
                            "city": "Greenbrae",
                            "state": "California",
                            "zip": "94904",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.94854,
                                "lon": -122.5247
                            }
                        },
                        {
                            "facility": "Office Of Richard Cherlin, Md",
                            "city": "Los Gatos",
                            "state": "California",
                            "zip": "95032",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.22661,
                                "lon": -121.97468
                            }
                        },
                        {
                            "facility": "Diabetes Medical Center Of California",
                            "city": "Northridge",
                            "state": "California",
                            "zip": "91325",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.22834,
                                "lon": -118.53675
                            }
                        },
                        {
                            "facility": "Apex Research Of Riverside",
                            "city": "Riverside",
                            "state": "California",
                            "zip": "92505",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.95335,
                                "lon": -117.39616
                            }
                        },
                        {
                            "facility": "La Biomed At Harbor Ucla Med Ctr.",
                            "city": "Torrance",
                            "state": "California",
                            "zip": "90502",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.83585,
                                "lon": -118.34063
                            }
                        },
                        {
                            "facility": "Endocrine Associates Of The Rockies",
                            "city": "Denver",
                            "state": "Colorado",
                            "zip": "80220",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.73915,
                                "lon": -104.9847
                            }
                        },
                        {
                            "facility": "Panhandle Family Care Associates",
                            "city": "Marianna",
                            "state": "Florida",
                            "zip": "32446",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.77436,
                                "lon": -85.22687
                            }
                        },
                        {
                            "facility": "Genesis Clinical Research",
                            "city": "Tampa",
                            "state": "Florida",
                            "zip": "33614",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 27.94752,
                                "lon": -82.45843
                            }
                        },
                        {
                            "facility": "Endocrine Research Solutions, Inc.",
                            "city": "Roswell",
                            "state": "Georgia",
                            "zip": "30076",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.02316,
                                "lon": -84.36159
                            }
                        },
                        {
                            "facility": "Twin Cities Clinical Research",
                            "city": "Brooklyn Center",
                            "state": "Minnesota",
                            "zip": "55430",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 45.07608,
                                "lon": -93.33273
                            }
                        },
                        {
                            "facility": "Kcva Medical Center Research Svc (151)",
                            "city": "Kansas City",
                            "state": "Missouri",
                            "zip": "64128",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.09973,
                                "lon": -94.57857
                            }
                        },
                        {
                            "facility": "Va Nebraska-Western Iowa Health Care System (Nwihcs)",
                            "city": "Omaha",
                            "state": "Nebraska",
                            "zip": "68105",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.25626,
                                "lon": -95.94043
                            }
                        },
                        {
                            "facility": "University Of Medicine And Dentistry Of New Jersey",
                            "city": "Voorhees",
                            "state": "New Jersey",
                            "zip": "08043",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.48122,
                                "lon": -74.48321
                            }
                        },
                        {
                            "facility": "Winthrop University Hospital",
                            "city": "Mineola",
                            "state": "New York",
                            "zip": "11501",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.74927,
                                "lon": -73.64068
                            }
                        },
                        {
                            "facility": "Slocum-Dickson Medical Group, Pllc",
                            "city": "New Hartford",
                            "state": "New York",
                            "zip": "13413",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 43.0734,
                                "lon": -75.28767
                            }
                        },
                        {
                            "facility": "Community Health Care Of Manchester",
                            "city": "Akron",
                            "state": "Ohio",
                            "zip": "44319",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.08144,
                                "lon": -81.51901
                            }
                        },
                        {
                            "facility": "Center For Thyroid Diseases And Endocrinology",
                            "city": "Beachwood",
                            "state": "Ohio",
                            "zip": "44122",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.4645,
                                "lon": -81.50873
                            }
                        },
                        {
                            "facility": "Physician Research, Inc.",
                            "city": "Zanesville",
                            "state": "Ohio",
                            "zip": "43701",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.94035,
                                "lon": -82.01319
                            }
                        },
                        {
                            "facility": "Univ Of Oklahoma Health Science Center",
                            "city": "Oklahoma City",
                            "state": "Oklahoma",
                            "zip": "73104",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.46756,
                                "lon": -97.51643
                            }
                        },
                        {
                            "facility": "Rogue Valley Clinical Research",
                            "city": "Medford",
                            "state": "Oregon",
                            "zip": "97504",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.32652,
                                "lon": -122.87559
                            }
                        },
                        {
                            "facility": "Drexel University College Of Medicine",
                            "city": "Philadelphia",
                            "state": "Pennsylvania",
                            "zip": "19102",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.95233,
                                "lon": -75.16379
                            }
                        },
                        {
                            "facility": "Thomas Jefferson University",
                            "city": "Philadelphia",
                            "state": "Pennsylvania",
                            "zip": "19107",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.95233,
                                "lon": -75.16379
                            }
                        },
                        {
                            "facility": "Low Country Internal Medicine Of Sc, Pa",
                            "city": "Charleston",
                            "state": "South Carolina",
                            "zip": "29406",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.77657,
                                "lon": -79.93092
                            }
                        },
                        {
                            "facility": "Carolina Health Specialists",
                            "city": "Myrtle Beach",
                            "state": "South Carolina",
                            "zip": "29572",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.68906,
                                "lon": -78.88669
                            }
                        },
                        {
                            "facility": "Palmetto Clinical Research",
                            "city": "Summerville",
                            "state": "South Carolina",
                            "zip": "29485",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.0185,
                                "lon": -80.17565
                            }
                        },
                        {
                            "facility": "Research Institute Of Dallas",
                            "city": "Dallas",
                            "state": "Texas",
                            "zip": "75231",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.78306,
                                "lon": -96.80667
                            }
                        },
                        {
                            "facility": "Westbury Medical Clinic P.A.",
                            "city": "Houston",
                            "state": "Texas",
                            "zip": "77005",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.76328,
                                "lon": -95.36327
                            }
                        },
                        {
                            "facility": "The Strelitz Diabetes Center",
                            "city": "Norfolk",
                            "state": "Virginia",
                            "zip": "23510",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.84681,
                                "lon": -76.28522
                            }
                        },
                        {
                            "facility": "Capital Clinical Research Center",
                            "city": "Olympia",
                            "state": "Washington",
                            "zip": "98502",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 47.03787,
                                "lon": -122.9007
                            }
                        },
                        {
                            "facility": "Cedar Research Llc",
                            "city": "Tacoma",
                            "state": "Washington",
                            "zip": "98405",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 47.25288,
                                "lon": -122.44429
                            }
                        },
                        {
                            "facility": "Aurora Advanced Healthcare",
                            "city": "Milwaukee",
                            "state": "Wisconsin",
                            "zip": "53209",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 43.0389,
                                "lon": -87.90647
                            }
                        },
                        {
                            "facility": "Zablocki Veterans Affairs Medical Center",
                            "city": "Milwaukee",
                            "state": "Wisconsin",
                            "zip": "53295",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 43.0389,
                                "lon": -87.90647
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Capital Federal",
                            "state": "Buenos Aires",
                            "zip": "C1405BCJ",
                            "country": "Argentina",
                            "geoPoint": {
                                "lat": -34.61315,
                                "lon": -58.37723
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Mar Del Plata",
                            "state": "Buenos Aires",
                            "zip": "7600",
                            "country": "Argentina",
                            "geoPoint": {
                                "lat": -38.00228,
                                "lon": -57.55754
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Zarate",
                            "state": "Buenos Aires",
                            "zip": "2800",
                            "country": "Argentina",
                            "geoPoint": {
                                "lat": -34.09814,
                                "lon": -59.02858
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Buenos Aires",
                            "zip": "C1012AAR",
                            "country": "Argentina",
                            "geoPoint": {
                                "lat": -34.61315,
                                "lon": -58.37723
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Buenos Aires",
                            "zip": "C1408INH",
                            "country": "Argentina",
                            "geoPoint": {
                                "lat": -34.61315,
                                "lon": -58.37723
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Cordoba",
                            "zip": "5000",
                            "country": "Argentina",
                            "geoPoint": {
                                "lat": -31.4135,
                                "lon": -64.18105
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Cordoba",
                            "zip": "X5006CBI",
                            "country": "Argentina",
                            "geoPoint": {
                                "lat": -31.4135,
                                "lon": -64.18105
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Salta",
                            "zip": "A4406CLA",
                            "country": "Argentina",
                            "geoPoint": {
                                "lat": -24.7859,
                                "lon": -65.41166
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Camperdown",
                            "state": "New South Wales",
                            "zip": "2050",
                            "country": "Australia",
                            "geoPoint": {
                                "lat": -33.88965,
                                "lon": 151.17642
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "St Leonards",
                            "state": "New South Wales",
                            "zip": "2065",
                            "country": "Australia",
                            "geoPoint": {
                                "lat": -33.82344,
                                "lon": 151.19836
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Woollongong",
                            "state": "New South Wales",
                            "zip": "2500",
                            "country": "Australia"
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Launceston",
                            "state": "Tasmania",
                            "zip": "7250",
                            "country": "Australia",
                            "geoPoint": {
                                "lat": -41.43876,
                                "lon": 147.13467
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Calgary",
                            "state": "Alberta",
                            "zip": "T3B 0M3",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 51.05011,
                                "lon": -114.08529
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Winnipeg",
                            "state": "Manitoba",
                            "zip": "R3E 3P4",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 49.8844,
                                "lon": -97.14704
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Barrie",
                            "state": "Ontario",
                            "zip": "L4M 7G1",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 44.40011,
                                "lon": -79.66634
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Thornhill",
                            "state": "Ontario",
                            "zip": "L4J 8L7",
                            "country": "Canada"
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Toronto",
                            "state": "Ontario",
                            "zip": "M4N 3M5",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 43.70011,
                                "lon": -79.4163
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Toronto",
                            "state": "Ontario",
                            "zip": "M4R 2G4",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 43.70011,
                                "lon": -79.4163
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Gatineau",
                            "state": "Quebec",
                            "zip": "J8V 2P5",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 45.47723,
                                "lon": -75.70164
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Laval",
                            "state": "Quebec",
                            "zip": "H7T 2P5",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 45.56995,
                                "lon": -73.692
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Sherbrooke",
                            "state": "Quebec",
                            "zip": "J1G 5K2",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 45.40008,
                                "lon": -71.89908
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Regina",
                            "state": "Saskatchewan",
                            "zip": "S4P 0W5",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 50.45008,
                                "lon": -104.6178
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Copenhagen Nv",
                            "zip": "2400",
                            "country": "Denmark",
                            "geoPoint": {
                                "lat": 55.67594,
                                "lon": 12.56553
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Gentofte",
                            "zip": "2820",
                            "country": "Denmark",
                            "geoPoint": {
                                "lat": 55.74903,
                                "lon": 12.54601
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Hvidovre",
                            "zip": "2650",
                            "country": "Denmark",
                            "geoPoint": {
                                "lat": 55.65719,
                                "lon": 12.47364
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Besancon Cedex",
                            "zip": "25030",
                            "country": "France",
                            "geoPoint": {
                                "lat": 47.24878,
                                "lon": 6.01815
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Brest Cedex",
                            "zip": "29609",
                            "country": "France",
                            "geoPoint": {
                                "lat": 48.3903,
                                "lon": -4.48628
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Paris Cedex 10",
                            "zip": "75475",
                            "country": "France",
                            "geoPoint": {
                                "lat": 48.85341,
                                "lon": 2.3488
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Paris",
                            "zip": "75877",
                            "country": "France",
                            "geoPoint": {
                                "lat": 48.85341,
                                "lon": 2.3488
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Poitiers Cedex",
                            "zip": "86021",
                            "country": "France",
                            "geoPoint": {
                                "lat": 46.58333,
                                "lon": 0.33333
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Indore",
                            "state": "Madhya Pradesh",
                            "zip": "452001",
                            "country": "India",
                            "geoPoint": {
                                "lat": 22.71792,
                                "lon": 75.8333
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Pune",
                            "state": "Maharashtra",
                            "zip": "411 004",
                            "country": "India",
                            "geoPoint": {
                                "lat": 18.51957,
                                "lon": 73.85535
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Bangalore",
                            "zip": "560 052",
                            "country": "India",
                            "geoPoint": {
                                "lat": 12.97194,
                                "lon": 77.59369
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Bangalore",
                            "zip": "560034",
                            "country": "India",
                            "geoPoint": {
                                "lat": 12.97194,
                                "lon": 77.59369
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Chennai",
                            "zip": "600029",
                            "country": "India",
                            "geoPoint": {
                                "lat": 13.08784,
                                "lon": 80.27847
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Pune, Maharashtra",
                            "zip": "411011",
                            "country": "India"
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Rajasthan",
                            "zip": "302 001",
                            "country": "India"
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Chieri",
                            "zip": "10023",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 45.01054,
                                "lon": 7.82133
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Chieti Scalo",
                            "zip": "66013",
                            "country": "Italy"
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Modena",
                            "zip": "41100",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 44.64783,
                                "lon": 10.92539
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Padova",
                            "zip": "35128",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 45.40797,
                                "lon": 11.88586
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Perugia",
                            "zip": "06126",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 43.1122,
                                "lon": 12.38878
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Pisa",
                            "zip": "56126",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 43.70853,
                                "lon": 10.4036
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Roma",
                            "zip": "00189",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 41.89193,
                                "lon": 12.51133
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Siena",
                            "zip": "53100",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 43.31822,
                                "lon": 11.33064
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Df",
                            "state": "Distrito Federal",
                            "zip": "01120",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 19.42847,
                                "lon": -99.12766
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Df",
                            "state": "Distrito Federal",
                            "zip": "06700",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 19.42847,
                                "lon": -99.12766
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Df",
                            "state": "Distrito Federal",
                            "zip": "11800",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 19.42847,
                                "lon": -99.12766
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Celaya",
                            "state": "Guanajuato",
                            "zip": "38000",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 20.52353,
                                "lon": -100.8157
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Guadalajara",
                            "state": "Jalisco",
                            "zip": "44670",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 20.66682,
                                "lon": -103.39182
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Monterrey",
                            "state": "Nuevo Leon",
                            "zip": "64460",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 25.67507,
                                "lon": -100.31847
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Durango",
                            "zip": "34075",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 24.02032,
                                "lon": -104.65756
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Cercado De Lima",
                            "state": "Lima",
                            "zip": "1",
                            "country": "Peru"
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Arequipa",
                            "country": "Peru",
                            "geoPoint": {
                                "lat": -16.39889,
                                "lon": -71.535
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Lima",
                            "zip": "18",
                            "country": "Peru",
                            "geoPoint": {
                                "lat": -12.04318,
                                "lon": -77.02824
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Lima",
                            "zip": "LIMA 13",
                            "country": "Peru",
                            "geoPoint": {
                                "lat": -12.04318,
                                "lon": -77.02824
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Caguas",
                            "zip": "00725",
                            "country": "Puerto Rico",
                            "geoPoint": {
                                "lat": 18.23412,
                                "lon": -66.0485
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "San Juan",
                            "zip": "00909",
                            "country": "Puerto Rico",
                            "geoPoint": {
                                "lat": 18.46633,
                                "lon": -66.10572
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Singapore",
                            "zip": "119074",
                            "country": "Singapore",
                            "geoPoint": {
                                "lat": 1.28967,
                                "lon": 103.85007
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Barcelona",
                            "zip": "08036",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 41.38879,
                                "lon": 2.15899
                            }
                        },
                        {
                            "facility": "Local Institution",
                            "city": "San Sebastian De Los",
                            "zip": "28702",
                            "country": "Spain"
                        },
                        {
                            "facility": "Local Institution",
                            "city": "Vizcaya",
                            "zip": "48903",
                            "country": "Spain"
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "27306615",
                            "type": "DERIVED",
                            "citation": "Fioretto P, Stefansson BV, Johnsson E, Cain VA, Sjostrom CD. Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment. Diabetologia. 2016 Sep;59(9):2036-9. doi: 10.1007/s00125-016-4017-1. Epub 2016 Jun 15. No abstract available."
                        },
                        {
                            "pmid": "24067431",
                            "type": "DERIVED",
                            "citation": "Kohan DE, Fioretto P, Tang W, List JF. Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control. Kidney Int. 2014 Apr;85(4):962-71. doi: 10.1038/ki.2013.356. Epub 2013 Sep 25."
                        }
                    ],
                    "seeAlsoLinks": [
                        {
                            "label": "Publication",
                            "url": "http://rd.springer.com/article/10.1007%2Fs00125-016-4017-1"
                        },
                        {
                            "label": "Publication long-term",
                            "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973038/"
                        },
                        {
                            "label": "MB102029_Redacted_CSR_synopsis",
                            "url": "http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=3639&filename=MB102029_Redacted_CSR_synopsis.pdf"
                        }
                    ]
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "recruitmentDetails": "Of 631 participants enrolled, 276 completed a qualification period. Of these 276 participants, 252 were randomized and received treatment. Of these 252 participants, 204 completed double-blind treatment period.",
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "Placebo",
                            "description": "Participants received dapagliflozin matching placebo once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label anti-diabetic therapy as rescue)"
                        },
                        {
                            "id": "FG001",
                            "title": "Dapagliflozin 5 mg",
                            "description": "Participants received dapagliflozin 5 mg once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label metformin as rescue)"
                        },
                        {
                            "id": "FG002",
                            "title": "Dapagliflozin 10 mg",
                            "description": "Participants received dapagliflozin 10 mg once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label metformin as rescue)"
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "84"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "83"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "85"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "63"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "72"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "69"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "21"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "11"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "16"
                                        }
                                    ]
                                }
                            ],
                            "dropWithdraws": [
                                {
                                    "type": "Lack of Efficacy",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "2"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "0"
                                        }
                                    ]
                                },
                                {
                                    "type": "Adverse Event",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "12"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "7"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "6"
                                        }
                                    ]
                                },
                                {
                                    "type": "Withdrawal by Subject",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "6"
                                        }
                                    ]
                                },
                                {
                                    "type": "Death",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "1"
                                        }
                                    ]
                                },
                                {
                                    "type": "Lost to Follow-up",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "0"
                                        }
                                    ]
                                },
                                {
                                    "type": "non-compliance, not met criteria, etc.",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "2"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "3"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "populationDescription": "All randomized participants who received at least 1 dose of study medication",
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "Placebo",
                            "description": "Participants received dapagliflozin matching placebo once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label anti-diabetic therapy as rescue)"
                        },
                        {
                            "id": "BG001",
                            "title": "Dapagliflozin 5 mg",
                            "description": "Participants received dapagliflozin 5 mg once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label metformin as rescue)"
                        },
                        {
                            "id": "BG002",
                            "title": "Dapagliflozin 10 mg",
                            "description": "Participants received dapagliflozin 10 mg once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label metformin as rescue)"
                        },
                        {
                            "id": "BG003",
                            "title": "Total",
                            "description": "Total of all reporting groups"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "84"
                                },
                                {
                                    "groupId": "BG001",
                                    "value": "83"
                                },
                                {
                                    "groupId": "BG002",
                                    "value": "85"
                                },
                                {
                                    "groupId": "BG003",
                                    "value": "252"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Continuous",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "Years",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "67",
                                                    "spread": "8.6"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "66",
                                                    "spread": "8.9"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "68",
                                                    "spread": "7.7"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "67",
                                                    "spread": "8.4"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Age, Customized",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "title": "Younger than 65 years",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "36"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "39"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "29"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "104"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "65 years and older",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "48"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "44"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "56"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "148"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex/Gender, Customized",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "title": "Male",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "53"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "55"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "56"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "164"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Female",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "31"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "28"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "29"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "88"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Race/Ethnicity, Customized",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "title": "WHITE",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "69"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "65"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "77"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "211"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "BLACK OR AFRICAN AMERICAN",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "7"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "12"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "ASIAN",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "6"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "13"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "OTHER",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "8"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "7"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "16"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Weight",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "kg",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "89.61",
                                                    "spread": "20.046"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "95.23",
                                                    "spread": "20.909"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "93.25",
                                                    "spread": "17.309"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "92.69",
                                                    "spread": "19.529"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Pre-Enrollment Anti-Hyperglycemic Therapy",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "title": "INSULIN-BASED REGIMEN",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "55"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "54"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "55"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "164"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "SULFONYLUREA-BASED REGIMEN",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "21"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "21"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "21"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "63"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "THIAZOLIINEDIONE-BASED REGIMEN",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "4"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "OTHER REGIMEN",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "7"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "7"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "7"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "21"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "Adjusted Mean Change From Baseline in Hemoglobin A1C (HbA1c) at Week 24 (Last Observation Carried Forward [LOCF]",
                            "description": "HbA1c was measured as percent of hemoglobin by a central laboratory. Data after rescue medication was excluded from this analysis. Baseline was defined as the last assessment prior to the start date and time of the first dose of the double-blind study medication. In cases where time of the first dose or time of the assessment was not available, baseline was defined as the last assessment on or prior to the date of the first dose of the double-blind study medication. HbA1c measurements were obtained during the qualification and lead-in periods and on Day 1 and Weeks 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, and 24 in the double-blind period.",
                            "populationDescription": "All randomized participants who received study medication and had nonmissing HbA1c values at baseline and Week 24 (LOCF)",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Error",
                            "unitOfMeasure": "% of hemoglobin",
                            "timeFrame": "From Baseline to Week 24",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Placebo",
                                    "description": "Participants received dapagliflozin matching placebo once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label anti-diabetic therapy as rescue)"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Dapagliflozin 5 mg",
                                    "description": "Participants received dapagliflozin 5 mg once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label metformin as rescue)"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Dapagliflozin 10 mg",
                                    "description": "Participants received dapagliflozin 10 mg once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label metformin as rescue)"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "82"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "83"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "82"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-0.32",
                                                    "spread": "0.1701"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.41",
                                                    "spread": "0.1701"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-0.44",
                                                    "spread": "0.1708"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "0.561",
                                    "pValueComment": "Primary endpoints were tested at alpha=0.027 applying Dunnett's adjustment",
                                    "statisticalMethod": "ANCOVA",
                                    "paramType": "Mean Difference (Final Values)",
                                    "paramValue": "-0.08",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-0.37",
                                    "ciUpperLimit": "0.20",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "0.1448"
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG002"
                                    ],
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "0.435",
                                    "pValueComment": "Primary endpoints were tested at alpha=0.027 applying Dunnett's adjustment",
                                    "statisticalMethod": "ANCOVA",
                                    "paramType": "Mean Difference (Final Values)",
                                    "paramValue": "-0.11",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-0.40",
                                    "ciUpperLimit": "0.17",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "0.1457"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Adjusted Mean Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24 (Last Observation Carried Forward [LOCF])",
                            "description": "Secondary endpoints were tested using sequential testing procedure and are presented in hierarchical order. Fasting plasma glucose was measured as milligrams per deciliter(mg/dL) by a central laboratory. Baseline was defined as the last assessment prior to the start date and time of the first dose of the double-blind study medication. In cases where time of the first dose or time of the assessment was not available, baseline was defined as the last assessment on or prior to the date of the first dose of the double-blind study medication. FPG measurements were obtained during the qualification and lead-in periods and on Day 1 and Weeks 1, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, and 24 in the double-blind period",
                            "populationDescription": "All randomized participants who received study medication and had nonmissing FPG values at baseline and Week 24 (LOCF)",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Error",
                            "unitOfMeasure": "mg/dL",
                            "timeFrame": "From Baseline to Week 24",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Placebo",
                                    "description": "Participants received dapagliflozin matching placebo once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label anti-diabetic therapy as rescue)"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Dapagliflozin 5 mg",
                                    "description": "Participants received dapagliflozin 5 mg once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label metformin as rescue)"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Dapagliflozin 10 mg",
                                    "description": "Participants received dapagliflozin 10 mg once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label metformin as rescue)"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "83"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "83"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "85"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "8.4",
                                                    "spread": "9.621"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-5.2",
                                                    "spread": "9.548"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-0.6",
                                                    "spread": "9.524"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValueComment": "Secondary endpoints were tested following a sequential testing procedure at alpha=0.05; secondary efficacy analyses were not tested since the primary endpoint was not significant.",
                                    "statisticalMethod": "ANCOVA",
                                    "paramType": "Mean Difference (Final Values)",
                                    "paramValue": "-13.6",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-29.7",
                                    "ciUpperLimit": "2.4",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "8.142"
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG002"
                                    ],
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValueComment": "Secondary endpoints were tested following a sequential testing procedure at alpha=0.05; secondary efficacy analyses were not tested since the primary endpoint was not significant.",
                                    "statisticalMethod": "ANCOVA",
                                    "paramType": "Mean Difference (Final Values)",
                                    "paramValue": "-9.0",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-25.0",
                                    "ciUpperLimit": "7.0",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "8.136"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Adjusted Mean Change From Baseline in Total Body Weight (kg) at Week 24 (Last Observation Carried Forward [LOCF])",
                            "description": "Secondary endpoints were tested using sequential testing procedure and are presented in hierarchical order. Adjusted mean change from baseline in total body weight at Week 24 (or the last postbaseline measurement prior to Week 24 if no Week 24 assessment was available was determined. Data after rescue medication was excluded from this analysis. Baseline was defined as the last assessment prior to the start date and time of the first dose of the double-blind study medication. In cases where time of the first dose or time of the assessment was not available, baseline was defined as the last assessment on or prior to the date of the first dose of the double-blind study medication. Body weight measurements were obtained during the qualification and lead-in periods and on Day 1 and Weeks 1, 2, 4, 8, 12, 16, 20, and 24 of the double-blind period.",
                            "populationDescription": "All randomized participants who received study medication and had nonmissing body weight values at baseline and Week 24 (LOCF)",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Error",
                            "unitOfMeasure": "kg",
                            "timeFrame": "From Baseline to Week 24",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Placebo",
                                    "description": "Participants received dapagliflozin matching placebo once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label anti-diabetic therapy as rescue)"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Dapagliflozin 5 mg",
                                    "description": "Participants received dapagliflozin 5 mg once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label metformin as rescue)"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Dapagliflozin 10 mg",
                                    "description": "Participants received dapagliflozin 10 mg once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label metformin as rescue)"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "84"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "83"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "85"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.27",
                                                    "spread": "0.4872"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-1.54",
                                                    "spread": "0.4815"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-1.89",
                                                    "spread": "0.4693"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValueComment": "Secondary endpoints were tested following a sequential testing procedure at alpha=0.05; secondary efficacy analyses were not tested since the primary endpoint was not significant.",
                                    "statisticalMethod": "ANCOVA",
                                    "paramType": "Mean Difference (Final Values)",
                                    "paramValue": "-1.81",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-2.68",
                                    "ciUpperLimit": "-0.94",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "0.4435"
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG002"
                                    ],
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValueComment": "Secondary endpoints were tested following a sequential testing procedure at alpha=0.05; secondary efficacy analyses were not tested since the primary endpoint was not significant.",
                                    "statisticalMethod": "ANCOVA",
                                    "paramType": "Mean Difference (Final Values)",
                                    "paramValue": "-2.16",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-3.03",
                                    "ciUpperLimit": "-1.29",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "0.4395"
                                }
                            ]
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "5",
                    "timeFrame": "Onset on or after the first date of double-blind treatment and on or prior to the last day of double-blind treatment 24 weeks plus 4 days for non-serious adverse event; plus 30 days for serious adverse event.",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "Placebo",
                            "description": "Participants received dapagliflozin matching placebo once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label anti-diabetic therapy as rescue)",
                            "seriousNumAffected": 9,
                            "seriousNumAtRisk": 84,
                            "otherNumAffected": 39,
                            "otherNumAtRisk": 84
                        },
                        {
                            "id": "EG001",
                            "title": "Dapagliflozin 5 mg",
                            "description": "Participants received dapagliflozin 5 mg once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label metformin as rescue)",
                            "seriousNumAffected": 7,
                            "seriousNumAtRisk": 83,
                            "otherNumAffected": 45,
                            "otherNumAtRisk": 83
                        },
                        {
                            "id": "EG002",
                            "title": "Dapagliflozin 10 mg",
                            "description": "Participants received dapagliflozin 10 mg once daily for up to 24 weeks (Subjects were to continue their original pre-enrollment anti-diabetic therapy; may include the addition of open-label metformin as rescue)",
                            "seriousNumAffected": 12,
                            "seriousNumAtRisk": 85,
                            "otherNumAffected": 42,
                            "otherNumAtRisk": 85
                        }
                    ],
                    "seriousEvents": [
                        {
                            "term": "HYPOGLYCAEMIA",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "HYPERGLYCAEMIA",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "HYPERKALAEMIA",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "CEREBRAL INFARCTION",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "SYNCOPE",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "MYOCARDIAL INFARCTION",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "ACUTE MYOCARDIAL INFARCTION",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "CARDIAC FAILURE",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "CARDIOMYOPATHY",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "RETINAL DETACHMENT",
                            "organSystem": "Eye disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "SEPTIC SHOCK",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "CELLULITIS",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "PNEUMONIA",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "HEART RATE INCREASED",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "PROSTATE CANCER",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "URINARY RETENTION",
                            "organSystem": "Renal and urinary disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "HYPOTENSION",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "ANAEMIA",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "INGUINAL HERNIA",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "CHEST PAIN",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "OEDEMA",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "HYPERSENSITIVITY",
                            "organSystem": "Immune system disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "TRAUMATIC BRAIN INJURY",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "OSTEOARTHRITIS",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "SPONDYLOLISTHESIS",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "TENDON DISORDER",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "BALANOPOSTHITIS",
                            "organSystem": "Reproductive system and breast disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "DYSPNOEA",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 85
                                }
                            ]
                        }
                    ],
                    "otherEvents": [
                        {
                            "term": "POLLAKIURIA",
                            "organSystem": "Renal and urinary disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 3,
                                    "numAffected": 3,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 7,
                                    "numAffected": 5,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 12,
                                    "numAffected": 10,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "COUGH",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 3,
                                    "numAffected": 2,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 9,
                                    "numAffected": 8,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 10,
                                    "numAffected": 8,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "DIARRHOEA",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 3,
                                    "numAffected": 3,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 4,
                                    "numAffected": 3,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 9,
                                    "numAffected": 8,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "MUSCULOSKELETAL PAIN",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 5,
                                    "numAffected": 3,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 3,
                                    "numAffected": 3,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 8,
                                    "numAffected": 7,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "NAUSEA",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 5,
                                    "numAffected": 3,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 7,
                                    "numAffected": 7,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "UPPER RESPIRATORY TRACT INFECTION",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 4,
                                    "numAffected": 3,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 4,
                                    "numAffected": 3,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 7,
                                    "numAffected": 6,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "DIZZINESS",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 4,
                                    "numAffected": 4,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 14,
                                    "numAffected": 10,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 5,
                                    "numAffected": 5,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "HYPERKALAEMIA",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 16,
                                    "numAffected": 10,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 9,
                                    "numAffected": 7,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 6,
                                    "numAffected": 5,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "HYPERTENSION",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 6,
                                    "numAffected": 5,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 5,
                                    "numAffected": 5,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "NASOPHARYNGITIS",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 8,
                                    "numAffected": 5,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 6,
                                    "numAffected": 6,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 5,
                                    "numAffected": 4,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "OEDEMA PERIPHERAL",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 4,
                                    "numAffected": 4,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 10,
                                    "numAffected": 8,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 6,
                                    "numAffected": 4,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "ARTHRALGIA",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 6,
                                    "numAffected": 5,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 5,
                                    "numAffected": 5,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "BACK PAIN",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 7,
                                    "numAffected": 6,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 8,
                                    "numAffected": 7,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "MICTURITION URGENCY",
                            "organSystem": "Renal and urinary disorders",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 5,
                                    "numAffected": 5,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 3,
                                    "numAffected": 2,
                                    "numAtRisk": 85
                                }
                            ]
                        },
                        {
                            "term": "GASTROENTERITIS",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA Version: 13.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 6,
                                    "numAffected": 5,
                                    "numAtRisk": 84
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 83
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 85
                                }
                            ]
                        }
                    ]
                },
                "moreInfoModule": {
                    "certainAgreement": {
                        "piSponsorEmployee": false,
                        "restrictiveAgreement": false
                    },
                    "pointOfContact": {
                        "title": "Anna Maria Langkilde",
                        "organization": "AstraZeneca",
                        "email": "ClinicalTrialTransparency@astrazeneca.com"
                    }
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2025-05-07",
                    "removedCountries": [
                        "Brazil",
                        "Israel"
                    ]
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D003920",
                            "term": "Diabetes Mellitus"
                        },
                        {
                            "id": "D003924",
                            "term": "Diabetes Mellitus, Type 2"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D044882",
                            "term": "Glucose Metabolism Disorders"
                        },
                        {
                            "id": "D008659",
                            "term": "Metabolic Diseases"
                        },
                        {
                            "id": "D004700",
                            "term": "Endocrine System Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M7115",
                            "name": "Diabetes Mellitus",
                            "asFound": "Diabetes Mellitus",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M7119",
                            "name": "Diabetes Mellitus, Type 2",
                            "asFound": "Diabetes Mellitus, Type 2",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M26718",
                            "name": "Renal Insufficiency",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M11639",
                            "name": "Metabolic Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M25403",
                            "name": "Glucose Metabolism Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7862",
                            "name": "Endocrine System Diseases",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC18",
                            "name": "Nutritional and Metabolic Diseases"
                        },
                        {
                            "abbrev": "BC19",
                            "name": "Gland and Hormone Related Diseases"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BXS",
                            "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "C529054",
                            "term": "Dapagliflozin"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000077203",
                            "term": "Sodium-Glucose Transporter 2 Inhibitors"
                        },
                        {
                            "id": "D045504",
                            "term": "Molecular Mechanisms of Pharmacological Action"
                        },
                        {
                            "id": "D007004",
                            "term": "Hypoglycemic Agents"
                        },
                        {
                            "id": "D045505",
                            "term": "Physiological Effects of Drugs"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M348449",
                            "name": "Dapagliflozin",
                            "asFound": "Cream",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M1691",
                            "name": "Sodium-Glucose Transporter 2 Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10054",
                            "name": "Hypoglycemic Agents",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "Hypo",
                            "name": "Hypoglycemic Agents"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        }
                    ]
                }
            },
            "hasResults": true
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT02058160",
                    "orgStudyIdInfo": {
                        "id": "EFC12405"
                    },
                    "secondaryIdInfos": [
                        {
                            "id": "2013-003132-79",
                            "type": "EUDRACT_NUMBER"
                        },
                        {
                            "id": "U1111-1148-4351",
                            "type": "OTHER",
                            "domain": "UTN"
                        }
                    ],
                    "organization": {
                        "fullName": "Sanofi",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes",
                    "officialTitle": "A Randomized, 30-week, Active-controlled, Open Label, 2- Treatment Arm, Parallel-group, Multicenter Study Comparing the Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine With or Without Metformin in Patients With Type 2 Diabetes Mellitus (T2DM)",
                    "acronym": "LixiLan-L"
                },
                "statusModule": {
                    "statusVerifiedDate": "2017-03",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2014-01"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2015-07",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2015-07",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2014-02-06",
                    "studyFirstSubmitQcDate": "2014-02-06",
                    "studyFirstPostDateStruct": {
                        "date": "2014-02-07",
                        "type": "ESTIMATED"
                    },
                    "resultsFirstSubmitDate": "2016-12-16",
                    "resultsFirstSubmitQcDate": "2016-12-16",
                    "resultsFirstPostDateStruct": {
                        "date": "2017-02-10",
                        "type": "ACTUAL"
                    },
                    "dispFirstSubmitDate": "2016-07-01",
                    "dispFirstSubmitQcDate": "2016-07-01",
                    "dispFirstPostDateStruct": {
                        "date": "2016-07-06",
                        "type": "ESTIMATED"
                    },
                    "lastUpdateSubmitDate": "2017-03-31",
                    "lastUpdatePostDateStruct": {
                        "date": "2017-05-09",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Sanofi",
                        "class": "INDUSTRY"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": true
                },
                "descriptionModule": {
                    "briefSummary": "Primary Objective:\n\nTo demonstrate the superiority of the insulin glargine/lixisenatide fixed ratio combination (FRC) to insulin glargine in glycated hemoglobin (HbA1c) change from baseline to Week 30.\n\nSecondary Objective:\n\nTo compare the overall efficacy and safety of insulin glargine/lixisenatide FRC to insulin glargine (with or without metformin) over a 30 week treatment period in participants with type 2 diabetes.",
                    "detailedDescription": "Maximum duration of approximately 39 weeks: an up to 8-week screening period, a 30-week randomized treatment period and 3 days post-treatment safety follow up period."
                },
                "conditionsModule": {
                    "conditions": [
                        "Type 2 Diabetes"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE3"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 736,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC)",
                            "type": "EXPERIMENTAL",
                            "description": "FRC once daily (QD) for 30 weeks. Dose individually adjusted.",
                            "interventionNames": [
                                "Drug: Insulin glargine/lixisenatide (HOE901/AVE0010)",
                                "Drug: Metformin (Background Drug)"
                            ]
                        },
                        {
                            "label": "Insulin glargine",
                            "type": "ACTIVE_COMPARATOR",
                            "description": "Insulin glargine 100 U/mL QD for 30 weeks. Dose individually adjusted.",
                            "interventionNames": [
                                "Drug: Insulin glargine (HOE901)",
                                "Drug: Metformin (Background Drug)"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "Insulin glargine/lixisenatide (HOE901/AVE0010)",
                            "description": "Insulin glargine/lixisenatide FRC was self-administered by subcutaneous (SC) injection within 1 hour before breakfast using one of 2 SoloStar® pen-injectors: Pen A (ratio of 2 Units (U) of insulin glargine U 100:1 mcg of lixisenatide) or Pen B (ratio of 3 U of insulin glargine U 100:1 mcg of lixisenatide). After run-in, the FRC was initiated at a dose of either 20 U/10 mcg with Pen A or 30 U/10 mcg with Pen B, depending on participant's dose of Insulin glargine on the day prior to randomization.\n\nDose was adjusted weekly to reach and maintain fasting self-monitored plasma glucose (SMPG) of 80 mg/dL to 100 mg/dL (4.4 mmol/L to 5.6 mmol/L). Pen A was used for administration of doses up to 40 U/20 mcg and Pen B for administration of doses from 30 U/10 mcg up to 60 U/20 mcg.",
                            "armGroupLabels": [
                                "Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC)"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Insulin glargine (HOE901)",
                            "description": "Insulin glargine was self-administered QD by SC injection at approximately the same time every day.\n\nAfter screening, eligible participants entered 6 week run-in phase during which they were switched (if necessary) to insulin glargine and dose was stabilized. The first dose after randomization was same as the one administered on the day prior to randomization and then dose was adjusted weekly to reach and maintain fasting SMPG of 80 mg/dL to 100 mg/dL (4.4 mmol/L to 5.6 mmol/L).",
                            "armGroupLabels": [
                                "Insulin glargine"
                            ],
                            "otherNames": [
                                "Lantus"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Metformin (Background Drug)",
                            "description": "Pharmaceutical form: Tablet; Route of administration: Oral administration",
                            "armGroupLabels": [
                                "Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC)",
                                "Insulin glargine"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Change in Glycated Hemoglobin (HbA1c) From Baseline to Week 30",
                            "description": "Change in HbA1c was calculated by subtracting baseline value from Week 30 value.",
                            "timeFrame": "Baseline, Week 30"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Percentage of Participants With HbA1c <7.0% or ≤6.5% at Week 30",
                            "timeFrame": "Week 30"
                        },
                        {
                            "measure": "Change in 2-hour Plasma Blood Glucose Excursion From Baseline to Week 30",
                            "description": "Plasma glucose excursion = 2-hour postprandial glucose (PPG) minus plasma glucose value obtained 30 minutes prior to the start of the meal and before investigational medicinal product (IMP) administration, if IMP was injected before breakfast. Change in plasma glucose excursions was calculated by subtracting baseline value from Week 30 value.",
                            "timeFrame": "Baseline, Week 30"
                        },
                        {
                            "measure": "Change in Body Weight From Baseline to Week 30",
                            "description": "Change in body weight was calculated by subtracting baseline value from Week 30 value.",
                            "timeFrame": "Baseline, Week 30"
                        },
                        {
                            "measure": "Mean Change in 7-point Self-monitored Plasma Glucose (SMPG) Profile From Baseline to Week 30",
                            "description": "Participants recorded a 7-point plasma glucose profile measured before and 2-hours after each meal and at bedtime, two times in a week before baseline, before visit Week 12 and before visit Week 30 and the average value across the profiles performed in the week before a visit for the 7 time points was calculated. Change in average 7 point SMPG was calculated by subtracting baseline value from Week 30 value. The analysis included all scheduled measurements obtained during the study. The missing data was handled by mixed effect model with repeated measures (MMRM) approach.",
                            "timeFrame": "Baseline, Week 30"
                        },
                        {
                            "measure": "Percentage of Participants Reaching HbA1c <7.0% With No Body Weight Gain at Week 30",
                            "timeFrame": "Week 30"
                        },
                        {
                            "measure": "Change in Daily Insulin Glargine Dose From Baseline to Week 30",
                            "timeFrame": "Baseline, Week 30"
                        },
                        {
                            "measure": "Percentage of Participants Reaching HbA1c <7.0% With No Body Weight Gain at Week 30 and No Documented Symptomatic Hypoglycemia (Plasma Glucose [PG] ≤ 70 mg/dL [3.9 mmol/L]) During 30-Week Treatment Period",
                            "description": "Documented symptomatic hypoglycemia was an event during which typical symptoms of hypoglycemia were accompanied by a measured plasma glucose concentration of ≤70 mg/dL (3.9 mmol/L).",
                            "timeFrame": "Baseline up to Week 30"
                        },
                        {
                            "measure": "Change in FPG From Baseline to Week 30",
                            "description": "Change in FPG was calculated by subtracting baseline value from Week 30 value.",
                            "timeFrame": "Baseline, Week 30"
                        },
                        {
                            "measure": "Change in 2-hour PPG From Baseline to Week 30",
                            "description": "Change in PPG was calculated by subtracting baseline value from Week 30 value.",
                            "timeFrame": "Baseline, Week 30"
                        },
                        {
                            "measure": "Percentage of Participants Reaching HbA1c <7.0% With No Documented Symptomatic Hypoglycemia (PG ≤ 70 mg/dL [3.9 mmol/L]) During 30-Week Treatment Period",
                            "description": "Documented symptomatic hypoglycemia was an event during which typical symptoms of hypoglycemia were accompanied by a measured plasma glucose concentration of ≤70 mg/dL (3.9 mmol/L).",
                            "timeFrame": "Baseline up to Week 30"
                        },
                        {
                            "measure": "Percentage of Participants Requiring Rescue Therapy During 30-Week Treatment Period",
                            "description": "Routine fasting SMPG and central laboratory FPG (and HbA1c after Week 12) values were used to determine the requirement of rescue medication. If fasting SMPG value exceeded the specified limit for 3 consecutive days, the central laboratory FPG (and HbA1c after Week 12) were performed. Threshold values - from Week 8 to Week 12: fasting SMPG/FPG \\>240 mg/dL (13.3 mmol/L), and from Week 12 to Week 30: fasting SMPG/FPG \\>200 mg/dL (11.1 mmol/L) or HbA1c \\>8%.",
                            "timeFrame": "Baseline up to Week 30"
                        },
                        {
                            "measure": "Number of Documented Symptomatic Hypoglycemia Events Per Subject-Year",
                            "description": "Documented symptomatic hypoglycemia was an event during which typical symptoms of hypoglycemia were accompanied by a measured plasma glucose concentration of ≤70 mg/dL (3.9 mmol/L).",
                            "timeFrame": "First dose of study drug up to 1 day after the last dose administration (median treatment exposure 211 days [FRC], 210 days [Insulin glargine])"
                        },
                        {
                            "measure": "Percentage of Participants With Documented Symptomatic Hypoglycemia",
                            "description": "Documented symptomatic hypoglycemia was an event during which typical symptoms of hypoglycemia were accompanied by a measured plasma glucose concentration of ≤70 mg/dL (3.9 mmol/L).",
                            "timeFrame": "First dose of study drug up to 1 day after the last dose administration (median treatment exposure 211 days [FRC], 210 days [Insulin glargine])"
                        },
                        {
                            "measure": "Percentage of Participants With Severe Symptomatic Hypoglycemia",
                            "description": "Severe symptomatic hypoglycemia was an event requiring assistance of another person to actively administer carbohydrate, glucagon, or other resuscitative actions. Plasma glucose measurements might not had been available during such an event, but neurological recovery attributable to the restoration of plasma glucose to normal was considered sufficient evidence that the event had been induced by a low plasma glucose concentration. Severe symptomatic hypoglycemia included all episodes in which neurological impairment was severe enough to prevent self-treatment, and which were thus thought to place participants at risk for injury to themselves or others.",
                            "timeFrame": "First dose of study drug up to 1 day after the last dose administration (median treatment exposure 211 days [FRC], 210 days [Insulin glargine])"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion criteria :\n\n* Type 2 diabetes mellitus diagnosed at least 1 year before the screening visit.\n* Treatment with basal insulin for at least 6 months before the screening visit.\n* Stable basal insulin regimen (i.e. type of insulin and time/frequency of the injection) for at least 3 months before the screening visit.\n* Stable (plus/minus 20 percent) total daily basal insulin dose between 15 and 40 Units/day for at least 2 months prior to the screening visit.\n* For participants receiving basal insulin and 1 or 2 oral anti-diabetic drugs (OADs): the OAD dose(s) must be stable during the 3 months before the screening visit. The OADs could be 1 to 2 out of:\n\n  * metformin (more than or equal to 1500 mg/day or maximal tolerated dose),\n  * a sulfonylurea,\n  * a glinide,\n  * a dipeptidyl-peptidase-4 inhibitor,\n  * a sodium glucose co-transporter 2 inhibitor,\n* Fasting Plasma Glucose (FPG) less than or equal to 180 mg/dL(10.0 mmol/L) at screening visit for participants receiving basal insulin in combination with 2 OADs or with 1 OAD other than metformin; FPG less than or equal to 200 mg/dL (11.1 mmol/L) at screening visit for participants on basal insulin only or basal insulin plus metformin at screening visit.\n* Signed written informed consent.\n\nExclusion criteria:\n\n* Age under legal age of adulthood at screening visit.\n* HbA1c at screening visit less than 7.5% or above 10%.\n* Pregnancy or lactation, women of childbearing potential with no effective contraceptive method.\n* Use of other oral or injectable glucose-lowering agents than stated in the inclusion criteria in a period of 3 months prior to screening.\n* Previous use of insulin other than basal insulin eg, prandial or pre-mixed insulin, in the year prior to screening. Note: Short term treatment (≤10 days) due to intercurrent illness is allowed.\n* History discontinuation of a previous treatment with Glucagon Like Peptide -1 Receptor Agonists for safety/tolerability or lack of efficacy.\n* Participant who had previously participated in any clinical trial with lixisenatide or the insulin glargine/lixisenatide FRC or had previously received lixisenatide.\n* Use of weight loss drugs within 3 months prior to screening visit.\n* Within the last 6 months prior to screening visit: history of stroke, myocardial infarction, unstable angina, or heart failure requiring hospitalization. Planned coronary, carotid or peripheral artery revascularisation procedures to be performed during the study period.\n* History of pancreatitis (unless pancreatitis was related to gallstones and cholecystectomy was already performed), chronic pancreatitis, pancreatitis during a previous treatment with incretin therapies, pancreatectomy, stomach/gastric surgery.\n* Personal or immediate family history of medullary thyroid cancer (MTC) or genetic conditions that predispose to MTC (eg, multiple endocrine neoplasia syndromes).\n* Uncontrolled or inadequately controlled hypertension (systolic blood pressure above 180 mmHg or diastolic blood pressure above 95 mmHg) at screening visit.\n* At screening visit, Body Mass Index (BMI) less than or equal to 20 or above 40 kg/m\\^2.\n* At screening visit amylase and/or lipase more than 3 times the upper limit of the normal (ULN) laboratory range.\n* At screening visit alanine aminotransferase (ALT) or alkaline phosphatase (AST) more than 3 ULN.\n* At screening visit calcitonin above or equal to 20 pg/mL (5.9 pmol/L).\n* Any contraindication to metformin use, according to local labeling, if the participant was taking metformin.\n* Participant who had a renal function impairment with creatinine clearance less than 30 mL/min (using the Cockcroft and Gault formula) or end-stage renal disease for participants, not treated with metformin.\n\nExclusion criteria for randomization:\n\n* HbA1c less than 7% or above 10% .\n* Mean fasting SMPG calculated from the self-measurements for 7 days the week before randomization visit was above 140 mg/dL (7.8 mmol/L).\n* Average insulin glargine daily dose less than 20 Units or above 50 Units (in the week before randomization visit).\n* Amylase and/or lipase more than 3 ULN .\n\nThe above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Clinical Sciences & Operations",
                            "affiliation": "Sanofi",
                            "role": "STUDY_DIRECTOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Investigational Site Number 840607",
                            "city": "Birmingham",
                            "state": "Alabama",
                            "zip": "35205",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.52066,
                                "lon": -86.80249
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840570",
                            "city": "Sun City",
                            "state": "Arizona",
                            "zip": "85351",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.59754,
                                "lon": -112.27182
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840562",
                            "city": "Tempe",
                            "state": "Arizona",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.41477,
                                "lon": -111.90931
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840577",
                            "city": "Tucson",
                            "state": "Arizona",
                            "zip": "85723",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.22174,
                                "lon": -110.92648
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840517",
                            "city": "Little Rock",
                            "state": "Arkansas",
                            "zip": "72205",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.74648,
                                "lon": -92.28959
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840537",
                            "city": "Little Rock",
                            "state": "Arkansas",
                            "zip": "72205",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.74648,
                                "lon": -92.28959
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840568",
                            "city": "Bell Gardens",
                            "state": "California",
                            "zip": "90201",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.96529,
                                "lon": -118.15146
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840550",
                            "city": "Chino",
                            "state": "California",
                            "zip": "91710",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.01223,
                                "lon": -117.68894
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840529",
                            "city": "Chula Vista",
                            "state": "California",
                            "zip": "91911",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.64005,
                                "lon": -117.0842
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840623",
                            "city": "Corona",
                            "state": "California",
                            "zip": "92879",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.87529,
                                "lon": -117.56644
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840566",
                            "city": "Fresno",
                            "state": "California",
                            "zip": "93720",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.74773,
                                "lon": -119.77237
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840552",
                            "city": "Greenbrae",
                            "state": "California",
                            "zip": "94904",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.94854,
                                "lon": -122.5247
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840578",
                            "city": "Lancaster",
                            "state": "California",
                            "zip": "93534",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.69804,
                                "lon": -118.13674
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840626",
                            "city": "Los Angeles",
                            "state": "California",
                            "zip": "90017",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.05223,
                                "lon": -118.24368
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840581",
                            "city": "Los Angeles",
                            "state": "California",
                            "zip": "90057",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.05223,
                                "lon": -118.24368
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840621",
                            "city": "Mission Viejo",
                            "state": "California",
                            "zip": "92691",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.60002,
                                "lon": -117.672
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840511",
                            "city": "Northridge",
                            "state": "California",
                            "zip": "91325",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.22834,
                                "lon": -118.53675
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840573",
                            "city": "Palm Springs",
                            "state": "California",
                            "zip": "92262",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.8303,
                                "lon": -116.54529
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840559",
                            "city": "Port Hueneme",
                            "state": "California",
                            "zip": "93041",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.14778,
                                "lon": -119.19511
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840536",
                            "city": "San Ramon",
                            "state": "California",
                            "zip": "94583",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.77993,
                                "lon": -121.97802
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840567",
                            "city": "Santa Ana",
                            "state": "California",
                            "zip": "92704",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.74557,
                                "lon": -117.86783
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840569",
                            "city": "Tarzana",
                            "state": "California",
                            "zip": "91356",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.17334,
                                "lon": -118.55397
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840572",
                            "city": "West Hills",
                            "state": "California",
                            "zip": "91345",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.19731,
                                "lon": -118.64398
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840582",
                            "city": "Aurora",
                            "state": "Colorado",
                            "zip": "80045",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.72943,
                                "lon": -104.83192
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840509",
                            "city": "Denver",
                            "state": "Colorado",
                            "zip": "80246",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.73915,
                                "lon": -104.9847
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840549",
                            "city": "Wilmington",
                            "state": "Delaware",
                            "zip": "19713",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.74595,
                                "lon": -75.54659
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840510",
                            "city": "Miami",
                            "state": "Florida",
                            "zip": "33156-7563",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 25.77427,
                                "lon": -80.19366
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840521",
                            "city": "New Port Richey",
                            "state": "Florida",
                            "zip": "34652",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 28.24418,
                                "lon": -82.71927
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840602",
                            "city": "Ocala",
                            "state": "Florida",
                            "zip": "34471",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.1872,
                                "lon": -82.14009
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840538",
                            "city": "Ocoee",
                            "state": "Florida",
                            "zip": "34761",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 28.56917,
                                "lon": -81.54396
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840534",
                            "city": "Palm Harbor",
                            "state": "Florida",
                            "zip": "34684",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 28.07807,
                                "lon": -82.76371
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840594",
                            "city": "Atlanta",
                            "state": "Georgia",
                            "zip": "30322",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.749,
                                "lon": -84.38798
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840614",
                            "city": "Columbus",
                            "state": "Georgia",
                            "zip": "31904",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.46098,
                                "lon": -84.98771
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840501",
                            "city": "Lawrenceville",
                            "state": "Georgia",
                            "zip": "30046",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.95621,
                                "lon": -83.98796
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840525",
                            "city": "Roswell",
                            "state": "Georgia",
                            "zip": "30076",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.02316,
                                "lon": -84.36159
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840588",
                            "city": "Idaho Falls",
                            "state": "Idaho",
                            "zip": "83404",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 43.46658,
                                "lon": -112.03414
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840580",
                            "city": "Arlington Heights",
                            "state": "Illinois",
                            "zip": "60005",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.08836,
                                "lon": -87.98063
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840519",
                            "city": "Chicago",
                            "state": "Illinois",
                            "zip": "60607",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.85003,
                                "lon": -87.65005
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840612",
                            "city": "Chicago",
                            "state": "Illinois",
                            "zip": "60616",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.85003,
                                "lon": -87.65005
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840556",
                            "city": "Springfield",
                            "state": "Illinois",
                            "zip": "62704",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.80172,
                                "lon": -89.64371
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840543",
                            "city": "Avon",
                            "state": "Indiana",
                            "zip": "46123",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.76282,
                                "lon": -86.39972
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840565",
                            "city": "Evansville",
                            "state": "Indiana",
                            "zip": "47713",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.97476,
                                "lon": -87.55585
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840585",
                            "city": "Evansville",
                            "state": "Indiana",
                            "zip": "47714",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.97476,
                                "lon": -87.55585
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840615",
                            "city": "Evansville",
                            "state": "Indiana",
                            "zip": "47714",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.97476,
                                "lon": -87.55585
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840563",
                            "city": "Indianapolis",
                            "state": "Indiana",
                            "zip": "46202",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.76838,
                                "lon": -86.15804
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840507",
                            "city": "Indianapolis",
                            "state": "Indiana",
                            "zip": "46260",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.76838,
                                "lon": -86.15804
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840516",
                            "city": "Louisville",
                            "state": "Kentucky",
                            "zip": "40213",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.25424,
                                "lon": -85.75941
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840595",
                            "city": "Lewiston",
                            "state": "Maine",
                            "zip": "04240",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 44.10035,
                                "lon": -70.21478
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840520",
                            "city": "Baltimore",
                            "state": "Maryland",
                            "zip": "21237",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.29038,
                                "lon": -76.61219
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840560",
                            "city": "Baltimore",
                            "state": "Maryland",
                            "zip": "21237",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.29038,
                                "lon": -76.61219
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840522",
                            "city": "Rockville",
                            "state": "Maryland",
                            "zip": "20852",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.084,
                                "lon": -77.15276
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840505",
                            "city": "Dearborn",
                            "state": "Michigan",
                            "zip": "48124",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.32226,
                                "lon": -83.17631
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840575",
                            "city": "Flint",
                            "state": "Michigan",
                            "zip": "48504",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 43.01253,
                                "lon": -83.68746
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840564",
                            "city": "Minneapolis",
                            "state": "Minnesota",
                            "zip": "55416",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 44.97997,
                                "lon": -93.26384
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840558",
                            "city": "Butte",
                            "state": "Montana",
                            "zip": "59701",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 46.00382,
                                "lon": -112.53474
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840506",
                            "city": "Omaha",
                            "state": "Nebraska",
                            "zip": "68131",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.25626,
                                "lon": -95.94043
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840600",
                            "city": "Henderson",
                            "state": "Nevada",
                            "zip": "89074",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.0397,
                                "lon": -114.98194
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840532",
                            "city": "Las Vegas",
                            "state": "Nevada",
                            "zip": "89119",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.17497,
                                "lon": -115.13722
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840599",
                            "city": "Las Vegas",
                            "state": "Nevada",
                            "zip": "89148",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.17497,
                                "lon": -115.13722
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840539",
                            "city": "Nashua",
                            "state": "New Hampshire",
                            "zip": "03063",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.76537,
                                "lon": -71.46757
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840576",
                            "city": "Albuquerque",
                            "state": "New Mexico",
                            "zip": "87131",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.08449,
                                "lon": -106.65114
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840583",
                            "city": "Jamaica",
                            "state": "New York",
                            "zip": "11432",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.69149,
                                "lon": -73.80569
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840531",
                            "city": "New Hyde Park",
                            "state": "New York",
                            "zip": "11042",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.7351,
                                "lon": -73.68791
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840557",
                            "city": "Syracuse",
                            "state": "New York",
                            "zip": "13214-2016",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 43.04812,
                                "lon": -76.14742
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840541",
                            "city": "Durham",
                            "state": "North Carolina",
                            "zip": "27710",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.99403,
                                "lon": -78.89862
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840604",
                            "city": "Greenville",
                            "state": "North Carolina",
                            "zip": "27858",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.61266,
                                "lon": -77.36635
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840540",
                            "city": "Hickory",
                            "state": "North Carolina",
                            "zip": "28601",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.73319,
                                "lon": -81.3412
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840513",
                            "city": "Morehead City",
                            "state": "North Carolina",
                            "zip": "28557",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.72294,
                                "lon": -76.72604
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840592",
                            "city": "Salisbury",
                            "state": "North Carolina",
                            "zip": "28144",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.67097,
                                "lon": -80.47423
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840535",
                            "city": "Wilmington",
                            "state": "North Carolina",
                            "zip": "28401",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.22573,
                                "lon": -77.94471
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840515",
                            "city": "Winston-Salem",
                            "state": "North Carolina",
                            "zip": "27103",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.09986,
                                "lon": -80.24422
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840579",
                            "city": "Columbus",
                            "state": "Ohio",
                            "zip": "43213",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.96118,
                                "lon": -82.99879
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840524",
                            "city": "Dayton",
                            "state": "Ohio",
                            "zip": "45439",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.75895,
                                "lon": -84.19161
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840503",
                            "city": "Maumee",
                            "state": "Ohio",
                            "zip": "43537",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.56283,
                                "lon": -83.65382
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840618",
                            "city": "Eugene",
                            "state": "Oregon",
                            "zip": "97404",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 44.05207,
                                "lon": -123.08675
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840610",
                            "city": "Philadelphia",
                            "state": "Pennsylvania",
                            "zip": "19107",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.95233,
                                "lon": -75.16379
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840551",
                            "city": "Smithfield",
                            "state": "Pennsylvania",
                            "zip": "15478",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.80313,
                                "lon": -79.80783
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840584",
                            "city": "Tipton",
                            "state": "Pennsylvania",
                            "zip": "16684",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.6359,
                                "lon": -78.29585
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840622",
                            "city": "Charleston",
                            "state": "South Carolina",
                            "zip": "29407",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.77657,
                                "lon": -79.93092
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840611",
                            "city": "Rapid City",
                            "state": "South Dakota",
                            "zip": "57701",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 44.08054,
                                "lon": -103.23101
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840605",
                            "city": "Amarillo",
                            "state": "Texas",
                            "zip": "79106",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.222,
                                "lon": -101.8313
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840553",
                            "city": "Austin",
                            "state": "Texas",
                            "zip": "78731",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.26715,
                                "lon": -97.74306
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840598",
                            "city": "Austin",
                            "state": "Texas",
                            "zip": "78731",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.26715,
                                "lon": -97.74306
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840502",
                            "city": "Corpus Christi",
                            "state": "Texas",
                            "zip": "78404",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 27.80058,
                                "lon": -97.39638
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840601",
                            "city": "Dallas",
                            "state": "Texas",
                            "zip": "75208",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.78306,
                                "lon": -96.80667
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840586",
                            "city": "Dallas",
                            "state": "Texas",
                            "zip": "75216",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.78306,
                                "lon": -96.80667
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840547",
                            "city": "Dallas",
                            "state": "Texas",
                            "zip": "75230",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.78306,
                                "lon": -96.80667
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840530",
                            "city": "Dallas",
                            "state": "Texas",
                            "zip": "75231",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.78306,
                                "lon": -96.80667
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840545",
                            "city": "Dallas",
                            "state": "Texas",
                            "zip": "75246",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.78306,
                                "lon": -96.80667
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840554",
                            "city": "Edinburg",
                            "state": "Texas",
                            "zip": "78539",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 26.30174,
                                "lon": -98.16334
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840544",
                            "city": "Houston",
                            "state": "Texas",
                            "zip": "77030",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.76328,
                                "lon": -95.36327
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840514",
                            "city": "Hurst",
                            "state": "Texas",
                            "zip": "76054",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.82346,
                                "lon": -97.17057
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840617",
                            "city": "N Richland Hill",
                            "state": "Texas",
                            "zip": "76180",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.8343,
                                "lon": -97.2289
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840512",
                            "city": "Draper",
                            "state": "Utah",
                            "zip": "84020",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.52467,
                                "lon": -111.86382
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840591",
                            "city": "Murray",
                            "state": "Utah",
                            "zip": "84123",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.66689,
                                "lon": -111.88799
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840526",
                            "city": "Ogden",
                            "state": "Utah",
                            "zip": "84405",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.223,
                                "lon": -111.97383
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840597",
                            "city": "Orem",
                            "state": "Utah",
                            "zip": "84058",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.2969,
                                "lon": -111.69465
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840590",
                            "city": "Salt Lake City",
                            "state": "Utah",
                            "zip": "84102",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.76078,
                                "lon": -111.89105
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840613",
                            "city": "Burlington",
                            "state": "Vermont",
                            "zip": "05401",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 44.47588,
                                "lon": -73.21207
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840504",
                            "city": "Chesapeake",
                            "state": "Virginia",
                            "zip": "23321",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.81904,
                                "lon": -76.27494
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840561",
                            "city": "Norfolk",
                            "state": "Virginia",
                            "zip": "23510",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.84681,
                                "lon": -76.28522
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840625",
                            "city": "Norfolk",
                            "state": "Virginia",
                            "zip": "23510",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.84681,
                                "lon": -76.28522
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840606",
                            "city": "Richmond",
                            "state": "Virginia",
                            "zip": "23227",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.55376,
                                "lon": -77.46026
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840608",
                            "city": "Salem",
                            "state": "Virginia",
                            "zip": "24153",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.29347,
                                "lon": -80.05476
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840571",
                            "city": "Federal Way",
                            "state": "Washington",
                            "zip": "98003",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 47.32232,
                                "lon": -122.31262
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840593",
                            "city": "Spokane",
                            "state": "Washington",
                            "zip": "99220",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 47.65966,
                                "lon": -117.42908
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840609",
                            "city": "Tacoma",
                            "state": "Washington",
                            "zip": "98415-0299",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 47.25288,
                                "lon": -122.44429
                            }
                        },
                        {
                            "facility": "Investigational Site Number 840546",
                            "city": "Milwaukee",
                            "state": "Wisconsin",
                            "zip": "53209-0996",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 43.0389,
                                "lon": -87.90647
                            }
                        },
                        {
                            "facility": "Investigational Site Number 036505",
                            "city": "Box Hill",
                            "zip": "3128",
                            "country": "Australia",
                            "geoPoint": {
                                "lat": -37.81887,
                                "lon": 145.12545
                            }
                        },
                        {
                            "facility": "Investigational Site Number 036501",
                            "city": "Heidelberg",
                            "zip": "3081",
                            "country": "Australia",
                            "geoPoint": {
                                "lat": -37.75,
                                "lon": 145.06667
                            }
                        },
                        {
                            "facility": "Investigational Site Number 036504",
                            "city": "Parkville",
                            "zip": "3050",
                            "country": "Australia",
                            "geoPoint": {
                                "lat": -37.78333,
                                "lon": 144.95
                            }
                        },
                        {
                            "facility": "Investigational Site Number 124504",
                            "city": "Beamsville",
                            "zip": "L0R 1B0",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 43.16681,
                                "lon": -79.48291
                            }
                        },
                        {
                            "facility": "Investigational Site Number 124512",
                            "city": "Brampton",
                            "zip": "L6R 3J5",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 43.68341,
                                "lon": -79.76633
                            }
                        },
                        {
                            "facility": "Investigational Site Number 124502",
                            "city": "Guelph",
                            "zip": "N1H 1B1",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 43.54594,
                                "lon": -80.25599
                            }
                        },
                        {
                            "facility": "Investigational Site Number 124507",
                            "city": "Kelowna",
                            "zip": "V1Y 1Z9",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 49.88307,
                                "lon": -119.48568
                            }
                        },
                        {
                            "facility": "Investigational Site Number 124505",
                            "city": "Montreal",
                            "zip": "H1W 2R7",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 45.50884,
                                "lon": -73.58781
                            }
                        },
                        {
                            "facility": "Investigational Site Number 124511",
                            "city": "Oakville",
                            "zip": "L6H 3P1",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 43.45011,
                                "lon": -79.68292
                            }
                        },
                        {
                            "facility": "Investigational Site Number 124509",
                            "city": "St-Romuald",
                            "zip": "G6W 5M6",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 46.75818,
                                "lon": -71.23921
                            }
                        },
                        {
                            "facility": "Investigational Site Number 124503",
                            "city": "Toronto",
                            "zip": "M9V 4B4",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 43.70011,
                                "lon": -79.4163
                            }
                        },
                        {
                            "facility": "Investigational Site Number 124510",
                            "city": "Toronto",
                            "zip": "M9W 4L9",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 43.70011,
                                "lon": -79.4163
                            }
                        },
                        {
                            "facility": "Investigational Site Number 124501",
                            "city": "Vancouver",
                            "zip": "V5Y 3W2",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 49.24966,
                                "lon": -123.11934
                            }
                        },
                        {
                            "facility": "Investigational Site Number 124508",
                            "city": "Victoria",
                            "zip": "V8V 4A1",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 48.43294,
                                "lon": -123.3693
                            }
                        },
                        {
                            "facility": "Investigational Site Number 152511",
                            "city": "Puerto Varas",
                            "zip": "5480000",
                            "country": "Chile",
                            "geoPoint": {
                                "lat": -41.31946,
                                "lon": -72.98538
                            }
                        },
                        {
                            "facility": "Investigational Site Number 152502",
                            "city": "Santiago",
                            "zip": "7500347",
                            "country": "Chile",
                            "geoPoint": {
                                "lat": -33.45694,
                                "lon": -70.64827
                            }
                        },
                        {
                            "facility": "Investigational Site Number 152501",
                            "city": "Santiago",
                            "zip": "7500710",
                            "country": "Chile",
                            "geoPoint": {
                                "lat": -33.45694,
                                "lon": -70.64827
                            }
                        },
                        {
                            "facility": "Investigational Site Number 152514",
                            "city": "Santiago",
                            "zip": "7500739",
                            "country": "Chile",
                            "geoPoint": {
                                "lat": -33.45694,
                                "lon": -70.64827
                            }
                        },
                        {
                            "facility": "Investigational Site Number 152503",
                            "city": "Santiago",
                            "zip": "8053095",
                            "country": "Chile",
                            "geoPoint": {
                                "lat": -33.45694,
                                "lon": -70.64827
                            }
                        },
                        {
                            "facility": "Investigational Site Number 152507",
                            "city": "Santiago",
                            "country": "Chile",
                            "geoPoint": {
                                "lat": -33.45694,
                                "lon": -70.64827
                            }
                        },
                        {
                            "facility": "Investigational Site Number 152509",
                            "city": "Talagante",
                            "country": "Chile",
                            "geoPoint": {
                                "lat": -33.66386,
                                "lon": -70.92734
                            }
                        },
                        {
                            "facility": "Investigational Site Number 152513",
                            "city": "Temuco",
                            "zip": "4780000",
                            "country": "Chile",
                            "geoPoint": {
                                "lat": -38.73965,
                                "lon": -72.59842
                            }
                        },
                        {
                            "facility": "Investigational Site Number 152504",
                            "city": "Vina Del Mar",
                            "country": "Chile",
                            "geoPoint": {
                                "lat": -33.02457,
                                "lon": -71.55183
                            }
                        },
                        {
                            "facility": "Investigational Site Number 203502",
                            "city": "Cheb",
                            "zip": "35002",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 50.07963,
                                "lon": 12.37392
                            }
                        },
                        {
                            "facility": "Investigational Site Number 203504",
                            "city": "Hranice",
                            "zip": "75301",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 49.54796,
                                "lon": 17.73469
                            }
                        },
                        {
                            "facility": "Investigational Site Number 203507",
                            "city": "Krnov",
                            "zip": "79401",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 50.08967,
                                "lon": 17.70385
                            }
                        },
                        {
                            "facility": "Investigational Site Number 203506",
                            "city": "Liberec",
                            "zip": "460 01",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 50.76711,
                                "lon": 15.05619
                            }
                        },
                        {
                            "facility": "Investigational Site Number 203503",
                            "city": "Olomouc",
                            "zip": "77900",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 49.59552,
                                "lon": 17.25175
                            }
                        },
                        {
                            "facility": "Investigational Site Number 203514",
                            "city": "Plzen",
                            "zip": "301 66",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 49.74747,
                                "lon": 13.37759
                            }
                        },
                        {
                            "facility": "Investigational Site Number 203515",
                            "city": "Plzen",
                            "zip": "301 66",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 49.74747,
                                "lon": 13.37759
                            }
                        },
                        {
                            "facility": "Investigational Site Number 203511",
                            "city": "Praha 4",
                            "zip": "14900",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 50.08804,
                                "lon": 14.42076
                            }
                        },
                        {
                            "facility": "Investigational Site Number 203508",
                            "city": "Praha 5",
                            "zip": "15030",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 50.08804,
                                "lon": 14.42076
                            }
                        },
                        {
                            "facility": "Investigational Site Number 203509",
                            "city": "Praha 8",
                            "zip": "18100",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 50.08804,
                                "lon": 14.42076
                            }
                        },
                        {
                            "facility": "Investigational Site Number 203505",
                            "city": "Prostejov",
                            "zip": "79601",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 49.47188,
                                "lon": 17.11184
                            }
                        },
                        {
                            "facility": "Investigational Site Number 208503",
                            "city": "Aarhus C",
                            "zip": "8000",
                            "country": "Denmark",
                            "geoPoint": {
                                "lat": 56.15674,
                                "lon": 10.21076
                            }
                        },
                        {
                            "facility": "Investigational Site Number 208509",
                            "city": "Horsens",
                            "zip": "8700",
                            "country": "Denmark",
                            "geoPoint": {
                                "lat": 55.86066,
                                "lon": 9.85034
                            }
                        },
                        {
                            "facility": "Investigational Site Number 208502",
                            "city": "Kolding",
                            "zip": "6000",
                            "country": "Denmark",
                            "geoPoint": {
                                "lat": 55.4904,
                                "lon": 9.47216
                            }
                        },
                        {
                            "facility": "Investigational Site Number 208501",
                            "city": "København Nv",
                            "zip": "2400",
                            "country": "Denmark",
                            "geoPoint": {
                                "lat": 55.67594,
                                "lon": 12.56553
                            }
                        },
                        {
                            "facility": "Investigational Site Number 208505",
                            "city": "København S",
                            "zip": "2300",
                            "country": "Denmark",
                            "geoPoint": {
                                "lat": 55.67594,
                                "lon": 12.56553
                            }
                        },
                        {
                            "facility": "Investigational Site Number 208504",
                            "city": "Viborg",
                            "zip": "8800",
                            "country": "Denmark",
                            "geoPoint": {
                                "lat": 56.45319,
                                "lon": 9.40201
                            }
                        },
                        {
                            "facility": "Investigational Site Number 233502",
                            "city": "Pärnu",
                            "zip": "80018",
                            "country": "Estonia",
                            "geoPoint": {
                                "lat": 58.38588,
                                "lon": 24.49711
                            }
                        },
                        {
                            "facility": "Investigational Site Number 233503",
                            "city": "Tallinn",
                            "zip": "10138",
                            "country": "Estonia",
                            "geoPoint": {
                                "lat": 59.43696,
                                "lon": 24.75353
                            }
                        },
                        {
                            "facility": "Investigational Site Number 233501",
                            "city": "Tartu",
                            "zip": "50406",
                            "country": "Estonia",
                            "geoPoint": {
                                "lat": 58.38062,
                                "lon": 26.72509
                            }
                        },
                        {
                            "facility": "Investigational Site Number 348503",
                            "city": "Budapest",
                            "zip": "1134",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.49801,
                                "lon": 19.03991
                            }
                        },
                        {
                            "facility": "Investigational Site Number 348501",
                            "city": "Budapest",
                            "zip": "1138",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.49801,
                                "lon": 19.03991
                            }
                        },
                        {
                            "facility": "Investigational Site Number 348505",
                            "city": "Budapest",
                            "zip": "1212",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.49801,
                                "lon": 19.03991
                            }
                        },
                        {
                            "facility": "Investigational Site Number 348502",
                            "city": "Debrecen",
                            "zip": "4031",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.53333,
                                "lon": 21.63333
                            }
                        },
                        {
                            "facility": "Investigational Site Number 348506",
                            "city": "Kaposvár",
                            "zip": "7400",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 46.36667,
                                "lon": 17.8
                            }
                        },
                        {
                            "facility": "Investigational Site Number 348504",
                            "city": "Pápa",
                            "zip": "8500",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.33004,
                                "lon": 17.4674
                            }
                        },
                        {
                            "facility": "Investigational Site Number 440501",
                            "city": "Kaunas",
                            "zip": "48259",
                            "country": "Lithuania",
                            "geoPoint": {
                                "lat": 54.90272,
                                "lon": 23.90961
                            }
                        },
                        {
                            "facility": "Investigational Site Number 440503",
                            "city": "Kaunas",
                            "zip": "49449",
                            "country": "Lithuania",
                            "geoPoint": {
                                "lat": 54.90272,
                                "lon": 23.90961
                            }
                        },
                        {
                            "facility": "Investigational Site Number 440505",
                            "city": "Kedainiai",
                            "zip": "LT-57164",
                            "country": "Lithuania",
                            "geoPoint": {
                                "lat": 55.28782,
                                "lon": 23.97276
                            }
                        },
                        {
                            "facility": "Investigational Site Number 440504",
                            "city": "Klaipeda",
                            "zip": "LT-92253",
                            "country": "Lithuania",
                            "geoPoint": {
                                "lat": 55.70888,
                                "lon": 21.14311
                            }
                        },
                        {
                            "facility": "Investigational Site Number 440502",
                            "city": "Vilnius",
                            "zip": "LT-10323",
                            "country": "Lithuania",
                            "geoPoint": {
                                "lat": 54.68916,
                                "lon": 25.2798
                            }
                        },
                        {
                            "facility": "Investigational Site Number 484508",
                            "city": "Celaya",
                            "zip": "38000",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 20.52353,
                                "lon": -100.8157
                            }
                        },
                        {
                            "facility": "Investigational Site Number 484501",
                            "city": "Cuernavaca",
                            "zip": "62250",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 18.9261,
                                "lon": -99.23075
                            }
                        },
                        {
                            "facility": "Investigational Site Number 484503",
                            "city": "Guadalajara",
                            "zip": "44130",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 20.66682,
                                "lon": -103.39182
                            }
                        },
                        {
                            "facility": "Investigational Site Number 484504",
                            "city": "Guadalajara",
                            "zip": "44210",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 20.66682,
                                "lon": -103.39182
                            }
                        },
                        {
                            "facility": "Investigational Site Number 484506",
                            "city": "Guadalajara",
                            "zip": "44600",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 20.66682,
                                "lon": -103.39182
                            }
                        },
                        {
                            "facility": "Investigational Site Number 484509",
                            "city": "México",
                            "zip": "06700",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 19.42847,
                                "lon": -99.12766
                            }
                        },
                        {
                            "facility": "Investigational Site Number 484507",
                            "city": "Pachuca",
                            "zip": "42084",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 20.11697,
                                "lon": -98.73329
                            }
                        },
                        {
                            "facility": "Investigational Site Number 484505",
                            "city": "Puebla",
                            "zip": "72190",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 19.03793,
                                "lon": -98.20346
                            }
                        },
                        {
                            "facility": "Investigational Site Number 528505",
                            "city": "Almere",
                            "zip": "1311 RL",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 52.37535,
                                "lon": 5.25295
                            }
                        },
                        {
                            "facility": "Investigational Site Number 616502",
                            "city": "Bialystok",
                            "zip": "15-435",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 53.13333,
                                "lon": 23.16433
                            }
                        },
                        {
                            "facility": "Investigational Site Number 616505",
                            "city": "Krakow",
                            "zip": "31-261",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 50.06143,
                                "lon": 19.93658
                            }
                        },
                        {
                            "facility": "Investigational Site Number 616506",
                            "city": "Krakow",
                            "zip": "31-548",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 50.06143,
                                "lon": 19.93658
                            }
                        },
                        {
                            "facility": "Investigational Site Number 616507",
                            "city": "Plock",
                            "zip": "09-400",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 52.54682,
                                "lon": 19.70638
                            }
                        },
                        {
                            "facility": "Investigational Site Number 616504",
                            "city": "Szczecin",
                            "zip": "70-506",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 53.42894,
                                "lon": 14.55302
                            }
                        },
                        {
                            "facility": "Investigational Site Number 616503",
                            "city": "Warszawa",
                            "zip": "01-518",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 52.22977,
                                "lon": 21.01178
                            }
                        },
                        {
                            "facility": "Investigational Site Number 616501",
                            "city": "Warszawa",
                            "zip": "02-507",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 52.22977,
                                "lon": 21.01178
                            }
                        },
                        {
                            "facility": "Investigational Site Number 642507",
                            "city": "Brasov",
                            "zip": "500365",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 45.64861,
                                "lon": 25.60613
                            }
                        },
                        {
                            "facility": "Investigational Site Number 642510",
                            "city": "Bucharest",
                            "zip": "010825",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 44.43225,
                                "lon": 26.10626
                            }
                        },
                        {
                            "facility": "Investigational Site Number 642508",
                            "city": "Bucuresti",
                            "zip": "020042",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 44.42802,
                                "lon": 26.09665
                            }
                        },
                        {
                            "facility": "Investigational Site Number 642509",
                            "city": "Bucuresti",
                            "zip": "020475",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 44.42802,
                                "lon": 26.09665
                            }
                        },
                        {
                            "facility": "Investigational Site Number 642506",
                            "city": "Hunedoara",
                            "zip": "331057",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 45.75,
                                "lon": 22.9
                            }
                        },
                        {
                            "facility": "Investigational Site Number 642505",
                            "city": "Iasi",
                            "zip": "700547",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 47.16667,
                                "lon": 27.6
                            }
                        },
                        {
                            "facility": "Investigational Site Number 642502",
                            "city": "Oradea",
                            "zip": "410169",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 47.0458,
                                "lon": 21.91833
                            }
                        },
                        {
                            "facility": "Investigational Site Number 642511",
                            "city": "Sibiu",
                            "zip": "550371",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 45.8,
                                "lon": 24.15
                            }
                        },
                        {
                            "facility": "Investigational Site Number 642501",
                            "city": "Targu Mures",
                            "zip": "540142",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 46.54245,
                                "lon": 24.55747
                            }
                        },
                        {
                            "facility": "Investigational Site Number 642504",
                            "city": "Timisoara",
                            "zip": "300125",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 45.75372,
                                "lon": 21.22571
                            }
                        },
                        {
                            "facility": "Investigational Site Number 642503",
                            "city": "Timisoara",
                            "zip": "300456",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 45.75372,
                                "lon": 21.22571
                            }
                        },
                        {
                            "facility": "Investigational Site Number 643511",
                            "city": "Arkhangelsk",
                            "zip": "163045",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 64.5401,
                                "lon": 40.5433
                            }
                        },
                        {
                            "facility": "Investigational Site Number 643512",
                            "city": "Moscow",
                            "zip": "119435",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 55.75222,
                                "lon": 37.61556
                            }
                        },
                        {
                            "facility": "Investigational Site Number 643508",
                            "city": "Penza",
                            "zip": "440026",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 53.20066,
                                "lon": 45.00464
                            }
                        },
                        {
                            "facility": "Investigational Site Number 643501",
                            "city": "Saint-Petersburg",
                            "zip": "190013",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 59.93863,
                                "lon": 30.31413
                            }
                        },
                        {
                            "facility": "Investigational Site Number 643513",
                            "city": "Samara",
                            "zip": "443041",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 53.20007,
                                "lon": 50.15
                            }
                        },
                        {
                            "facility": "Investigational Site Number 643507",
                            "city": "Saratov",
                            "zip": "410030",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 51.54056,
                                "lon": 46.00861
                            }
                        },
                        {
                            "facility": "Investigational Site Number 643514",
                            "city": "Saratov",
                            "zip": "410053",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 51.54056,
                                "lon": 46.00861
                            }
                        },
                        {
                            "facility": "Investigational Site Number 643506",
                            "city": "St-Petersburg",
                            "zip": "194291",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 59.93863,
                                "lon": 30.31413
                            }
                        },
                        {
                            "facility": "Investigational Site Number 643503",
                            "city": "St-Petersburg",
                            "zip": "194354",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 59.93863,
                                "lon": 30.31413
                            }
                        },
                        {
                            "facility": "Investigational Site Number 643504",
                            "city": "St-Petersburg",
                            "zip": "194354",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 59.93863,
                                "lon": 30.31413
                            }
                        },
                        {
                            "facility": "Investigational Site Number 643502",
                            "city": "St-Petersburg",
                            "zip": "195257",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 59.93863,
                                "lon": 30.31413
                            }
                        },
                        {
                            "facility": "Investigational Site Number 643505",
                            "city": "St. Petersburg",
                            "zip": "194358",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 59.93863,
                                "lon": 30.31413
                            }
                        },
                        {
                            "facility": "Investigational Site Number 643509",
                            "city": "Voronezh",
                            "zip": "394018",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 51.67204,
                                "lon": 39.1843
                            }
                        },
                        {
                            "facility": "Investigational Site Number 703505",
                            "city": "Bratislava",
                            "zip": "85101",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 48.14816,
                                "lon": 17.10674
                            }
                        },
                        {
                            "facility": "Investigational Site Number 703507",
                            "city": "Bytca",
                            "zip": "01401",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 49.22404,
                                "lon": 18.55878
                            }
                        },
                        {
                            "facility": "Investigational Site Number 703502",
                            "city": "Kosice",
                            "zip": "04001",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 48.71395,
                                "lon": 21.25808
                            }
                        },
                        {
                            "facility": "Investigational Site Number 703512",
                            "city": "Kosice",
                            "zip": "04001",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 48.71395,
                                "lon": 21.25808
                            }
                        },
                        {
                            "facility": "Investigational Site Number 703510",
                            "city": "Kosice",
                            "zip": "04013",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 48.71395,
                                "lon": 21.25808
                            }
                        },
                        {
                            "facility": "Investigational Site Number 703511",
                            "city": "Lubochna",
                            "zip": "3491",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 49.12011,
                                "lon": 19.16891
                            }
                        },
                        {
                            "facility": "Investigational Site Number 703508",
                            "city": "Moldava Nad Bodvou",
                            "zip": "04525",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 48.61428,
                                "lon": 20.99957
                            }
                        },
                        {
                            "facility": "Investigational Site Number 703504",
                            "city": "Nove Mesto Nad Vahom",
                            "zip": "91501",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 48.75763,
                                "lon": 17.8309
                            }
                        },
                        {
                            "facility": "Investigational Site Number 703509",
                            "city": "Nove Zamky",
                            "zip": "94001",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 47.98544,
                                "lon": 18.16195
                            }
                        },
                        {
                            "facility": "Investigational Site Number 703513",
                            "city": "Trnava",
                            "zip": "91701",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 48.37741,
                                "lon": 17.58723
                            }
                        },
                        {
                            "facility": "Investigational Site Number 703501",
                            "city": "Zilina",
                            "zip": "01001",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 49.22315,
                                "lon": 18.73941
                            }
                        },
                        {
                            "facility": "Investigational Site Number 724509",
                            "city": "Alicante",
                            "zip": "03010",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 38.34517,
                                "lon": -0.48149
                            }
                        },
                        {
                            "facility": "Investigational Site Number 724506",
                            "city": "Alzira",
                            "zip": "46600",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 39.15,
                                "lon": -0.43333
                            }
                        },
                        {
                            "facility": "Investigational Site Number 724504",
                            "city": "Barcelona",
                            "zip": "08035",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 41.38879,
                                "lon": 2.15899
                            }
                        },
                        {
                            "facility": "Investigational Site Number 724510",
                            "city": "Barcelona",
                            "zip": "08036",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 41.38879,
                                "lon": 2.15899
                            }
                        },
                        {
                            "facility": "Investigational Site Number 724505",
                            "city": "Cáceres",
                            "zip": "10003",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 39.47649,
                                "lon": -6.37224
                            }
                        },
                        {
                            "facility": "Investigational Site Number 724503",
                            "city": "El Ferrol",
                            "zip": "15405",
                            "country": "Spain"
                        },
                        {
                            "facility": "Investigational Site Number 724508",
                            "city": "La Coruña",
                            "zip": "15006",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 43.37135,
                                "lon": -8.396
                            }
                        },
                        {
                            "facility": "Investigational Site Number 724501",
                            "city": "Sabadell",
                            "zip": "08208",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 41.54329,
                                "lon": 2.10942
                            }
                        },
                        {
                            "facility": "Investigational Site Number 724507",
                            "city": "Segovia",
                            "zip": "40002",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 40.94808,
                                "lon": -4.11839
                            }
                        },
                        {
                            "facility": "Investigational Site Number 724502",
                            "city": "Valencia",
                            "zip": "46014",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 39.46975,
                                "lon": -0.37739
                            }
                        },
                        {
                            "facility": "Investigational Site Number 752501",
                            "city": "Ljungby",
                            "zip": "341 82",
                            "country": "Sweden",
                            "geoPoint": {
                                "lat": 56.83324,
                                "lon": 13.94082
                            }
                        },
                        {
                            "facility": "Investigational Site Number 752503",
                            "city": "Malmö",
                            "zip": "211 52",
                            "country": "Sweden",
                            "geoPoint": {
                                "lat": 55.60587,
                                "lon": 13.00073
                            }
                        },
                        {
                            "facility": "Investigational Site Number 752504",
                            "city": "Rättvik",
                            "zip": "79530",
                            "country": "Sweden",
                            "geoPoint": {
                                "lat": 60.88632,
                                "lon": 15.11787
                            }
                        },
                        {
                            "facility": "Investigational Site Number 752506",
                            "city": "Stenungssund",
                            "zip": "44431",
                            "country": "Sweden"
                        },
                        {
                            "facility": "Investigational Site Number 752505",
                            "city": "Stockholm",
                            "zip": "11526",
                            "country": "Sweden",
                            "geoPoint": {
                                "lat": 59.33258,
                                "lon": 18.0649
                            }
                        },
                        {
                            "facility": "Investigational Site Number 752502",
                            "city": "Vällingby",
                            "zip": "16268",
                            "country": "Sweden",
                            "geoPoint": {
                                "lat": 59.36441,
                                "lon": 17.87407
                            }
                        },
                        {
                            "facility": "Investigational Site Number 804501",
                            "city": "Chernivtsi",
                            "zip": "58022",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 48.29149,
                                "lon": 25.94034
                            }
                        },
                        {
                            "facility": "Investigational Site Number 804510",
                            "city": "Kyiv",
                            "zip": "03049",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 50.45466,
                                "lon": 30.5238
                            }
                        },
                        {
                            "facility": "Investigational Site Number 804507",
                            "city": "Kyiv",
                            "zip": "04050",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 50.45466,
                                "lon": 30.5238
                            }
                        },
                        {
                            "facility": "Investigational Site Number 804511",
                            "city": "Kyiv",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 50.45466,
                                "lon": 30.5238
                            }
                        },
                        {
                            "facility": "Investigational Site Number 804513",
                            "city": "Lviv",
                            "zip": "79010",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 49.83826,
                                "lon": 24.02324
                            }
                        },
                        {
                            "facility": "Investigational Site Number 804502",
                            "city": "Vinnytsya",
                            "zip": "21001",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 49.23278,
                                "lon": 28.48097
                            }
                        },
                        {
                            "facility": "Investigational Site Number 804508",
                            "city": "Vinnytsya",
                            "zip": "21010",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 49.23278,
                                "lon": 28.48097
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "27650977",
                            "type": "RESULT",
                            "citation": "Aroda VR, Rosenstock J, Wysham C, Unger J, Bellido D, Gonzalez-Galvez G, Takami A, Guo H, Niemoeller E, Souhami E, Bergenstal RM; LixiLan-L Trial Investigators. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care. 2016 Nov;39(11):1972-1980. doi: 10.2337/dc16-1495. Epub 2016 Sep 20. Erratum In: Diabetes Care. 2017 Jun;40(6):809. doi: 10.2337/dc17-er06d."
                        },
                        {
                            "pmid": "31848983",
                            "type": "DERIVED",
                            "citation": "Tabak AG, Anderson J, Aschner P, Liu M, Saremi A, Stella P, Tinahones FJ, Wysham C, Meier JJ. Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis. Diabetes Ther. 2020 Jan;11(1):305-318. doi: 10.1007/s13300-019-00735-7. Epub 2019 Dec 17."
                        },
                        {
                            "pmid": "31359368",
                            "type": "DERIVED",
                            "citation": "Blonde L, Bailey TS, Chao J, Dex TA, Frias JP, Meneghini LF, Roberts M, Aroda VR. Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial. Adv Ther. 2019 Sep;36(9):2310-2326. doi: 10.1007/s12325-019-01033-1. Epub 2019 Jul 29."
                        },
                        {
                            "pmid": "31114694",
                            "type": "DERIVED",
                            "citation": "Dailey G, Bajaj HS, Dex T, Groleau M, Stager W, Vinik A. Post hoc efficacy and safety analysis of insulin glargine/lixisenatide fixed- ratio combination in North American patients compared with the rest of world. BMJ Open Diabetes Res Care. 2019 Mar 21;7(1):e000581. doi: 10.1136/bmjdrc-2018-000581. eCollection 2019."
                        },
                        {
                            "pmid": "30550345",
                            "type": "DERIVED",
                            "citation": "Schmider W, Belder R, Lee M, Niemoeller E, Souhami E, Frias JP. Impact of dose capping in insulin glargine/lixisenatide fixed-ratio combination trials in patients with type 2 diabetes. Curr Med Res Opin. 2019 Jun;35(6):1081-1089. doi: 10.1080/03007995.2018.1558852. Epub 2019 Jan 11."
                        },
                        {
                            "pmid": "30218434",
                            "type": "DERIVED",
                            "citation": "Zisman A, Dex T, Roberts M, Saremi A, Chao J, Aroda VR. Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L. Diabetes Ther. 2018 Oct;9(5):2155-2162. doi: 10.1007/s13300-018-0507-0. Epub 2018 Sep 14. Erratum In: Diabetes Ther. 2019 Feb;10(1):327. doi: 10.1007/s13300-018-0544-8."
                        },
                        {
                            "pmid": "29974618",
                            "type": "DERIVED",
                            "citation": "Rosenstock J, Handelsman Y, Vidal J, Ampudia Blasco FJ, Giorgino F, Liu M, Perfetti R, Meier JJ. Propensity-score-matched comparative analyses of simultaneously administered fixed-ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes. Diabetes Obes Metab. 2018 Dec;20(12):2821-2829. doi: 10.1111/dom.13462. Epub 2018 Aug 13."
                        },
                        {
                            "pmid": "29923298",
                            "type": "DERIVED",
                            "citation": "Trujillo JM, Roberts M, Dex T, Chao J, White J, LaSalle J. Low incidence of gastrointestinal adverse events over time with a fixed-ratio combination of insulin glargine and lixisenatide versus lixisenatide alone. Diabetes Obes Metab. 2018 Nov;20(11):2690-2694. doi: 10.1111/dom.13444. Epub 2018 Aug 21."
                        },
                        {
                            "pmid": "29143919",
                            "type": "DERIVED",
                            "citation": "Niemoeller E, Souhami E, Wu Y, Jensen KH. iGlarLixi Reduces Glycated Hemoglobin to a Greater Extent Than Basal Insulin Regardless of Levels at Screening: Post Hoc Analysis of LixiLan-L. Diabetes Ther. 2018 Feb;9(1):373-382. doi: 10.1007/s13300-017-0336-6. Epub 2017 Nov 16."
                        },
                        {
                            "pmid": "28386990",
                            "type": "DERIVED",
                            "citation": "Wysham C, Bonadonna RC, Aroda VR, Puig Domingo M, Kapitza C, Stager W, Yu C, Niemoeller E, Souhami E, Bergenstal RM; LixiLan-L trial investigators. Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) vs insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial. Diabetes Obes Metab. 2017 Oct;19(10):1408-1415. doi: 10.1111/dom.12961. Epub 2017 Jun 8."
                        }
                    ]
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "preAssignmentDetails": "After screening phase, 1018 participants entered 6 week run-in phase during which participants were switched (if necessary) to insulin glargine and dose was titrated/stabilized, any oral anti-diabetic drugs (OAD) other than metformin were stopped. 282 participants were run-in failures and 736 were randomized in 1:1(FRC:insulin glargine arms) ratio.",
                    "recruitmentDetails": "The study was conducted at 236 centers in 18 countries. A total of 1930 participants were screened between January 27, 2014 and October 15, 2014. 912 participants were not eligible for run-in-phase mainly due to glycated hemoglobin (HbA1c) value being out of the protocol defined range.",
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC)",
                            "description": "FRC injected subcutaneously once daily (QD) for 30 weeks. Dose individually adjusted."
                        },
                        {
                            "id": "FG001",
                            "title": "Insulin Glargine",
                            "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "367"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "369"
                                        }
                                    ]
                                },
                                {
                                    "type": "Treated",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "365"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "365"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "336"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "355"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "31"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "14"
                                        }
                                    ]
                                }
                            ],
                            "dropWithdraws": [
                                {
                                    "type": "Randomized but not treated",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "2"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "4"
                                        }
                                    ]
                                },
                                {
                                    "type": "Poor compliance to protocol",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "4"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "1"
                                        }
                                    ]
                                },
                                {
                                    "type": "Adverse Event",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "12"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "3"
                                        }
                                    ]
                                },
                                {
                                    "type": "Lost to Follow-up",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        }
                                    ]
                                },
                                {
                                    "type": "Other than specified above",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "12"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "6"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination",
                            "description": "FRC injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                        },
                        {
                            "id": "BG001",
                            "title": "Insulin Glargine",
                            "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                        },
                        {
                            "id": "BG002",
                            "title": "Total",
                            "description": "Total of all reporting groups"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "367"
                                },
                                {
                                    "groupId": "BG001",
                                    "value": "369"
                                },
                                {
                                    "groupId": "BG002",
                                    "value": "736"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Continuous",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "years",
                            "classes": [
                                {
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "59.6",
                                                    "spread": "9.4"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "60.3",
                                                    "spread": "8.7"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "60.0",
                                                    "spread": "9.1"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex: Female, Male",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "title": "Female",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "202"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "190"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "392"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Male",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "165"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "179"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "344"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Race",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "title": "Caucasian",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "337"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "338"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "675"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Black",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "17"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "21"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "38"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian/Oriental",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "12"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "8"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "20"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Other",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "3"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Ethnicity",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "title": "Hispanic",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "66"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "66"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "132"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Not Hispanic",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "301"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "303"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "604"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "OAD Use",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "title": "Yes",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "349"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "350"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "699"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "No",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "18"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "19"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "37"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "OAD Use at Screening by Class",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "title": "Metformin",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "170"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "190"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "360"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Sulfonylurea",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "16"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "14"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "30"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Sodium glucose co-transporter 2 (SGLT-2) inhibitor",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "1"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Dipeptidyl-peptidase 4 (DPP-4) inhibitor",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "6"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Glinide",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "2"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Metformin + Sulfonylurea",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "137"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "118"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "255"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Metformin + DPP-4 inhibitor",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "20"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "18"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "38"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Metfomrin + Glinide",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "5"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Sulfonylurea + DPP-4 inhibitor",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "2"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "None",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "18"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "19"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "37"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Body Mass Index (BMI)",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "kg/m^2",
                            "classes": [
                                {
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "31.33",
                                                    "spread": "4.25"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "30.96",
                                                    "spread": "4.15"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "31.14",
                                                    "spread": "4.20"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Duration of Diabetes",
                            "populationDescription": "Only participants with available data for this baseline measure were included in the analysis.",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "years",
                            "classes": [
                                {
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "368"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "735"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "12.02",
                                                    "spread": "6.64"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "12.13",
                                                    "spread": "6.85"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "12.08",
                                                    "spread": "6.74"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Daily Dose of Metformin",
                            "populationDescription": "Only participants with available data for this baseline measure were included in the analysis.",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "mg",
                            "classes": [
                                {
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "329"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "329"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "658"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "2082.8",
                                                    "spread": "499.2"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "2042.0",
                                                    "spread": "455.9"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "2062.4",
                                                    "spread": "478.1"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Screening Glycated Hemoglobin (HbA1c)",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "percentage of HbA1c",
                            "classes": [
                                {
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "8.51",
                                                    "spread": "0.65"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "8.54",
                                                    "spread": "0.67"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "8.53",
                                                    "spread": "0.66"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Baseline HbA1c",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "percentage of HbA1c",
                            "classes": [
                                {
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "8.07",
                                                    "spread": "0.68"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "8.08",
                                                    "spread": "0.73"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "8.08",
                                                    "spread": "0.71"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Fasting Plasma Glucose (FPG)",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "mmol/L",
                            "classes": [
                                {
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "367"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "369"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "736"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "7.34",
                                                    "spread": "1.95"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "7.36",
                                                    "spread": "2.12"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "7.35",
                                                    "spread": "2.04"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "Change in Glycated Hemoglobin (HbA1c) From Baseline to Week 30",
                            "description": "Change in HbA1c was calculated by subtracting baseline value from Week 30 value.",
                            "populationDescription": "Modified intent-to-treat (mITT) population: all randomized participants who had both baseline and at least one post-baseline efficacy assessment. Here, number of participants analyzed = participants with baseline and at least one post-baseline HbA1c assessment during study period.",
                            "reportingStatus": "POSTED",
                            "paramType": "LEAST_SQUARES_MEAN",
                            "dispersionType": "Standard Error",
                            "unitOfMeasure": "percentage of HbA1c",
                            "timeFrame": "Baseline, Week 30",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination",
                                    "description": "FRC injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Insulin Glargine",
                                    "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "364"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "364"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-1.13",
                                                    "spread": "0.057"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.62",
                                                    "spread": "0.055"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Analysis was performed using Mixed-effect model with repeated measures (MMRM) with treatment groups, randomization strata of Week -1 HbA1c (\\<8.0, ≥8.0%), randomization strata of metformin use at screening, visits, treatment-by-visit interaction and country as fixed effects and baseline HbA1c value-by-visit interaction as covariates. A hierarchical testing procedure was used to control type I error and handle multiple endpoint analyses.",
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "<0.0001",
                                    "pValueComment": "Threshold for significance at 0.05 level.",
                                    "statisticalMethod": "Mixed Models Analysis",
                                    "paramType": "Least square (LS) mean difference",
                                    "paramValue": "-0.52",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-0.633",
                                    "ciUpperLimit": "-0.397",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "0.06",
                                    "estimateComment": "Insulin Glargine/Lixisenatide FRC vs Insulin Glargine"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Percentage of Participants With HbA1c <7.0% or ≤6.5% at Week 30",
                            "populationDescription": "mITT population. Participants with no value for HbA1c at Week 30 were counted as non-responders.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "percentage of participants",
                            "timeFrame": "Week 30",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination",
                                    "description": "FRC injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Insulin Glargine",
                                    "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "366"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "365"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "HbA1c <7.0%",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "54.9"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "29.6"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "HbA1c ≤ 6.5%",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "33.9"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "14.2"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "HbA1c \\<7.0%: Insulin Glargine/Lixisenatide FRC vs Insulin Glargine.\n\nAnalysis was performed using Cochran-Mantel-Haenszel method stratified on randomization strata of Week -1 HbA1c (\\<8.0%, ≥8.0%) and randomization strata of metformin use at screening. This analysis was out of testing order.",
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "<0.0001",
                                    "pValueComment": "Threshold for significance at 0.05 level.",
                                    "statisticalMethod": "Cochran-Mantel-Haenszel",
                                    "paramType": "Difference in percentage",
                                    "paramValue": "25.52",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "18.94",
                                    "ciUpperLimit": "32.10",
                                    "estimateComment": "HbA1c \\<7.0%: Insulin Glargine/Lixisenatide FRC vs Insulin Glargine"
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "HbA1c ≤6.5%: Insulin Glargine/Lixisenatide FRC vs Insulin Glargine.\n\nAnalysis was performed using Cochran-Mantel-Haenszel method stratified on randomization strata of Week -1 HbA1c (\\<8.0%, ≥8.0%) and randomization strata of metformin use at screening. This analysis was out of testing order.",
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "<0.0001",
                                    "statisticalMethod": "Cochran-Mantel-Haenszel",
                                    "paramType": "Difference in percentage",
                                    "paramValue": "19.76",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "13.90",
                                    "ciUpperLimit": "25.62",
                                    "estimateComment": "HbA1c ≤6.5%: Insulin Glargine/Lixisenatide FRC vs Insulin Glargine"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Change in 2-hour Plasma Blood Glucose Excursion From Baseline to Week 30",
                            "description": "Plasma glucose excursion = 2-hour postprandial glucose (PPG) minus plasma glucose value obtained 30 minutes prior to the start of the meal and before investigational medicinal product (IMP) administration, if IMP was injected before breakfast. Change in plasma glucose excursions was calculated by subtracting baseline value from Week 30 value.",
                            "populationDescription": "mITT population. Here, number of participants analyzed = participants with baseline and at least one post-baseline plasma glucose excursion assessment during study period. Missing data was imputed using last observation carried forward (LOCF).",
                            "reportingStatus": "POSTED",
                            "paramType": "LEAST_SQUARES_MEAN",
                            "dispersionType": "Standard Error",
                            "unitOfMeasure": "mmol/L",
                            "timeFrame": "Baseline, Week 30",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination",
                                    "description": "FRC injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Insulin Glargine",
                                    "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "329"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "336"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-3.9",
                                                    "spread": "0.285"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.47",
                                                    "spread": "0.274"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Testing according to the hierarchical testing procedure (continued only if previous endpoints were statistically significant). Analysis was performed using analysis of covariance (ANCOVA) model with treatment groups, randomization strata of Week -1 HbA1c (\\<8.0, ≥8.0%), randomization strata of metformin use at screening and country as fixed effects and baseline 2-hour plasma glucose excursion value as a covariate.",
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "<0.0001",
                                    "pValueComment": "Threshold for significance at 0.05 level.",
                                    "statisticalMethod": "ANCOVA",
                                    "paramType": "LS Mean Difference",
                                    "paramValue": "-3.43",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-3.925",
                                    "ciUpperLimit": "-2.939",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "0.251",
                                    "estimateComment": "Insulin Glargine/Lixisenatide FRC vs Insulin Glargine"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Change in Body Weight From Baseline to Week 30",
                            "description": "Change in body weight was calculated by subtracting baseline value from Week 30 value.",
                            "populationDescription": "mITT population. Here, number of participants analyzed = participants with baseline and at least one post-baseline body weight assessment during study period.",
                            "reportingStatus": "POSTED",
                            "paramType": "LEAST_SQUARES_MEAN",
                            "dispersionType": "Standard Error",
                            "unitOfMeasure": "kg",
                            "timeFrame": "Baseline, Week 30",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination",
                                    "description": "FRC injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Insulin Glargine",
                                    "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "365"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "365"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-0.67",
                                                    "spread": "0.181"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.7",
                                                    "spread": "0.178"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Testing according to the hierarchical testing procedure (continued only if previous endpoints were statistically significant). Analysis was performed using MMRM model with treatment groups, randomization strata of Week -1 HbA1c (\\<8.0, ≥8.0%), randomization strata of metformin use at screening, scheduled visits, treatment-by-visit interaction and country as fixed effects and baseline body weight value-by-visit interaction as covariates.",
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "<0.0001",
                                    "pValueComment": "Threshold for significance at 0.05 level.",
                                    "statisticalMethod": "Mixed Models Analysis",
                                    "paramType": "LS Mean Difference",
                                    "paramValue": "-1.37",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-1.808",
                                    "ciUpperLimit": "-0.93",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "0.224",
                                    "estimateComment": "Insulin Glargine/Lixisenatide FRC vs Insulin Glargine"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Mean Change in 7-point Self-monitored Plasma Glucose (SMPG) Profile From Baseline to Week 30",
                            "description": "Participants recorded a 7-point plasma glucose profile measured before and 2-hours after each meal and at bedtime, two times in a week before baseline, before visit Week 12 and before visit Week 30 and the average value across the profiles performed in the week before a visit for the 7 time points was calculated. Change in average 7 point SMPG was calculated by subtracting baseline value from Week 30 value. The analysis included all scheduled measurements obtained during the study. The missing data was handled by mixed effect model with repeated measures (MMRM) approach.",
                            "populationDescription": "mITT population. Here, number of participants analyzed= participants with baseline and at least one post-baseline 7-point SMPG assessment during study period.",
                            "reportingStatus": "POSTED",
                            "paramType": "LEAST_SQUARES_MEAN",
                            "dispersionType": "Standard Error",
                            "unitOfMeasure": "mmol/L",
                            "timeFrame": "Baseline, Week 30",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination",
                                    "description": "FRC injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Insulin Glargine",
                                    "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "323"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "320"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-1.5",
                                                    "spread": "0.137"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.6",
                                                    "spread": "0.13"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Testing according to the hierarchical testing procedure (continued only if previous endpoints were statistically significant). Analysis was performed using MMRM model with treatment groups, randomization strata of Week -1 HbA1c (\\<8.0, ≥8.0%), randomization strata of metformin use at screening, scheduled visits, treatment-by-visit interaction and country as fixed effects and baseline average SMPG value-by-visit interaction as covariates.",
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "<0.0001",
                                    "pValueComment": "Threshold for significance at 0.05 level.",
                                    "statisticalMethod": "Mixed Models Analysis",
                                    "paramType": "LS Mean Difference",
                                    "paramValue": "-0.9",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-1.154",
                                    "ciUpperLimit": "-0.64",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "0.131",
                                    "estimateComment": "Insulin Glargine/Lixisenatide FRC vs Insulin Glargine"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Percentage of Participants Reaching HbA1c <7.0% With No Body Weight Gain at Week 30",
                            "populationDescription": "mITT population. Participants without HbA1c and/or body weight value at Week 30 were counted as non-responders.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "percentage of participants",
                            "timeFrame": "Week 30",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination",
                                    "description": "FRC injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Insulin Glargine",
                                    "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "366"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "365"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "34.2"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "13.4"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Testing according to the hierarchical testing procedure (continued only if previous endpoints were statistically significant). Analysis was performed using Cochran-Mantel-Haenszel method stratified on randomization strata of Week -1 HbA1c (\\<8.0%, ≥8.0%) and randomization strata of metformin use at screening.",
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "<0.0001",
                                    "pValueComment": "Threshold for significance at 0.05 level.",
                                    "statisticalMethod": "Cochran-Mantel-Haenszel",
                                    "paramType": "difference in percentage",
                                    "paramValue": "20.82",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "14.98",
                                    "ciUpperLimit": "26.66",
                                    "estimateComment": "Insulin Glargine/Lixisenatide FRC vs Insulin Glargine"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Change in Daily Insulin Glargine Dose From Baseline to Week 30",
                            "populationDescription": "mITT population. The analysis included scheduled measurements obtained up to the date of last injection of IMP. Here, number of participants analyzed= participants with insulin glargine dose assessment during study period.",
                            "reportingStatus": "POSTED",
                            "paramType": "LEAST_SQUARES_MEAN",
                            "dispersionType": "Standard Error",
                            "unitOfMeasure": "Units (U)",
                            "timeFrame": "Baseline, Week 30",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination",
                                    "description": "FRC injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Insulin Glargine",
                                    "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "364"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "365"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "10.64",
                                                    "spread": "0.601"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "10.89",
                                                    "spread": "0.587"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Testing according to the hierarchical testing procedure (continued only if previous endpoints were statistically significant). Analysis was performed using MMRM model with treatment groups, randomization strata of Week -1 HbA1c (\\<8.0, ≥8.0%), randomization strata of metformin use at screening, scheduled visits, treatment-by-visit interaction and country as fixed effects and baseline daily insulin glargine dose-by-visit interaction as a covariate.",
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "0.7362",
                                    "pValueComment": "Threshold for significance at 0.05 level.",
                                    "statisticalMethod": "Mixed Models Analysis",
                                    "paramType": "LS Mean Difference",
                                    "paramValue": "-0.26",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-1.762",
                                    "ciUpperLimit": "1.246",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "0.766",
                                    "estimateComment": "Insulin Glargine/Lixisenatide FRC vs Insulin Glargine"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Percentage of Participants Reaching HbA1c <7.0% With No Body Weight Gain at Week 30 and No Documented Symptomatic Hypoglycemia (Plasma Glucose [PG] ≤ 70 mg/dL [3.9 mmol/L]) During 30-Week Treatment Period",
                            "description": "Documented symptomatic hypoglycemia was an event during which typical symptoms of hypoglycemia were accompanied by a measured plasma glucose concentration of ≤70 mg/dL (3.9 mmol/L).",
                            "populationDescription": "mITT population. Participants without HbA1c and/or body weight value at Week 30 were counted as non-responders.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "percentage of participants",
                            "timeFrame": "Baseline up to Week 30",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination",
                                    "description": "FRC injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Insulin Glargine",
                                    "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "366"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "365"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "19.9"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "9.0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Change in FPG From Baseline to Week 30",
                            "description": "Change in FPG was calculated by subtracting baseline value from Week 30 value.",
                            "populationDescription": "mITT population. Here, number of participants analyzed= participants with baseline and at least one post-baseline FPG assessment during study period.",
                            "reportingStatus": "POSTED",
                            "paramType": "LEAST_SQUARES_MEAN",
                            "dispersionType": "Standard Error",
                            "unitOfMeasure": "mmol/L",
                            "timeFrame": "Baseline, Week 30",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination",
                                    "description": "FRC injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Insulin Glargine",
                                    "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "364"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "364"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-0.35",
                                                    "spread": "0.142"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.46",
                                                    "spread": "0.138"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Change in 2-hour PPG From Baseline to Week 30",
                            "description": "Change in PPG was calculated by subtracting baseline value from Week 30 value.",
                            "populationDescription": "mITT population. Here, number of participants analyzed= participants with baseline and at least one post-baseline PPG assessment during study period.",
                            "reportingStatus": "POSTED",
                            "paramType": "LEAST_SQUARES_MEAN",
                            "dispersionType": "Standard Error",
                            "unitOfMeasure": "mmol/L",
                            "timeFrame": "Baseline, Week 30",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination",
                                    "description": "FRC injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Insulin Glargine",
                                    "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "332"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "340"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-4.72",
                                                    "spread": "0.322"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-1.39",
                                                    "spread": "0.31"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Percentage of Participants Reaching HbA1c <7.0% With No Documented Symptomatic Hypoglycemia (PG ≤ 70 mg/dL [3.9 mmol/L]) During 30-Week Treatment Period",
                            "description": "Documented symptomatic hypoglycemia was an event during which typical symptoms of hypoglycemia were accompanied by a measured plasma glucose concentration of ≤70 mg/dL (3.9 mmol/L).",
                            "populationDescription": "mITT population. Participants with no value for HbA1c at Week 30 were counted as non-responders.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "percentage of participants",
                            "timeFrame": "Baseline up to Week 30",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination",
                                    "description": "FRC injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Insulin Glargine",
                                    "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "366"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "365"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "31.7"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "18.6"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Percentage of Participants Requiring Rescue Therapy During 30-Week Treatment Period",
                            "description": "Routine fasting SMPG and central laboratory FPG (and HbA1c after Week 12) values were used to determine the requirement of rescue medication. If fasting SMPG value exceeded the specified limit for 3 consecutive days, the central laboratory FPG (and HbA1c after Week 12) were performed. Threshold values - from Week 8 to Week 12: fasting SMPG/FPG \\>240 mg/dL (13.3 mmol/L), and from Week 12 to Week 30: fasting SMPG/FPG \\>200 mg/dL (11.1 mmol/L) or HbA1c \\>8%.",
                            "populationDescription": "mITT population.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "percentage of participants",
                            "timeFrame": "Baseline up to Week 30",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination",
                                    "description": "FRC injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Insulin Glargine",
                                    "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "366"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "365"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.7"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "6"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Number of Documented Symptomatic Hypoglycemia Events Per Subject-Year",
                            "description": "Documented symptomatic hypoglycemia was an event during which typical symptoms of hypoglycemia were accompanied by a measured plasma glucose concentration of ≤70 mg/dL (3.9 mmol/L).",
                            "populationDescription": "Analysis was performed on safety population defined as all randomized participants who received at least one dose of IMP regardless of the amount of treatment administered.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "events per subject-year",
                            "timeFrame": "First dose of study drug up to 1 day after the last dose administration (median treatment exposure 211 days [FRC], 210 days [Insulin glargine])",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination",
                                    "description": "FRC injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Insulin Glargine",
                                    "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "365"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "365"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.03"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "4.22"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Percentage of Participants With Documented Symptomatic Hypoglycemia",
                            "description": "Documented symptomatic hypoglycemia was an event during which typical symptoms of hypoglycemia were accompanied by a measured plasma glucose concentration of ≤70 mg/dL (3.9 mmol/L).",
                            "populationDescription": "Analysis was performed on safety population.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "percentage of participants",
                            "timeFrame": "First dose of study drug up to 1 day after the last dose administration (median treatment exposure 211 days [FRC], 210 days [Insulin glargine])",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination",
                                    "description": "FRC injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Insulin Glargine",
                                    "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "365"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "365"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "40"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "42.5"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Percentage of Participants With Severe Symptomatic Hypoglycemia",
                            "description": "Severe symptomatic hypoglycemia was an event requiring assistance of another person to actively administer carbohydrate, glucagon, or other resuscitative actions. Plasma glucose measurements might not had been available during such an event, but neurological recovery attributable to the restoration of plasma glucose to normal was considered sufficient evidence that the event had been induced by a low plasma glucose concentration. Severe symptomatic hypoglycemia included all episodes in which neurological impairment was severe enough to prevent self-treatment, and which were thus thought to place participants at risk for injury to themselves or others.",
                            "populationDescription": "Analysis was performed on safety population.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "percentage of participants",
                            "timeFrame": "First dose of study drug up to 1 day after the last dose administration (median treatment exposure 211 days [FRC], 210 days [Insulin glargine])",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination",
                                    "description": "FRC injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Insulin Glargine",
                                    "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "365"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "365"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "1.1"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.3"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "5",
                    "timeFrame": "All Adverse Events (AE) were collected from signature of the informed consent form up to the final visit (Week 30) regardless of seriousness or relationship to investigational product.",
                    "description": "Reported AEs are treatment-emergent that is AEs that developed/worsened during 'on-emergent period' (time from first injection of open-label IMP up to 3 days after the last injection of IMP). Analysis was performed on safety population.",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "Insulin Glargine/Lixisenatide Fixed Ratio Combination",
                            "description": "FRC injected subcutaneously QD for 30 weeks. Dose individually adjusted (median exposure: 211 days).",
                            "seriousNumAffected": 20,
                            "seriousNumAtRisk": 365,
                            "otherNumAffected": 81,
                            "otherNumAtRisk": 365
                        },
                        {
                            "id": "EG001",
                            "title": "Insulin Glargine",
                            "description": "Insulin glargine 100 U/mL injected subcutaneously QD for 30 weeks. Dose individually adjusted (median exposure: 210 days).",
                            "seriousNumAffected": 18,
                            "seriousNumAtRisk": 365,
                            "otherNumAffected": 42,
                            "otherNumAtRisk": 365
                        }
                    ],
                    "seriousEvents": [
                        {
                            "term": "Pneumonia",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Osteomyelitis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Wound infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Benign breast neoplasm",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Benign gastric neoplasm",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Breast cancer",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Squamous cell carcinoma of the tongue",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Gallbladder cancer",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Kaposi's sarcoma",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Hypoglycaemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Hypoglycaemic unconsciousness",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Hypoglycaemic seizure",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Glaucoma",
                            "organSystem": "Eye disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Acute myocardial infarction",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Angina unstable",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Arteriosclerosis coronary artery",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Myocardial infarction",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Supraventricular tachycardia",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Cardiac failure congestive",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Cardiopulmonary failure",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Hypertension",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Cholecystitis chronic",
                            "organSystem": "Hepatobiliary disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Cholecystitis acute",
                            "organSystem": "Hepatobiliary disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Osteoarthritis",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Tendonitis",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Intervertebral disc protrusion",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Renal impairment",
                            "organSystem": "Renal and urinary disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Benign prostatic hyperplasia",
                            "organSystem": "Reproductive system and breast disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Chest discomfort",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Non-cardiac chest pain",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Scar",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Subdural haematoma",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Meniscus injury",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 365
                                }
                            ]
                        }
                    ],
                    "otherEvents": [
                        {
                            "term": "Nasopharyngitis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 32,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 32,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Headache",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 21,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 10,
                                    "numAtRisk": 365
                                }
                            ]
                        },
                        {
                            "term": "Nausea",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 18.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 38,
                                    "numAtRisk": 365
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 365
                                }
                            ]
                        }
                    ]
                },
                "moreInfoModule": {
                    "certainAgreement": {
                        "piSponsorEmployee": false,
                        "restrictionType": "OTHER",
                        "restrictiveAgreement": true,
                        "otherDetails": "If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights."
                    },
                    "pointOfContact": {
                        "title": "Trial Transparency Team",
                        "organization": "Sanofi",
                        "email": "Contact-US@sanofi.com"
                    }
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2025-05-07"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D003920",
                            "term": "Diabetes Mellitus"
                        },
                        {
                            "id": "D003924",
                            "term": "Diabetes Mellitus, Type 2"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D044882",
                            "term": "Glucose Metabolism Disorders"
                        },
                        {
                            "id": "D008659",
                            "term": "Metabolic Diseases"
                        },
                        {
                            "id": "D004700",
                            "term": "Endocrine System Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M7115",
                            "name": "Diabetes Mellitus",
                            "asFound": "Diabetes",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M7119",
                            "name": "Diabetes Mellitus, Type 2",
                            "asFound": "Type 2 Diabetes",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M11639",
                            "name": "Metabolic Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M25403",
                            "name": "Glucose Metabolism Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7862",
                            "name": "Endocrine System Diseases",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC18",
                            "name": "Nutritional and Metabolic Diseases"
                        },
                        {
                            "abbrev": "BC19",
                            "name": "Gland and Hormone Related Diseases"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D007328",
                            "term": "Insulin"
                        },
                        {
                            "id": "C557859",
                            "term": "Insulin, Globin Zinc"
                        },
                        {
                            "id": "D008687",
                            "term": "Metformin"
                        },
                        {
                            "id": "D000069036",
                            "term": "Insulin Glargine"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D007004",
                            "term": "Hypoglycemic Agents"
                        },
                        {
                            "id": "D045505",
                            "term": "Physiological Effects of Drugs"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M11667",
                            "name": "Metformin",
                            "asFound": "Chemotherapy",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M10365",
                            "name": "Insulin",
                            "asFound": "Program",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M4854",
                            "name": "Benzocaine",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M173166",
                            "name": "Insulin, Globin Zinc",
                            "asFound": "Program",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M13311",
                            "name": "Penicillin G",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M13312",
                            "name": "Penicillin G Benzathine",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M13313",
                            "name": "Penicillin G Procaine",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M347",
                            "name": "Insulin Glargine",
                            "asFound": "Coated",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M17768",
                            "name": "Zinc",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10054",
                            "name": "Hypoglycemic Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T433",
                            "name": "Tannic Acid",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "Hypo",
                            "name": "Hypoglycemic Agents"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "CNSDep",
                            "name": "Central Nervous System Depressants"
                        },
                        {
                            "abbrev": "Infe",
                            "name": "Anti-Infective Agents"
                        },
                        {
                            "abbrev": "Micro",
                            "name": "Micronutrients"
                        },
                        {
                            "abbrev": "Ot",
                            "name": "Other Dietary Supplements"
                        }
                    ]
                }
            },
            "hasResults": true
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT00505960",
                    "orgStudyIdInfo": {
                        "id": "R34DK071957",
                        "type": "NIH",
                        "link": "https://reporter.nih.gov/quickSearch/R34DK071957"
                    },
                    "organization": {
                        "fullName": "Johns Hopkins University",
                        "class": "OTHER"
                    },
                    "briefTitle": "Culturally Tailored Behavioral Diabetes Care Intervention for Korean Americans",
                    "officialTitle": "Diabetes Care for Korean Americans"
                },
                "statusModule": {
                    "statusVerifiedDate": "2010-12",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2007-09"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2008-09",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2008-09",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2007-07-20",
                    "studyFirstSubmitQcDate": "2007-07-20",
                    "studyFirstPostDateStruct": {
                        "date": "2007-07-25",
                        "type": "ESTIMATED"
                    },
                    "lastUpdateSubmitDate": "2010-12-20",
                    "lastUpdatePostDateStruct": {
                        "date": "2010-12-21",
                        "type": "ESTIMATED"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "oldNameTitle": "Miyong T. Kim",
                        "oldOrganization": "The Johns Hopkins University"
                    },
                    "leadSponsor": {
                        "name": "Johns Hopkins University",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": true
                },
                "descriptionModule": {
                    "briefSummary": "The purpose of this study is to assess the feasibility and efficacy of a culturally-tailored, comprehensive behavioral intervention program specially designed for linguistically challenged ethnic minority immigrant populations (Korean Americans) with type 2 DM.",
                    "detailedDescription": "Korean American immigrants (KAI), one of the most underserved and understudied minority populations in the U.S., suffer from diabetes, which goes under-diagnosed, inadequately treated and has a potential to result in costly and tragic consequences. Language barriers, the lack of self-confidence, and diminished social support that accompany the acculturation process prevent KAI from improving their health-seeking behaviors. Our previous research has indicated that overwhelming numbers of KAI suffer not only from uncontrolled hyperglycemia but also from a loss of self-confidence and social isolation because of language and cultural barriers. They are in urgent need of an intervention to assist them in their efforts to achieve better glycemic control and restore their self-confidence in diabetes and health management so that they are able to adjust successfully in this new environment. Therefore, The purpose of this study is to assess the feasibility and efficacy of a culturally-tailored, comprehensive behavioral intervention program specially designed for linguistically challenged KAIs with type 2 DM.\n\nThis pilot project will test the hypothesis: Compared to KAI in the control group, KAI with type 2 DM who receive a comprehensive DM management intervention through structured psycho-behavioral education, home glucose monitoring with a telephone transmission system, and interaction with a bilingual nurse case manager will show: (1) a greater level of glucose control; and (2) a greater level of self-help skills including knowledge related to glucose control, problem-solving skills, heightened confidence and mood/affect, adherence to treatment recommendations, and quality of life. An additional outcome will be to measure and obtain an ideal BP as the proposed intervention focuses on management of multiple risk factors with which many KA DM patients often struggle."
                },
                "conditionsModule": {
                    "conditions": [
                        "Diabetes"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE1"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "SUPPORTIVE_CARE",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 80,
                        "type": "ESTIMATED"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "1",
                            "type": "EXPERIMENTAL",
                            "interventionNames": [
                                "Behavioral: Diabetes Care for Korean Americans"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "BEHAVIORAL",
                            "name": "Diabetes Care for Korean Americans",
                            "description": "Intervention group participants receive a 6-week in-class education offered by trained nurses, followed by home glucose monitoring with monthly nurse telephone counseling.",
                            "armGroupLabels": [
                                "1"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "HbA1c",
                            "description": "The primary outcome varialbe is hemoglobin A1c level of the study participants to assess the status of blood gluocse management and control during previous 2-3 months.",
                            "timeFrame": "30 Weeks"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "BP control",
                            "timeFrame": "30 weeks"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Self-identified as a first generation Korean American\n* Age 30 years or older\n* Resides in Washington-Baltimore area\n* Expresses willingness to participate in all aspects of the study over its full course\n* Written consent to participate in the screening/eligibility visit\n* Self-identified with DM and HbA1c \\>= 8% within 6 months of screening\n* Written consent to participate in the clinical trial: agreeing to participate in study data collection procedures, receiving DM self -help education, using HGMT, and permitting contact with their own medical care provider.\n\nExclusion Criteria:\n\n* Unable to give informed consent\n* Physical or mental health conditions that could limit active participation in the study (e.g., blindness in both eyes, severe immobility, psychiatric diseases)\n* Hematological condition that would affect A1C assay, e.g., hemolytic anemia, sickle cell anemia.",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "30 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Miyong T Kim, PhD",
                            "affiliation": "Johns Hopkins University School of Nursing",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Korean Resource Center",
                            "city": "Ellicott City",
                            "state": "Maryland",
                            "zip": "20143",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.26733,
                                "lon": -76.79831
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "20651099",
                            "type": "BACKGROUND",
                            "citation": "Song HJ, Han HR, Lee JE, Kim J, Kim KB, Nguyen T, Kim MT. Translating current dietary guidelines into a culturally tailored nutrition education program for Korean American immigrants with type 2 diabetes. Diabetes Educ. 2010 Sep-Oct;36(5):752-61. doi: 10.1177/0145721710376328. Epub 2010 Jul 22."
                        },
                        {
                            "pmid": "19934458",
                            "type": "RESULT",
                            "citation": "Kim MT, Han HR, Song HJ, Lee JE, Kim J, Ryu JP, Kim KB. A community-based, culturally tailored behavioral intervention for Korean Americans with type 2 diabetes. Diabetes Educ. 2009 Nov-Dec;35(6):986-94. doi: 10.1177/0145721709345774."
                        },
                        {
                            "pmid": "22080707",
                            "type": "DERIVED",
                            "citation": "Nam S, Han HR, Song HJ, Song Y, Kim KB, Kim MT. Utility of a point-of-care device in recruiting ethnic minorities for diabetes research with community partners. J Health Care Poor Underserved. 2011 Nov;22(4):1253-63. doi: 10.1353/hpu.2011.0117."
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2025-05-07"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D003920",
                            "term": "Diabetes Mellitus"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D044882",
                            "term": "Glucose Metabolism Disorders"
                        },
                        {
                            "id": "D008659",
                            "term": "Metabolic Diseases"
                        },
                        {
                            "id": "D004700",
                            "term": "Endocrine System Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M7115",
                            "name": "Diabetes Mellitus",
                            "asFound": "Diabetes",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M11639",
                            "name": "Metabolic Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M25403",
                            "name": "Glucose Metabolism Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7862",
                            "name": "Endocrine System Diseases",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC18",
                            "name": "Nutritional and Metabolic Diseases"
                        },
                        {
                            "abbrev": "BC19",
                            "name": "Gland and Hormone Related Diseases"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT05132660",
                    "orgStudyIdInfo": {
                        "id": "C3825-R"
                    },
                    "organization": {
                        "fullName": "VA Office of Research and Development",
                        "class": "FED"
                    },
                    "briefTitle": "Treating Early Stage Diabetic Retinopathy",
                    "officialTitle": "Treating Early Stage Diabetic Retinopathy",
                    "acronym": "TESDR"
                },
                "statusModule": {
                    "statusVerifiedDate": "2025-05",
                    "overallStatus": "ENROLLING_BY_INVITATION",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2022-07-01",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2027-12-31",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2028-12-31",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2021-11-22",
                    "studyFirstSubmitQcDate": "2021-11-22",
                    "studyFirstPostDateStruct": {
                        "date": "2021-11-24",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2025-05-01",
                    "lastUpdatePostDateStruct": {
                        "date": "2025-05-04",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "VA Office of Research and Development",
                        "class": "FED"
                    },
                    "collaborators": [
                        {
                            "name": "Emory University",
                            "class": "OTHER"
                        }
                    ]
                },
                "oversightModule": {
                    "oversightHasDmc": true,
                    "isFdaRegulatedDrug": true,
                    "isFdaRegulatedDevice": false,
                    "isUsExport": true
                },
                "descriptionModule": {
                    "briefSummary": "To determine if levodopa will slow the appearance of blood vessel changes in the eyes of patients with diabetes. Treatment will be started in patients with diabetes show delays in the electrical activity of the retina when measured non-invasively with a electroretinogram.",
                    "detailedDescription": "Diabetic Retinopathy (DR) is a leading cause of vision loss in the US. To detect DR, individuals with diabetes are instructed to receive annual eye exams until visible retinopathy such as hemorrhages or aneurysms appear that often take years to develop. Even so, treatment is only provided when visually threatening disease is detected. The investigators' group and others have established that in people with diabetes, retinal neuronal dysfunction precedes clinically visible retinopathy. Non-invasive recordings of retinal function using the electroretinogram (ERG) have shown dysfunction with diabetes, particularly in the oscillatory potentials (OPs) that are generated by inner retinal neurons. A fundamental gap in the knowledge of DR pathology is whether neuronal dysfunction is associated with or causal to the late stage vascular defects. The overall hypothesis is that neuronal defects precede vascular defects in DR and that treating neuronal deficits early in DR will prevent late stage vascular defects that result in vision loss.\n\nDopamine, a key neuromodulator in the retina, is reduced in DR. The investigators demonstrated that treating rodent models of diabetes with levodopa, a dopamine precursor, is neuroprotective for neuronal dysfunction. Importantly, the investigators also showed that in patients with diabetes and retinal dysfunction, but without retinopathy, levodopa taken for only 2 weeks restored retinal dysfunction to normal levels. Thus, the preliminary data suggest that earlier screening and treatment are possible to prevent or delay retinal dysfunction in early DR. Since current clinical management of DR is directed at more advanced stages of disease when vascular defects are present, it is critical to determine if levodopa will also prevent vascular pathology.\n\nThe investigators propose the following specific aims to investigate the link between neuronal and vascular defects in DR by using neuronal (dim flash ERG) and vascular (fundus photography and optical coherence tomography angiography) primary outcome measures:\n\nAim 1: Investigate whether the appearance of early neuronal dysfunction predicts late stage vascular pathology in diabetes. The investigators propose follow-up testing on a cohort of participants with diabetes, and normal or delayed OPs, from a prior clinical study to determine how many develop signs of retinal vascular defects after 3-5 years.\n\nAim 2: Determine whether levodopa treatment initiated at detection of retinal dysfunction will prevent retinal dysfunction and vascular defects. The investigators will conduct a randomized clinical trial with levodopa versus placebo using participants with diabetes and confirmed OP delays from two groups: 1) without retinopathy and 2) with the earliest signs of DR (microaneurysms). Patients will receive levodopa or placebo twice daily for 6- or 24-months. For the 6-month duration, testing will be done at baseline, 3 months and 6 months. Patients will then return to routine standard of care and be re-tested at 12 and 24 months. For the 24-month duration, testing will be done at baseline and every 3 months until 24 months. Participants will be carefully monitored for levodopa side effects with the assistance of a neurologist.\n\nDetermining the association between neuronal and vascular defects in DR is critical to shifting clinical practice toward early diagnostic markers, a move that could transform the way DR is monitored and treated, ultimately leading to better preservation of normal visual function."
                },
                "conditionsModule": {
                    "conditions": [
                        "Diabetic Retinopathy"
                    ],
                    "keywords": [
                        "diabetes"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "EARLY_PHASE1"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "interventionModelDescription": "Sinemet CR 25 mg carbidopa/100 mg levodopa or placebo will be given twice daily for 6 months or 24 months.",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "DOUBLE",
                            "maskingDescription": "Participants will be assigned a number and treatment group will be assigned according to randomization strategy by pharmacy personnel",
                            "whoMasked": [
                                "PARTICIPANT",
                                "INVESTIGATOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 244,
                        "type": "ESTIMATED"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Sinemet",
                            "type": "EXPERIMENTAL",
                            "description": "25 mg carbidopa/100 mg levodopa",
                            "interventionNames": [
                                "Drug: Sinemet CR"
                            ]
                        },
                        {
                            "label": "Placebo",
                            "type": "PLACEBO_COMPARATOR",
                            "description": "Placebo pill of similar size/shape",
                            "interventionNames": [
                                "Drug: placebo"
                            ]
                        },
                        {
                            "label": "follow-up",
                            "type": "NO_INTERVENTION",
                            "description": "Follow-up testing on participants previously prescribed levodopa"
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "Sinemet CR",
                            "description": "25 mg carbidopa/100 mg levodopa",
                            "armGroupLabels": [
                                "Sinemet"
                            ],
                            "otherNames": [
                                "Levodopa"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "placebo",
                            "description": "Placebo pill of similar size/shape",
                            "armGroupLabels": [
                                "Placebo"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Electroretinogram",
                            "description": "Electrical activity of the retina measured by non-invasive electrodes on the face to a flash to light. A waveform will be recorded and timing of the waves measured in milliseconds",
                            "timeFrame": "24 months"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Optical coherence tomography angiography",
                            "description": "Non-invasive imaging of the retina to observe retinal and vascular structure",
                            "timeFrame": "24 months"
                        },
                        {
                            "measure": "Fundus photographs",
                            "description": "Image of the inside of the eye",
                            "timeFrame": "24 months"
                        },
                        {
                            "measure": "HbA1c",
                            "description": "Blood glucose test",
                            "timeFrame": "24 months"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* HbA1c 8-12%\n* Diabetic patients with no retinopathy as screened with teleretinal imaging\n* Diabetic patients with microaneurysms as detected with fundus teleretinal screening\n* ERG oscillatory potential delays in response to dim flash stimuli\n\nExclusion Criteria:\n\n* Patients with pituitary tumor, psychosis, Parkinson's disease\n* Patients with confounding ocular disease (visually significant cataract, glaucoma, macular degeneration, retinitis pigmentosa)\n* Patients with cognitive deficits (score of 24 or less on the Montreal Cognitive\n* Assessment-MOCA\n* No anti-VEGF or steroid treatments within the last 12 months\n* Pregnancy",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "30 Years",
                    "maximumAge": "80 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Machelle T. Pardue, PhD",
                            "affiliation": "Atlanta VA Medical and Rehab Center, Decatur, GA",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Atlanta VA Medical and Rehab Center, Decatur, GA",
                            "city": "Decatur",
                            "state": "Georgia",
                            "zip": "30033-4004",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.77483,
                                "lon": -84.29631
                            }
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO"
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2025-05-07"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D012164",
                            "term": "Retinal Diseases"
                        },
                        {
                            "id": "D003930",
                            "term": "Diabetic Retinopathy"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D005128",
                            "term": "Eye Diseases"
                        },
                        {
                            "id": "D003925",
                            "term": "Diabetic Angiopathies"
                        },
                        {
                            "id": "D014652",
                            "term": "Vascular Diseases"
                        },
                        {
                            "id": "D002318",
                            "term": "Cardiovascular Diseases"
                        },
                        {
                            "id": "D048909",
                            "term": "Diabetes Complications"
                        },
                        {
                            "id": "D003920",
                            "term": "Diabetes Mellitus"
                        },
                        {
                            "id": "D004700",
                            "term": "Endocrine System Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M7115",
                            "name": "Diabetes Mellitus",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14999",
                            "name": "Retinal Diseases",
                            "asFound": "Retinopathy",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M7125",
                            "name": "Diabetic Retinopathy",
                            "asFound": "Diabetic Retinopathy",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M8271",
                            "name": "Eye Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7120",
                            "name": "Diabetic Angiopathies",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17400",
                            "name": "Vascular Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M26004",
                            "name": "Diabetes Complications",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7862",
                            "name": "Endocrine System Diseases",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC18",
                            "name": "Nutritional and Metabolic Diseases"
                        },
                        {
                            "abbrev": "BC19",
                            "name": "Gland and Hormone Related Diseases"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC11",
                            "name": "Eye Diseases"
                        },
                        {
                            "abbrev": "BC14",
                            "name": "Heart and Blood Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D007980",
                            "term": "Levodopa"
                        },
                        {
                            "id": "C009265",
                            "term": "Carbidopa, levodopa drug combination"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000978",
                            "term": "Antiparkinson Agents"
                        },
                        {
                            "id": "D018726",
                            "term": "Anti-Dyskinesia Agents"
                        },
                        {
                            "id": "D015259",
                            "term": "Dopamine Agents"
                        },
                        {
                            "id": "D018377",
                            "term": "Neurotransmitter Agents"
                        },
                        {
                            "id": "D045504",
                            "term": "Molecular Mechanisms of Pharmacological Action"
                        },
                        {
                            "id": "D045505",
                            "term": "Physiological Effects of Drugs"
                        },
                        {
                            "id": "D000276",
                            "term": "Adjuvants, Immunologic"
                        },
                        {
                            "id": "D007155",
                            "term": "Immunologic Factors"
                        },
                        {
                            "id": "D018491",
                            "term": "Dopamine Agonists"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M10982",
                            "name": "Levodopa",
                            "asFound": "Botulinum Toxin",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M5489",
                            "name": "Carbidopa",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M250674",
                            "name": "Carbidopa, levodopa drug combination",
                            "asFound": "Exerted",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M4295",
                            "name": "Antiparkinson Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7473",
                            "name": "Dopamine",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17962",
                            "name": "Dopamine Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20504",
                            "name": "Neurotransmitter Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M3628",
                            "name": "Adjuvants, Immunologic",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10201",
                            "name": "Immunologic Factors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20595",
                            "name": "Dopamine Agonists",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "AnDyAg",
                            "name": "Anti-Dyskinesia Agents"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "CaAg",
                            "name": "Cardiotonic Agents"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT02777060",
                    "orgStudyIdInfo": {
                        "id": "1409482826"
                    },
                    "organization": {
                        "fullName": "University of Arizona",
                        "class": "OTHER"
                    },
                    "briefTitle": "Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures",
                    "officialTitle": "Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures"
                },
                "statusModule": {
                    "statusVerifiedDate": "2016-05",
                    "overallStatus": "UNKNOWN",
                    "lastKnownStatus": "RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2014-09"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2016-12",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2017-08",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2015-06-08",
                    "studyFirstSubmitQcDate": "2016-05-16",
                    "studyFirstPostDateStruct": {
                        "date": "2016-05-19",
                        "type": "ESTIMATED"
                    },
                    "lastUpdateSubmitDate": "2016-05-16",
                    "lastUpdatePostDateStruct": {
                        "date": "2016-05-19",
                        "type": "ESTIMATED"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "PRINCIPAL_INVESTIGATOR",
                        "investigatorFullName": "Bijan Najafi",
                        "investigatorTitle": "Professor of Surgery",
                        "investigatorAffiliation": "University of Arizona"
                    },
                    "leadSponsor": {
                        "name": "University of Arizona",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": false
                },
                "descriptionModule": {
                    "briefSummary": "Explore the benefit of the game-based virtual reality system in improving lower extremity kinematics and balance in patients suffering from disease/disorders including Diabetes, Cancer, Multiple Sclerosis, Arthritis, Parkinson's disease, Cognitive Disorders, Brain Injury, Stroke or Frailty. A four to six weeks of training with 2 training session/week will be provided.",
                    "detailedDescription": "Individuals suffering from certain disorders/diseases including diabetes, arthritis, cancer, osteoarthritis, stroke, Parkinson's disease, cognitive impairment or brain Injury are more likely to experience a fall or a fall-related injury than healthy individuals during to impaired postural stability or diminished joint perception. Under certain circumstance they may also experience pain, depression, anxiety, and a decreased quality of life. The investigators' research has been designed to provide exercise training using non-invasive body-worn sensors (similar to those used in an iPhone®) to provide real-time visual information about joint motion in a virtual environment. These sensors will be worn using a vest, t-shirt or elastic band. The investigators will, 1) assess changes in participant's perception of lower extremity position while they perform these exercises; 2) motivate and guide simple exercise performance in the clinic/home, using an interactive game-like scheme; and 3) assess changes in participant's postural stability and gait as a result of provided exercise training. The information gathered will provide new understanding about more helpful rehabilitation strategies that improve postural stability in patient population."
                },
                "conditionsModule": {
                    "conditions": [
                        "Diabetes",
                        "Cancer",
                        "Multiple Sclerosis",
                        "Arthritis",
                        "Parkinson's Disease",
                        "Cognitive Disorders",
                        "Brain Injury",
                        "Stroke"
                    ],
                    "keywords": [
                        "virtual reality",
                        "sensor-based balance training",
                        "gait",
                        "balance"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "NA"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "SINGLE",
                            "whoMasked": [
                                "OUTCOMES_ASSESSOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 200,
                        "type": "ESTIMATED"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Exergame",
                            "type": "EXPERIMENTAL",
                            "description": "inertial sensor based system (wearable sensors, LEGSys, Biosensics LLC) will be used for balance training with computerized feedback. The balance training program is focused on lower extremities including ankle joint exercise and virtual obstacle crossing tasks.",
                            "interventionNames": [
                                "Procedure: Exergame"
                            ]
                        },
                        {
                            "label": "Home based balance training",
                            "type": "ACTIVE_COMPARATOR",
                            "description": "The control group will ask to perform a home based program includes similar exercise components as proposed in the experimental group, however without computerized feedback. Exercises include postural balance tasks, such as backward and forward weight shifting, as well as dynamic balance exercises, such as marching in place (comparable to virtual obstacle crossing in experimental group).",
                            "interventionNames": [
                                "Procedure: Home based balance training"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "PROCEDURE",
                            "name": "Exergame",
                            "description": "Subjects will perform progressive and computerized foot and ankle exercises which include weight shifting, ankle reaching task while standing, and virtual obstacle crossing task (i.e. balancing on single leg) using wearable sensors technology (Exergaming) equipment). Subjects will perform these exercises for 4-6 weeks, twice per week. The duration of exercise per session is anticipated to be 30-45 minutes.",
                            "armGroupLabels": [
                                "Exergame"
                            ],
                            "otherNames": [
                                "sensor-based game like exercise training"
                            ]
                        },
                        {
                            "type": "PROCEDURE",
                            "name": "Home based balance training",
                            "description": "Subjects in the control group will ask to perform a standard home based balance program for 4-6 weeks. The home based program includes similar exercise components as proposed in the experimental group, however without computerized feedback and Exergaming equipment.",
                            "armGroupLabels": [
                                "Home based balance training"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Change in Balance",
                            "description": "Balance will be quantified by measuring area of sway of center of mass (with unit of cm2) during quite standing according to Romberg's protocol and using validated instrument (BalanSens, Biosensics, MA, USA)",
                            "timeFrame": "4-6 weeks"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Change in gait Speed",
                            "description": "Gait Speed (with unit of m/sec) will be measured using validated wearable technology (LEGSys, Biosensics, MA, USA) and during walking with habitual and fast speed walking",
                            "timeFrame": "4-6 weeks"
                        },
                        {
                            "measure": "Change in Stride length",
                            "description": "Stride Length (with unit of meter) will be measured using validated wearable technology (LEGSys, Biosensics, MA, USA) and during walking with habitual and fast speed walking",
                            "timeFrame": "4-6 weeks"
                        },
                        {
                            "measure": "Change in Stride time",
                            "description": "Stride time (with unit of second) will be measured using validated wearable technology (LEGSys, Biosensics, MA, USA) and during walking with habitual and fast speed walking",
                            "timeFrame": "4-6 weeks"
                        },
                        {
                            "measure": "Change in number of walking steps per day",
                            "description": "Average of walking steps (no unit) per day will be measured during 48 hours of daily physical activity monitoring using a validated wearable sensor technology (PAMSys, Biosensics, MA, USA)",
                            "timeFrame": "4-6 weeks"
                        },
                        {
                            "measure": "Change in average of walking bout",
                            "description": "Daily average of walking bout (continuous walking without stop, with unit of steps) will be measured over 48 hours monitoring of physical activity using a validated wearable sensor technology (PAMSys, Biosensics, MA, USA)",
                            "timeFrame": "4-6 weeks"
                        },
                        {
                            "measure": "Change in average of standing bout",
                            "description": "Daily average of standing bout (continuous standing without changing in posture with unit of seconds) will be measured over 48 hours monitoring of physical activity using a validated wearable sensor technology (PAMSys, Biosensics, MA, USA)",
                            "timeFrame": "4-6 weeks"
                        },
                        {
                            "measure": "Change in average of longest walking bout",
                            "description": "Daily average of longest walking bout (longest continuous walking without stop per day, with unit of steps) will be measured over 48 hours monitoring of physical activity using a validated wearable sensor technology (PAMSys, Biosensics, MA, USA)",
                            "timeFrame": "4-6 weeks"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\nDiagnosis of:\n\n* diabetes\n* cancer\n* multiple sclerosis\n* arthritis\n* Parkinson's disease\n* cognitive disorders\n* brain injury\n* frailty\n* stroke\n\nExclusion Criteria:\n\n* conditions not related to specific disorders affecting balance and gait",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "centralContacts": [
                        {
                            "name": "Bijan Najafi, PhD",
                            "role": "CONTACT",
                            "phone": "7137987536",
                            "email": "najafi.bijan@gmail.com"
                        }
                    ],
                    "overallOfficials": [
                        {
                            "name": "Bijan Najafi, PhD",
                            "affiliation": "University of Arizona",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "University of Arizona",
                            "status": "RECRUITING",
                            "city": "Tucson",
                            "state": "Arizona",
                            "zip": "85724",
                            "country": "United States",
                            "contacts": [
                                {
                                    "name": "Bijan S Najafi, PhD",
                                    "role": "CONTACT",
                                    "phone": "713-798-0477",
                                    "email": "najafi.bijan@gmail.com"
                                }
                            ],
                            "geoPoint": {
                                "lat": 32.22174,
                                "lon": -110.92648
                            }
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2025-05-07"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D010300",
                            "term": "Parkinson Disease"
                        },
                        {
                            "id": "D009103",
                            "term": "Multiple Sclerosis"
                        },
                        {
                            "id": "D001930",
                            "term": "Brain Injuries"
                        },
                        {
                            "id": "D060825",
                            "term": "Cognitive Dysfunction"
                        },
                        {
                            "id": "D003072",
                            "term": "Cognition Disorders"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D020734",
                            "term": "Parkinsonian Disorders"
                        },
                        {
                            "id": "D001480",
                            "term": "Basal Ganglia Diseases"
                        },
                        {
                            "id": "D001927",
                            "term": "Brain Diseases"
                        },
                        {
                            "id": "D002493",
                            "term": "Central Nervous System Diseases"
                        },
                        {
                            "id": "D009422",
                            "term": "Nervous System Diseases"
                        },
                        {
                            "id": "D009069",
                            "term": "Movement Disorders"
                        },
                        {
                            "id": "D000080874",
                            "term": "Synucleinopathies"
                        },
                        {
                            "id": "D019636",
                            "term": "Neurodegenerative Diseases"
                        },
                        {
                            "id": "D020278",
                            "term": "Demyelinating Autoimmune Diseases, CNS"
                        },
                        {
                            "id": "D020274",
                            "term": "Autoimmune Diseases of the Nervous System"
                        },
                        {
                            "id": "D003711",
                            "term": "Demyelinating Diseases"
                        },
                        {
                            "id": "D001327",
                            "term": "Autoimmune Diseases"
                        },
                        {
                            "id": "D007154",
                            "term": "Immune System Diseases"
                        },
                        {
                            "id": "D006259",
                            "term": "Craniocerebral Trauma"
                        },
                        {
                            "id": "D020196",
                            "term": "Trauma, Nervous System"
                        },
                        {
                            "id": "D014947",
                            "term": "Wounds and Injuries"
                        },
                        {
                            "id": "D019965",
                            "term": "Neurocognitive Disorders"
                        },
                        {
                            "id": "D001523",
                            "term": "Mental Disorders"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M12060",
                            "name": "Multiple Sclerosis",
                            "asFound": "Multiple Sclerosis",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M15415",
                            "name": "Sclerosis",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7115",
                            "name": "Diabetes Mellitus",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4476",
                            "name": "Arthritis",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M13213",
                            "name": "Parkinson Disease",
                            "asFound": "Parkinson's Disease",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M22306",
                            "name": "Stroke",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5207",
                            "name": "Brain Injuries",
                            "asFound": "Brain Injury",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M6301",
                            "name": "Cognition Disorders",
                            "asFound": "Cognitive Disorders",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M29705",
                            "name": "Cognitive Dysfunction",
                            "asFound": "Cognitive Disorders",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M22494",
                            "name": "Parkinsonian Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M25603",
                            "name": "Ganglion Cysts",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M16358",
                            "name": "Synovial Cyst",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4774",
                            "name": "Basal Ganglia Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5204",
                            "name": "Brain Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5742",
                            "name": "Central Nervous System Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M12029",
                            "name": "Movement Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M2217",
                            "name": "Synucleinopathies",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M21558",
                            "name": "Neurodegenerative Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4629",
                            "name": "Autoimmune Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M22098",
                            "name": "Demyelinating Autoimmune Diseases, CNS",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M22094",
                            "name": "Autoimmune Diseases of the Nervous System",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M6909",
                            "name": "Demyelinating Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10200",
                            "name": "Immune System Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17685",
                            "name": "Wounds and Injuries",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9349",
                            "name": "Craniocerebral Trauma",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M22023",
                            "name": "Trauma, Nervous System",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M21836",
                            "name": "Neurocognitive Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14473",
                            "name": "Psychotic Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4815",
                            "name": "Mental Disorders",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC10",
                            "name": "Nervous System Diseases"
                        },
                        {
                            "abbrev": "BC20",
                            "name": "Immune System Diseases"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "BC18",
                            "name": "Nutritional and Metabolic Diseases"
                        },
                        {
                            "abbrev": "BC19",
                            "name": "Gland and Hormone Related Diseases"
                        },
                        {
                            "abbrev": "BC05",
                            "name": "Musculoskeletal Diseases"
                        },
                        {
                            "abbrev": "BC14",
                            "name": "Heart and Blood Diseases"
                        },
                        {
                            "abbrev": "BC26",
                            "name": "Wounds and Injuries"
                        },
                        {
                            "abbrev": "BXM",
                            "name": "Behaviors and Mental Disorders"
                        },
                        {
                            "abbrev": "BC04",
                            "name": "Neoplasms"
                        },
                        {
                            "abbrev": "BC17",
                            "name": "Skin and Connective Tissue Diseases"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT01788527",
                    "nctIdAliases": [
                        "NCT01734031"
                    ],
                    "orgStudyIdInfo": {
                        "id": "12-0037-A"
                    },
                    "organization": {
                        "fullName": "Mount Sinai Hospital, Canada",
                        "class": "OTHER"
                    },
                    "briefTitle": "Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial",
                    "officialTitle": "Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial",
                    "acronym": "CONCEPTT"
                },
                "statusModule": {
                    "statusVerifiedDate": "2017-07",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2013-03"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2016-03",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2016-03",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2012-12-19",
                    "studyFirstSubmitQcDate": "2013-02-07",
                    "studyFirstPostDateStruct": {
                        "date": "2013-02-11",
                        "type": "ESTIMATED"
                    },
                    "lastUpdateSubmitDate": "2017-07-14",
                    "lastUpdatePostDateStruct": {
                        "date": "2017-07-19",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Mount Sinai Hospital, Canada",
                        "class": "OTHER"
                    },
                    "collaborators": [
                        {
                            "name": "Sunnybrook Research Institute",
                            "class": "OTHER"
                        },
                        {
                            "name": "Jaeb Center for Health Research",
                            "class": "OTHER"
                        },
                        {
                            "name": "Cambridge University Hospitals NHS Foundation Trust",
                            "class": "OTHER"
                        },
                        {
                            "name": "University of Cambridge",
                            "class": "OTHER"
                        }
                    ]
                },
                "oversightModule": {
                    "oversightHasDmc": true
                },
                "descriptionModule": {
                    "briefSummary": "The primary objective of the study is to determine if RT CGM (Real Time-Continuous Glucose Monitoring) can improve glycemic control in women with T1D who are pregnant or planning pregnancy.",
                    "detailedDescription": "In women with diabetes, hyperglycemia is associated with increased rates of numerous maternal and fetal adverse outcomes. Mothers are at increased risk of preeclampsia, polyhydramnios, and caesarean sections. Infants of mothers with diabetes have increased rates of congenital anomalies, premature delivery, macrosomia, stillbirth and NICU admissions. Macrosomia itself is associated with numerous adverse fetal outcomes including shoulder dystocia, birth injury, neonatal hypoglycemia, hyperbilirubinemia, respiratory distress syndrome and NICU admissions, asphyxia and death. Postprandial blood sugars in particular have been associated with increased macrosomia rates.\n\nNumerous studies have shown that pregnancy outcomes can be reduced with improved glycemic control. In particular, pre-pregnancy care has been shown to assist women improve glucose control during the crucial period of organogenesis, and is associated with reduced rates of adverse pregnancy outcome including major congenital malformation, stillbirth and neonatal death.\n\nTechnological advances aimed at reducing glycemic excursions and improving glucose control in patients with diabetes include the continuous glucose monitoring (CGM) system. We hypothesize that real-time CGM will assist women with type 1 diabetes to improve their glycemic control before and during pregnancy."
                },
                "conditionsModule": {
                    "conditions": [
                        "Type 1 Diabetics Who Are Pregnant or Planning Pregnancy"
                    ],
                    "keywords": [
                        "Diabetes",
                        "Type 1",
                        "CGM",
                        "Continuous Glucose Monitor",
                        "HGM",
                        "HbA1c"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "NA"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 325,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "CGM",
                            "type": "EXPERIMENTAL",
                            "description": "Continuous Glucose Monitoring",
                            "interventionNames": [
                                "Device: CGM"
                            ]
                        },
                        {
                            "label": "HGM",
                            "type": "NO_INTERVENTION",
                            "description": "Standard of care, Home Glucose Monitoring"
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DEVICE",
                            "name": "CGM",
                            "description": "Real Time Continuous Glucose Monitoring",
                            "armGroupLabels": [
                                "CGM"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Glycemic Control in pre-pregnant group",
                            "description": "Glycemic control as measured by HbA1c at 24 weeks or at conception. If the patient becomes pregnant, than a HbA1c will be measured post-confirmation of a positive pregnancy test and will contribute to the primary outcome.",
                            "timeFrame": "24 weeks or at conception"
                        },
                        {
                            "measure": "Glycemic Control in pregnant group",
                            "description": "Glycemic control as measured by HbA1c at 34 weeks gestation. In women who do not progress to 34 weeks gestation, the latest measured HbA1c will be used to contribute to the primary outcome.",
                            "timeFrame": "34 weeks gestation"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Time in target in pre-pregnant group",
                            "description": "Time in target at 12 and 24 weeks after randomization",
                            "timeFrame": "12 and 24 weeks after randomization"
                        },
                        {
                            "measure": "HbA1c and time in target, in pre-pregnant group who became pregnant within 24 weeks from randomization",
                            "description": "HbA1c and Time in target at post-confirmation of a positive pregnancy test, 24 weeks and 34 weeks gestation for those who start pre-pregnant and become pregnant",
                            "timeFrame": "24 weeks and 34 weeks gestation"
                        },
                        {
                            "measure": "Time in target in pregnant group",
                            "description": "Time in target at randomization, 24 weeks and 34 weeks gestation",
                            "timeFrame": "Randomization, 24 weeks and 34 weeks gestation"
                        },
                        {
                            "measure": "HbA1c measurement in pregnant group",
                            "description": "HbA1c at randomization, 24 weeks and 34 weeks gestation",
                            "timeFrame": "24 weeks and 34 weeks gestation"
                        },
                        {
                            "measure": "Hypertension in pregnant group",
                            "description": "Incidence of worsening chronic hypertension, gestational hypertension, preeclampsia; total and individual measures",
                            "timeFrame": "Up to 42 weeks gestation"
                        },
                        {
                            "measure": "Caesarean sections in pregnant group",
                            "description": "Caesarean section: primary and total",
                            "timeFrame": "At delivery"
                        },
                        {
                            "measure": "Gestational weight gain in pregnant group",
                            "description": "Entry to 34 weeks gestation; 16 weeks to 34 weeks gestation",
                            "timeFrame": "Up to 34 weeks gestation"
                        },
                        {
                            "measure": "AUC",
                            "description": "Area under the curve for blood sugars (a) \\>7.8 mmol/l or 140 mg/dl (b)\\>6.7 mmol/l or 120 mg/dl (c) \\<3.5 mmol/L or \\<63 mg/dl (d) \\<2.8 mmol/L or \\<50 mg/dl",
                            "timeFrame": "At delivery"
                        },
                        {
                            "measure": "Incidence of Clinical events",
                            "description": "Episodes of 'severe hypoglycemia' requiring assistance; mild-moderate episodes of hypoglycemia \\<3.5 (mild) and \\<2.8 (moderate) from CGM data defined as AUC \\<3.5 or AUC less than or equal to 2.8 for 20 minutes duration; nocturnal hypoglycemia (NH) defined as CGM glucose \\<3.5 (mild) and \\<2.8 (moderate) between the hours of 23.00-07.00",
                            "timeFrame": "Up to 42 weeks gestation"
                        },
                        {
                            "measure": "Glucose variability",
                            "description": "Mean amplitude of glycemic excursions (MAGE); Coefficient of Variation (CV); Standard deviation (SD) of CGM measurements; mean absolute rate of change of CGM based on one week of sensor values",
                            "timeFrame": "Up to delivery"
                        },
                        {
                            "measure": "Hospital stay",
                            "description": "Length of hospital stay",
                            "timeFrame": "Admission until hospital discharge"
                        },
                        {
                            "measure": "Infant Outcomes",
                            "description": "Infant birthweight \\>90th centile using customized growth curves; infant birthweight \\<10th centile using customized growth curves; infant birthweight \\>=4kg",
                            "timeFrame": "At birth of infant"
                        },
                        {
                            "measure": "Infant Outcomes",
                            "description": "Pregnancy loss (Miscarriage, stillbirth, neonatal death)",
                            "timeFrame": "=<28 days of life"
                        },
                        {
                            "measure": "Infant Outcomes",
                            "description": "Preterm delivery (\\<37 weeks and early preterm \\<34 weeks)",
                            "timeFrame": "At birth"
                        },
                        {
                            "measure": "Infant Outcomes",
                            "description": "Birth injury",
                            "timeFrame": "Until hospital discharge"
                        },
                        {
                            "measure": "Infant outcomes",
                            "description": "Shoulder dystocia",
                            "timeFrame": "Until hospital discharge"
                        },
                        {
                            "measure": "Infant outcomes",
                            "description": "Neonatal hypoglycemia with intravenous dextrose",
                            "timeFrame": "Until hospital discharge"
                        },
                        {
                            "measure": "Infant Outcomes",
                            "description": "Hyperbilirubinemia",
                            "timeFrame": "Within first 7 days of life"
                        },
                        {
                            "measure": "Infant Outcomes",
                            "description": "Respiratory Distress Syndrome (RDS)",
                            "timeFrame": "Within first 7 days of life"
                        },
                        {
                            "measure": "Infant Outcomes",
                            "description": "NICU admission \\> 24 hrs",
                            "timeFrame": "Until hospital discharge"
                        },
                        {
                            "measure": "Infant Outcomes",
                            "description": "Cord blood gas pH \\<7.0",
                            "timeFrame": "At birth"
                        },
                        {
                            "measure": "Infant Outcomes",
                            "description": "Hyperinsulinemia (using Cord C-peptide)",
                            "timeFrame": "At birth"
                        },
                        {
                            "measure": "Infant Outcomes",
                            "description": "Composite fetal outcome: pregnancy loss:miscarriage, stillbirth, neonatal death (death\\<=28 days of life), birth injury, neonatal hypoglycemia, hyperbilirubinemia, respiratory distress syndrome requiring therapy, NICU admission \\>24 hours",
                            "timeFrame": "Within first 7 days of life or until hospital discharge (whichever is last)"
                        },
                        {
                            "measure": "Infant Outcomes",
                            "description": "Sum of skinfolds \\>90th percentile for gestational age",
                            "timeFrame": "Within first 3 days of life"
                        },
                        {
                            "measure": "Infant Outcomes",
                            "description": "Other anthropometric measures",
                            "timeFrame": "Within first 3 days of life"
                        },
                        {
                            "measure": "Infant Outcomes",
                            "description": "Length of hospital stay",
                            "timeFrame": "Until hospital discharge"
                        },
                        {
                            "measure": "Insulin requirements",
                            "description": "Units per kg per day",
                            "timeFrame": "Pre-pregnant (randomization, 12 weeks, 24 weeks); Pregnant (randomization, 24 weeks and 34 weeks gestation)"
                        },
                        {
                            "measure": "Questionnaires",
                            "description": "BGMSRQ, HFS, PAID, SF12, CGM-SAT; NWTSQ",
                            "timeFrame": "Baseline and 24 weeks or at confirmed pregnancy (pre-pregnant); Baseline and 34 weeks (pregnant)"
                        },
                        {
                            "measure": "Study Contacts",
                            "description": "Scheduled and unscheduled visits",
                            "timeFrame": "Up to delivery"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Clinical diagnosis of type 1 diabetes and using daily insulin therapy for at least one year\n* Age 18-40 years\n* Insulin regimen involves either the use of an insulin pump or multiple daily injections of insulin (at least 3 shots per day). Subjects using premixed fixed doses of insulin at the time of enrolment will not be eligible. Insulin regimen must be stable for at least 4 weeks (i.e. on multiple insulin injections or on insulin pump) prior to randomization.\n* No expectation that subject will be moving out of the area of the clinical center during the next year, unless the move will be to an area served by another study center\n* Informed Consent Form signed by the subject\n\nIn addition, specific eligibility criteria apply to the respective groups:\n\nPre-pregnancy Group:\n\n* Patients who are planning pregnancy and wish to optimise glycemic control before conception\n\nPregnancy Group:\n\n* Pregnancy gestation ≤13 weeks, 6 days at time of randomization\n* Live singleton fetus\n* Dating ultrasound (US) done to confirm gestational age, viability and rule out multiples. Gestational age will be based on the last menstrual period (LMP) provided there is a ≤5 day discrepancy with US dates in the first trimester and ≤10 day discrepancy with US dates in the second trimester. If the dates from LMP are outside these limits, the US dates will be used as the best estimate of gestational age.\n\nExclusion Criteria:\n\n* Type 2 diabetes\n* Gestational diabetes\n* Previous participation in the study\n* Estimated GFR \\<60 ml/min/1.73\n* The presence of a significant medical disorder or use of a medication such as oral glucocorticoids that in the judgment of the investigator will affect the wearing of the sensors or the completion of any aspect of the protocol.\n\nIf the investigator is uncertain whether the patient would be eligible; i.e. if the medical disorder would constitute an exclusion, the Steering Committee will be asked to make the decision.\n\n* Inpatient psychiatric treatment in the past 6 months\n* Subjects using premixed fixed doses of insulin at the time of enrolment\n\nIn addition, specific exclusion criteria apply to the respective groups:\n\nPre-pregnancy Group:\n\n* HbA1c \\<7.0% or \\>10.0%\n\nPregnancy Group:\n\n* HbA1c \\<6.5% or \\>10.0%\n* Known current higher order pregnancies (twins, triplets, etc.) These women will be excluded as they have a higher rate of adverse outcomes and could lead to inequalities if they are unequally distributed between the groups.\n* Known potentially major fetal anomaly (as per EUROCAT criteria).",
                    "healthyVolunteers": false,
                    "sex": "FEMALE",
                    "minimumAge": "18 Years",
                    "maximumAge": "40 Years",
                    "stdAges": [
                        "ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Denice Feig, MD",
                            "affiliation": "MOUNT SINAI HOSPITAL",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Helen Murphy, MB BCh BAO FRACP MD",
                            "affiliation": "Cambridge University Hospital NHS Foundation Trust and University of Cambridge",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Sansum Diabetes Research Institute",
                            "city": "Santa Barbara",
                            "state": "California",
                            "zip": "93105",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.42083,
                                "lon": -119.69819
                            }
                        },
                        {
                            "facility": "Alberta Health Services - Calgary Zone",
                            "city": "Calgary",
                            "state": "Alberta",
                            "zip": "T2T 5C7",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 51.05011,
                                "lon": -114.08529
                            }
                        },
                        {
                            "facility": "IWK Health Centre",
                            "city": "Halifax",
                            "state": "Nova Scotia",
                            "zip": "B3K 6R8",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 44.64533,
                                "lon": -63.57239
                            }
                        },
                        {
                            "facility": "McMaster University",
                            "city": "Hamilton",
                            "state": "Ontario",
                            "zip": "L9H 1V1",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 43.25011,
                                "lon": -79.84963
                            }
                        },
                        {
                            "facility": "Kingston General Hospital",
                            "city": "Kingston",
                            "state": "Ontario",
                            "zip": "K7L 2V7",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 44.22976,
                                "lon": -76.48101
                            }
                        },
                        {
                            "facility": "St Joseph's Health Care",
                            "city": "London",
                            "state": "Ontario",
                            "zip": "N6A 4V2",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 42.98339,
                                "lon": -81.23304
                            }
                        },
                        {
                            "facility": "The Ottawa Hospital",
                            "city": "Ottawa",
                            "state": "Ontario",
                            "zip": "K1H 7W9",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 45.41117,
                                "lon": -75.69812
                            }
                        },
                        {
                            "facility": "Sunnybrook Health Sciences Centre",
                            "city": "Toronto",
                            "state": "Ontario",
                            "zip": "M4N 3M5",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 43.70011,
                                "lon": -79.4163
                            }
                        },
                        {
                            "facility": "Mount Sinai Hospital",
                            "city": "Toronto",
                            "state": "Ontario",
                            "zip": "M5G 1X5",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 43.70011,
                                "lon": -79.4163
                            }
                        },
                        {
                            "facility": "St-Luc Hospital- Centre hospitalier de L'Universite de Montreal",
                            "city": "Montreal",
                            "state": "Quebec",
                            "zip": "H2X 3J4",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 45.50884,
                                "lon": -73.58781
                            }
                        },
                        {
                            "facility": "Chuq-Chul",
                            "city": "Quebec City",
                            "state": "Quebec",
                            "zip": "G1V 4G2",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 46.81228,
                                "lon": -71.21454
                            }
                        },
                        {
                            "facility": "Royal University Saskatoon",
                            "city": "Saskatoon",
                            "state": "Saskatchewan",
                            "zip": "S7N 0W8",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 52.13238,
                                "lon": -106.66892
                            }
                        },
                        {
                            "facility": "Galway University Hospital",
                            "city": "Galway",
                            "country": "Ireland",
                            "geoPoint": {
                                "lat": 53.27194,
                                "lon": -9.04889
                            }
                        },
                        {
                            "facility": "Niguarda Ca' Granda Hospital",
                            "city": "Milan",
                            "zip": "20162",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 45.46427,
                                "lon": 9.18951
                            }
                        },
                        {
                            "facility": "Hospital De La Santa Creu I Sant Pau",
                            "city": "Barcelona",
                            "zip": "08025",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 41.38879,
                                "lon": 2.15899
                            }
                        },
                        {
                            "facility": "University of Aberdeen",
                            "city": "Aberdeen",
                            "state": "Scotland",
                            "zip": "AB25 2ZP",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 57.14369,
                                "lon": -2.09814
                            }
                        },
                        {
                            "facility": "Royal Infirmary of Edinburgh",
                            "city": "Edinburgh",
                            "state": "Scotland",
                            "zip": "EH16 4TJ",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 55.95206,
                                "lon": -3.19648
                            }
                        },
                        {
                            "facility": "Glasgow Royal Infirmary",
                            "city": "Glasgow",
                            "state": "Scotland",
                            "zip": "G31 2ER",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 55.86515,
                                "lon": -4.25763
                            }
                        },
                        {
                            "facility": "Russells Hall Hospital",
                            "city": "Dudley",
                            "state": "West Midlands",
                            "zip": "DY1 2HQ",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 52.5,
                                "lon": -2.08333
                            }
                        },
                        {
                            "facility": "Addenbrooke's Hospital",
                            "city": "Cambridge",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 52.2,
                                "lon": 0.11667
                            }
                        },
                        {
                            "facility": "Ipswich Hospital NHS Trust",
                            "city": "Ipswich",
                            "zip": "IP4 5PD",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 52.05917,
                                "lon": 1.15545
                            }
                        },
                        {
                            "facility": "St James University Hospital",
                            "city": "Leeds",
                            "zip": "LS9 7TF",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 53.79648,
                                "lon": -1.54785
                            }
                        },
                        {
                            "facility": "Guys & St. Thomas'",
                            "city": "London",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 51.50853,
                                "lon": -0.12574
                            }
                        },
                        {
                            "facility": "Kings College Hospital",
                            "city": "London",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 51.50853,
                                "lon": -0.12574
                            }
                        },
                        {
                            "facility": "Manchester University Hospital NHS Trust",
                            "city": "Manchester",
                            "zip": "M139WL",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 53.48095,
                                "lon": -2.23743
                            }
                        },
                        {
                            "facility": "South Tees Hospital NHS Trust",
                            "city": "Middlesbrough",
                            "zip": "TS4 3BW",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 54.57623,
                                "lon": -1.23483
                            }
                        },
                        {
                            "facility": "Royal Victoria Infirmary",
                            "city": "Newcastle",
                            "zip": "NE1 4EP",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 54.97328,
                                "lon": -1.61396
                            }
                        },
                        {
                            "facility": "Norfolk and Norwich University Hospital",
                            "city": "Norwich",
                            "zip": "NR4 7UY",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 52.62783,
                                "lon": 1.29834
                            }
                        },
                        {
                            "facility": "Queen's Medical Centre",
                            "city": "Nottingham",
                            "zip": "NG72UH",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 52.9536,
                                "lon": -1.15047
                            }
                        },
                        {
                            "facility": "Sheffield Teaching Hospitals",
                            "city": "Sheffield",
                            "zip": "S10 2RX",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 53.38297,
                                "lon": -1.4659
                            }
                        },
                        {
                            "facility": "Princess Anne Hospital",
                            "city": "Southampton",
                            "zip": "SO16 6YD",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 50.90395,
                                "lon": -1.40428
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "34088734",
                            "type": "DERIVED",
                            "citation": "Ahmed RJ, Gafni A, Hutton EK, Hu ZJ, Sanchez JJ, Murphy HR, Feig DS; CONCEPTT Collaborative Group. The cost implications of continuous glucose monitoring in pregnant women with type 1 diabetes in 3 Canadian provinces: a posthoc cost analysis of the CONCEPTT trial. CMAJ Open. 2021 Jun 4;9(2):E627-E634. doi: 10.9778/cmajo.20200128. Print 2021 Apr-Jun."
                        },
                        {
                            "pmid": "33945304",
                            "type": "DERIVED",
                            "citation": "Tundidor D, Meek CL, Yamamoto J, Martinez-Bru C, Gich I, Feig DS, Murphy HR, Corcoy R; CONCEPTT Collaborative Group. Continuous Glucose Monitoring Time-in-Range and HbA1c Targets in Pregnant Women with Type 1 Diabetes. Diabetes Technol Ther. 2021 Oct;23(10):710-714. doi: 10.1089/dia.2021.0073. Epub 2021 May 25."
                        },
                        {
                            "pmid": "33514342",
                            "type": "DERIVED",
                            "citation": "Meek CL, Corcoy R, Asztalos E, Kusinski LC, Lopez E, Feig DS, Murphy HR; CONCEPTT collaborative group. Which growth standards should be used to identify large- and small-for-gestational age infants of mothers with type 1 diabetes? A pre-specified analysis of the CONCEPTT trial. BMC Pregnancy Childbirth. 2021 Jan 29;21(1):96. doi: 10.1186/s12884-021-03554-6."
                        },
                        {
                            "pmid": "33495292",
                            "type": "DERIVED",
                            "citation": "Meek CL, Tundidor D, Feig DS, Yamamoto JM, Scott EM, Ma DD, Halperin JA, Murphy HR, Corcoy R; CONCEPTT Collaborative Group. Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 Diabetes. Diabetes Care. 2021 Mar;44(3):681-689. doi: 10.2337/dc20-2360. Epub 2021 Jan 25."
                        },
                        {
                            "pmid": "31694860",
                            "type": "DERIVED",
                            "citation": "Neoh SL, Yamamoto JM, Feig DS, Murphy HR; CONCEPTT Collaborative Group. Dietary Patterns of Insulin Pump and Multiple Daily Injection Users During Type 1 Diabetes Pregnancy. Diabetes Care. 2020 Jan;43(1):e5-e7. doi: 10.2337/dc19-1908. Epub 2019 Nov 6. No abstract available."
                        },
                        {
                            "pmid": "28923465",
                            "type": "DERIVED",
                            "citation": "Feig DS, Donovan LE, Corcoy R, Murphy KE, Amiel SA, Hunt KF, Asztalos E, Barrett JFR, Sanchez JJ, de Leiva A, Hod M, Jovanovic L, Keely E, McManus R, Hutton EK, Meek CL, Stewart ZA, Wysocki T, O'Brien R, Ruedy K, Kollman C, Tomlinson G, Murphy HR; CONCEPTT Collaborative Group. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017 Nov 25;390(10110):2347-2359. doi: 10.1016/S0140-6736(17)32400-5. Epub 2017 Sep 15. Erratum In: Lancet. 2017 Nov 25;390(10110):2346. doi: 10.1016/S0140-6736(17)32712-5."
                        },
                        {
                            "pmid": "27430714",
                            "type": "DERIVED",
                            "citation": "Feig DS, Asztalos E, Corcoy R, De Leiva A, Donovan L, Hod M, Jovanovic L, Keely E, Kollman C, McManus R, Murphy K, Ruedy K, Sanchez JJ, Tomlinson G, Murphy HR; CONCEPTT Collaborative Group. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol. BMC Pregnancy Childbirth. 2016 Jul 18;16(1):167. doi: 10.1186/s12884-016-0961-5."
                        }
                    ],
                    "seeAlsoLinks": [
                        {
                            "label": "Related Info",
                            "url": "http://conceptt.ca"
                        }
                    ]
                }
            },
            "annotationSection": {
                "annotationModule": {
                    "unpostedAnnotation": {
                        "unpostedResponsibleParty": "Mount Sinai Hospital, Canada",
                        "unpostedEvents": [
                            {
                                "type": "RELEASE",
                                "date": "2020-05-06"
                            },
                            {
                                "type": "RESET",
                                "date": "2020-05-28"
                            },
                            {
                                "type": "RELEASE",
                                "date": "2020-11-18"
                            },
                            {
                                "type": "RESET",
                                "date": "2020-12-11"
                            }
                        ]
                    }
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2025-05-07",
                    "removedCountries": [
                        "Israel"
                    ],
                    "submissionTracking": {
                        "estimatedResultsFirstSubmitDate": "2020-05-06",
                        "submissionInfos": [
                            {
                                "releaseDate": "2020-05-06",
                                "resetDate": "2020-05-28"
                            },
                            {
                                "releaseDate": "2020-11-18",
                                "resetDate": "2020-12-11"
                            }
                        ]
                    }
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D011254",
                            "term": "Pregnancy in Diabetics"
                        },
                        {
                            "id": "D016640",
                            "term": "Diabetes, Gestational"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D003920",
                            "term": "Diabetes Mellitus"
                        },
                        {
                            "id": "D044882",
                            "term": "Glucose Metabolism Disorders"
                        },
                        {
                            "id": "D008659",
                            "term": "Metabolic Diseases"
                        },
                        {
                            "id": "D004700",
                            "term": "Endocrine System Diseases"
                        },
                        {
                            "id": "D011248",
                            "term": "Pregnancy Complications"
                        },
                        {
                            "id": "D005261",
                            "term": "Female Urogenital Diseases and Pregnancy Complications"
                        },
                        {
                            "id": "D000091642",
                            "term": "Urogenital Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M7115",
                            "name": "Diabetes Mellitus",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M19012",
                            "name": "Diabetes, Gestational",
                            "asFound": "Diabetes in Pregnancy",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M14133",
                            "name": "Pregnancy in Diabetics",
                            "asFound": "Diabetes in Pregnancy",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M7117",
                            "name": "Diabetes Mellitus, Type 1",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M11639",
                            "name": "Metabolic Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M25403",
                            "name": "Glucose Metabolism Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7862",
                            "name": "Endocrine System Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14127",
                            "name": "Pregnancy Complications",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M2875",
                            "name": "Urogenital Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M27093",
                            "name": "Female Urogenital Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8399",
                            "name": "Female Urogenital Diseases and Pregnancy Complications",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC18",
                            "name": "Nutritional and Metabolic Diseases"
                        },
                        {
                            "abbrev": "BC19",
                            "name": "Gland and Hormone Related Diseases"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BXS",
                            "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                        },
                        {
                            "abbrev": "BC20",
                            "name": "Immune System Diseases"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT06939673",
                    "orgStudyIdInfo": {
                        "id": "REPRISE001"
                    },
                    "secondaryIdInfos": [
                        {
                            "id": "20240306",
                            "type": "OTHER",
                            "domain": "WCG IRB"
                        }
                    ],
                    "organization": {
                        "fullName": "Reprise Biomedical, Inc.",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care",
                    "officialTitle": "A Clinical Study of Reprise Biomedical's Miro3D Wound Matrix in the Outpatient Management of Wounds and Ulcerations"
                },
                "statusModule": {
                    "statusVerifiedDate": "2025-04",
                    "overallStatus": "RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2024-02-29",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2025-12-31",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2025-12-31",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2025-04-15",
                    "studyFirstSubmitQcDate": "2025-04-15",
                    "studyFirstPostDateStruct": {
                        "date": "2025-04-23",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2025-04-15",
                    "lastUpdatePostDateStruct": {
                        "date": "2025-04-23",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Reprise Biomedical, Inc.",
                        "class": "INDUSTRY"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": false,
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": true,
                    "isUsExport": false
                },
                "descriptionModule": {
                    "briefSummary": "This clinical study is being conducted to evaluate how well the Miro3D Wound Matrix helps heal difficult wounds and ulcerations in an outpatient care setting. Miro3D is a biologic wound dressing made from porcine (pig) liver tissue. It is processed to remove all cells, creating a clean scaffold that can support the body's natural healing process. The goal of this study is to see how effective Miro3D is when used alongside standard wound care for helping wounds close and reducing pain and discomfort.\n\nThe study is designed as a post-market, proof-of-concept trial, meaning the product is already commercially available, and researchers are evaluating how it works in real-world clinical settings. A total of up to 20 adult participants will be enrolled. Participants may have wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, or surgical wound dehiscence. These wounds may be complex in nature, including tunneling or undermining, which often makes them more difficult to treat.\n\nParticipants will receive standard wound care along with weekly Miro3D applications for the first 4 weeks. If the wound is not fully healed after 4 weeks, Miro3D will then be applied every 2 weeks until healing is achieved or up to 12 weeks total. Throughout the study, participants will return weekly for wound assessments and to complete brief questionnaires about their pain levels and quality of life.\n\nThe main goals of the study are:\n\n1. To measure how much the wound size shrinks (known as percent area reduction or PAR).\n2. To evaluate how much healthy granulation tissue (new tissue) forms in the wound.\n3. To compare healing outcomes when Miro3D is used weekly versus every two weeks.\n4. To understand how the treatment affects patients' quality of life, including pain, mobility, and emotional wellbeing.\n\nEach participant will be closely monitored by the clinical team throughout the 12-week study period. If a wound heals earlier, the participant will finish the study at that time. If the wound does not heal, the participant may return to their regular physician for follow-up care.",
                    "detailedDescription": "This clinical study is a prospective, post-market, proof-of-concept trial evaluating the safety and effectiveness of Miro3D Wound Matrix, a biologically derived, acellular scaffold developed by Reprise Biomedical, in the outpatient treatment of complex wounds and ulcerations. Miro3D is made from porcine liver tissue and processed to retain a porous, three-dimensional structure that provides a supportive environment for tissue regeneration.\n\nThe study investigates Miro3D's real-world impact on wound healing in adult subjects presenting with chronic or complex wounds, including but not limited to diabetic foot ulcers (DFUs), pressure ulcers, venous leg ulcers (VLUs), and surgical wound dehiscence (SWD). These types of wounds are often difficult to treat, particularly when they exhibit features like tunneling or undermining. The matrix is applied in conjunction with standard of care (SOC) therapies such as cleansing, offloading, compression, debridement, and the use of secondary dressings.\n\nUp to 20 adult participants will be enrolled at outpatient clinical sites under the supervision of a principal investigator. The study includes both a screening phase and a 12-week treatment phase. There is no run-in or washout period. Eligible subjects are identified based on criteria including wound size (1-40 cm²), duration, location, vascular perfusion, and willingness to adhere to follow-up and offloading instructions. Subjects with third-degree burns, active untreated osteomyelitis, malignancy, or known porcine allergy, among other conditions, are excluded.\n\nEach subject will receive Miro3D applied weekly for the first four weeks. If healing has not occurred at that point, Miro3D is reapplied every two weeks for up to twelve weeks or until the wound is fully closed. Wound healing is assessed weekly through manual measurements, photographs, and depth probing. The primary study endpoint is percentage area reduction (PAR) and granulation tissue formation at 4 and 12 weeks.\n\nSecondary endpoints include changes from baseline in patient-reported quality of life (QOL) using the Wound-QOL questionnaire, and pain intensity assessed using a visual analog scale (VAS). These questionnaires are completed weekly to gauge the impact of treatment on physical function, emotional wellbeing, pain, odor, and social engagement. In the event of premature withdrawal, efforts are made to gather final QOL and pain assessments.\n\nSubjects attend weekly study visits and may be seen for additional unscheduled visits at the investigator's discretion (e.g., for dressing changes). If the wound heals before 12 weeks, the subject exits the study. If the wound remains open, the subject exits after the final assessment and may return to their standard treating provider.\n\nThe study also closely monitors adverse events (AEs), serious adverse events (SAEs), and unanticipated adverse device effects (UADEs). Investigators assess each event's relationship to the study product and report them to the sponsor and IRB as required. All safety data are collected throughout the study and monitored by the study team and sponsor.\n\nThe data collected include subject demographics, medical and surgical history, wound type and size, infection status, tissue characteristics, exudate volume, and treatment regimen. These data are documented in source documents and transcribed into study-specific Case Report Forms (CRFs). Statistical analysis will be performed using summary statistics to evaluate wound closure rates, healing trajectories, and possible correlations between treatment schedule and healing outcomes.\n\nAs a post-market study, this trial does not require an Investigational Device Exemption (IDE) and is conducted in compliance with Good Clinical Practice (GCP), the Health Insurance Portability and Accountability Act (HIPAA), and FDA guidelines. It has been approved by an Institutional Review Board (IRB), and informed consent is required from all participants prior to enrollment.\n\nBy evaluating Miro3D in real-world outpatient conditions, this study aims to provide evidence on its ability to promote healing in challenging wounds. The findings may help guide future treatment approaches and inform larger clinical trials focused on specific wound types."
                },
                "conditionsModule": {
                    "conditions": [
                        "Diabetic Foot Ulcers (DFUs)",
                        "Venous Leg Ulcers (VLUs)",
                        "Pressure Ulcers",
                        "Surgical Wound Dehiscence (SWD)",
                        "Chronic Wounds",
                        "Undermined and Tunneling Wounds"
                    ],
                    "keywords": [
                        "Miro3D Wound Matrix",
                        "Acellular Wound Matrix",
                        "Porcine-Derived Scaffold",
                        "Chronic Wound Healing",
                        "Diabetic Foot Ulcer Treatment",
                        "Pressure Ulcer Management",
                        "Surgical Wound Dehiscence Therapy",
                        "Venous Leg Ulcer Treatment",
                        "Tunneling and Undermining Wounds",
                        "Complex Wound Management",
                        "Reprise Biomedical"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "NA"
                    ],
                    "designInfo": {
                        "allocation": "NA",
                        "interventionModel": "SINGLE_GROUP",
                        "interventionModelDescription": "All enrolled participants will receive the same intervention: Miro3D Wound Matrix plus standard of care (SOC). There is no comparator or control arm. The study follows a single-arm, prospective design.",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 20,
                        "type": "ESTIMATED"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Miro3D Wound Matrix plus Standard of Care (SOC)",
                            "type": "EXPERIMENTAL",
                            "description": "Participants in this single-arm study will receive Miro3D Wound Matrix in addition to standard wound care procedures. Miro3D is applied directly to the debrided wound bed. It will be applied once every 7 days for the first 4 weeks. If the wound has not closed by then, Miro3D will be applied every 14 days through week 12 or until wound closure, whichever comes first. Standard care includes debridement, dressing changes, offloading and/or compression, and infection management as needed. Weekly evaluations are performed to track healing progress.",
                            "interventionNames": [
                                "Device: Acellular Porcine-Derived Wound Matrix"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DEVICE",
                            "name": "Acellular Porcine-Derived Wound Matrix",
                            "description": "This intervention is a sterile, acellular, three-dimensional biologic scaffold derived from porcine liver tissue using a proprietary perfusion decellularization and drying process. It retains the native extracellular matrix structure and supports tissue granulation and healing in complex wounds. Miro3D is applied topically to the debrided wound bed and rehydrated prior to use. It is indicated for use in a range of chronic and complex wounds, including diabetic foot ulcers, venous leg ulcers, pressure injuries, and surgical dehiscence. In this study, it is administered in an outpatient setting alongside standard of care treatments.",
                            "armGroupLabels": [
                                "Miro3D Wound Matrix plus Standard of Care (SOC)"
                            ],
                            "otherNames": [
                                "Miro3D Wound Matrix"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Percent Area Reduction (PAR) and Granulation Tissue Formation at 4 and 12 Weeks",
                            "description": "The primary outcome is the measurement of the wound or ulcer's percent area reduction (PAR) and granulation tissue formation at week 4 and week 12. This is used to evaluate healing progression and the effectiveness of Miro3D. Measurements are taken using a ruler for length and width, and a probe for depth. Granulation is assessed visually by the clinical team.",
                            "timeFrame": "4 weeks and 12 weeks post-initial treatment"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Change in Quality of Life (QOL) Using Wound-QOL Instrument",
                            "description": "Subject-reported QOL will be assessed at each visit using the Wound-QOL questionnaire. This tool evaluates the impact of the wound on domains such as pain, odor, physical functioning, mobility, emotional wellbeing, and social isolation.",
                            "timeFrame": "Baseline and weekly through 12 weeks or until wound closure"
                        },
                        {
                            "measure": "Change in Pain Levels Using Visual Analog Scale (VAS)",
                            "description": "Pain intensity is assessed weekly using a 0-10 VAS, where 0 represents no pain and 10 represents the worst possible pain.",
                            "timeFrame": "Baseline and weekly through 12 weeks or until wound closure"
                        }
                    ],
                    "otherOutcomes": [
                        {
                            "measure": "Safety and Tolerability: Adverse Events (AEs), Serious Adverse Events (SAEs), and Unanticipated Adverse Device Effects (UADEs)",
                            "description": "The frequency and severity of adverse events, including product-related effects such as inflammation, irritation, or infection, will be recorded. Events will be assessed for seriousness, expectedness, and relatedness to the investigational product.",
                            "timeFrame": "From informed consent through 30 days after final study visit"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age 18 or older and able to provide informed consent.\n2. Has an open wound or ulceration, preferably with tunneling or undermining.\n3. If multiple wounds/ulcerations are present, only one will be selected for Miro3D treatment.\n4. Other wounds must be ≥2 cm away from the study wound.\n5. Wound should be debrided with a clinical goal of healing, even if some infection remains.\n6. Previous infections must be adequately treated and controlled (per IDSA guidelines).\n7. Willing and able to comply with offloading and/or compression requirements.\n8. Must have a stable living environment for wound care adherence.\n9. Study wound must have a clean base free of devitalized tissue or debris at the time of Miro3D placement.\n10. Provides consent for digital photo documentation.\n\nExclusion Criteria:\n\n1. Active, untreated osteomyelitis.\n2. Malignancy or vasculitis at the wound site.\n3. Undergoing chemotherapy.\n4. On dialysis.\n5. Use of investigational drugs or therapies within 30 days before screening.\n6. Conditions that significantly impair study adherence or known history of medical non-compliance.\n7. Known sensitivity to porcine materials.\n8. Third-degree burns.\n9. Worsening ischemia or gangrene at screening.\n10. Prior radiation to the study wound site.\n11. Exposed hardware, implants, or fixation devices in the study wound.\n12. Receiving palliative or comfort care.",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "centralContacts": [
                        {
                            "name": "Maria Swartz",
                            "role": "CONTACT",
                            "phone": "954-721-4806",
                            "email": "mswartz@barry.edu"
                        }
                    ],
                    "overallOfficials": [
                        {
                            "name": "Robert J. Snyder, DPM",
                            "affiliation": "Barry University",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Barry University Clinical Research",
                            "status": "RECRUITING",
                            "city": "Tamarac",
                            "state": "Florida",
                            "zip": "33321",
                            "country": "United States",
                            "contacts": [
                                {
                                    "name": "Maria Swartz",
                                    "role": "CONTACT",
                                    "phone": "954-721-4806",
                                    "email": "mswartz@barry.edu"
                                },
                                {
                                    "name": "Robert J. Snyder, DPM",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 26.21286,
                                "lon": -80.24977
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "23817703",
                            "type": "BACKGROUND",
                            "citation": "Smith ME, Totten A, Hickam DH, Fu R, Wasson N, Rahman B, Motu'apuaka M, Saha S. Pressure ulcer treatment strategies: a systematic comparative effectiveness review. Ann Intern Med. 2013 Jul 2;159(1):39-50. doi: 10.7326/0003-4819-159-1-201307020-00007."
                        },
                        {
                            "pmid": "29344337",
                            "type": "BACKGROUND",
                            "citation": "Raghav A, Khan ZA, Labala RK, Ahmad J, Noor S, Mishra BK. Financial burden of diabetic foot ulcers to world: a progressive topic to discuss always. Ther Adv Endocrinol Metab. 2018 Jan;9(1):29-31. doi: 10.1177/2042018817744513. Epub 2017 Dec 12."
                        },
                        {
                            "pmid": "30693644",
                            "type": "BACKGROUND",
                            "citation": "Padula WV, Delarmente BA. The national cost of hospital-acquired pressure injuries in the United States. Int Wound J. 2019 Jun;16(3):634-640. doi: 10.1111/iwj.13071. Epub 2019 Jan 28."
                        },
                        {
                            "pmid": "30664905",
                            "type": "BACKGROUND",
                            "citation": "Mervis JS, Phillips TJ. Pressure ulcers: Pathophysiology, epidemiology, risk factors, and presentation. J Am Acad Dermatol. 2019 Oct;81(4):881-890. doi: 10.1016/j.jaad.2018.12.069. Epub 2019 Jan 18."
                        },
                        {
                            "pmid": "24090179",
                            "type": "BACKGROUND",
                            "citation": "Kruger EA, Pires M, Ngann Y, Sterling M, Rubayi S. Comprehensive management of pressure ulcers in spinal cord injury: current concepts and future trends. J Spinal Cord Med. 2013 Nov;36(6):572-85. doi: 10.1179/2045772313Y.0000000093. Epub 2013 May 21."
                        },
                        {
                            "type": "BACKGROUND",
                            "citation": "Geriatric Medicine Gerontology Chapter 30 - Pressure Ulcers. (n.d.). Retrieved from Johns Hopkins: https://www.hopkinsmedicine.org/geriatric_medicine_gerontology/_downloads/readings/section8.pdf"
                        },
                        {
                            "pmid": "27861135",
                            "type": "BACKGROUND",
                            "citation": "Bauer K, Rock K, Nazzal M, Jones O, Qu W. Pressure Ulcers in the United States' Inpatient Population From 2008 to 2012: Results of a Retrospective Nationwide Study. Ostomy Wound Manage. 2016 Nov;62(11):30-38."
                        }
                    ],
                    "seeAlsoLinks": [
                        {
                            "label": "Miro3D Wound Matrix product webpage",
                            "url": "https://reprisebio.com/miro3d/"
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO"
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2025-05-07"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D017719",
                            "term": "Diabetic Foot"
                        },
                        {
                            "id": "D014647",
                            "term": "Varicose Ulcer"
                        },
                        {
                            "id": "D016523",
                            "term": "Foot Ulcer"
                        },
                        {
                            "id": "D007871",
                            "term": "Leg Ulcer"
                        },
                        {
                            "id": "D003668",
                            "term": "Pressure Ulcer"
                        },
                        {
                            "id": "D014456",
                            "term": "Ulcer"
                        },
                        {
                            "id": "D013529",
                            "term": "Surgical Wound Dehiscence"
                        },
                        {
                            "id": "D014947",
                            "term": "Wounds and Injuries"
                        },
                        {
                            "id": "D000072836",
                            "term": "Surgical Wound"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D010335",
                            "term": "Pathologic Processes"
                        },
                        {
                            "id": "D003925",
                            "term": "Diabetic Angiopathies"
                        },
                        {
                            "id": "D014652",
                            "term": "Vascular Diseases"
                        },
                        {
                            "id": "D002318",
                            "term": "Cardiovascular Diseases"
                        },
                        {
                            "id": "D012883",
                            "term": "Skin Ulcer"
                        },
                        {
                            "id": "D012871",
                            "term": "Skin Diseases"
                        },
                        {
                            "id": "D048909",
                            "term": "Diabetes Complications"
                        },
                        {
                            "id": "D003920",
                            "term": "Diabetes Mellitus"
                        },
                        {
                            "id": "D004700",
                            "term": "Endocrine System Diseases"
                        },
                        {
                            "id": "D003929",
                            "term": "Diabetic Neuropathies"
                        },
                        {
                            "id": "D005534",
                            "term": "Foot Diseases"
                        },
                        {
                            "id": "D014648",
                            "term": "Varicose Veins"
                        },
                        {
                            "id": "D011183",
                            "term": "Postoperative Complications"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M17206",
                            "name": "Ulcer",
                            "asFound": "Ulcer",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M17685",
                            "name": "Wounds and Injuries",
                            "asFound": "Wound",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M6870",
                            "name": "Pressure Ulcer",
                            "asFound": "Pressure Ulcer",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M19933",
                            "name": "Diabetic Foot",
                            "asFound": "Diabetic Foot",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M18919",
                            "name": "Foot Ulcer",
                            "asFound": "Foot Ulcer",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M1112",
                            "name": "Surgical Wound",
                            "asFound": "Surgical Wound",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M10883",
                            "name": "Leg Ulcer",
                            "asFound": "Leg Ulcers",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M17395",
                            "name": "Varicose Ulcer",
                            "asFound": "Venous Leg Ulcers",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M16309",
                            "name": "Surgical Wound Dehiscence",
                            "asFound": "Surgical Wound Dehiscence",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M7120",
                            "name": "Diabetic Angiopathies",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17400",
                            "name": "Vascular Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M15686",
                            "name": "Skin Ulcer",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M15674",
                            "name": "Skin Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7115",
                            "name": "Diabetes Mellitus",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M26004",
                            "name": "Diabetes Complications",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7862",
                            "name": "Endocrine System Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7124",
                            "name": "Diabetic Neuropathies",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8658",
                            "name": "Foot Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17396",
                            "name": "Varicose Veins",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14065",
                            "name": "Postoperative Complications",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T1303",
                            "name": "Chronic Graft Versus Host Disease",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC26",
                            "name": "Wounds and Injuries"
                        },
                        {
                            "abbrev": "BC17",
                            "name": "Skin and Connective Tissue Diseases"
                        },
                        {
                            "abbrev": "BC14",
                            "name": "Heart and Blood Diseases"
                        },
                        {
                            "abbrev": "BC19",
                            "name": "Gland and Hormone Related Diseases"
                        },
                        {
                            "abbrev": "BC18",
                            "name": "Nutritional and Metabolic Diseases"
                        },
                        {
                            "abbrev": "BC10",
                            "name": "Nervous System Diseases"
                        },
                        {
                            "abbrev": "BC05",
                            "name": "Musculoskeletal Diseases"
                        },
                        {
                            "abbrev": "Rare",
                            "name": "Rare Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "browseLeaves": [
                        {
                            "id": "M11110",
                            "name": "Liver Extracts",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "Hemat",
                            "name": "Hematinics"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        }
                    ]
                }
            },
            "hasResults": false
        }
    ],
    "nextPageToken": "NF0g5JGOk_A"
}